Technology Platforms for Transforming Complex Biological Studies by Marasco, Christina C
TECHNOLOGY PLATFORMS FOR TRANSFORMING COMPLEX BIOLOGICAL STUDIES 
By 
Christina C. Marasco 
 
Dissertation 
Submitted to the Faculty of the  
Graduate School of Vanderbilt University  
in partial fulfillment of the requirements  
for the degree of 
DOCTOR OF PHILOSOPHY 
in 
Biomedical Engineering 
August, 2012 
Nashville, Tennessee 
 
Approved: 
Professor John P. Wikswo 
Professor Kevin T. Seale 
Professor John A. McLean 
Professor David E. Cliffel 
Professor Hak-Joon Sung 
Professor Danny G. Winder 
 
  
ii 
 
 
 
 
 
 
 
 
 
 
In memory of Ben Liesch and Dean Paras 
Without loss, we would lack the drive to save. 
  
iii 
ACKNOWLEDGEMENTS 
 
 This work has been financially supported by the Defense Threat Reduction Agency 
(DTRA), the National Institute on Drug Abuse (NIDA), the Searle Systems Biology and 
Bioengineering Undergraduate Research Experience (SyBBURE-Searle), and the Vanderbilt 
Institute for Integrative Biosystems Research and Education (VIIBRE).  
 The work herein represents a highly collaborative multidisciplinary, inter-institutional 
research effort that spans the work of undergraduate students, graduate students, staff 
scientists and engineers, research associates, and faculty from Vanderbilt University, Duke 
University, and Cornell University. An exhaustive list of contributors and their affiliations can be 
found in Appendix A. I am overwhelmingly appreciative for all of their efforts, though this is not 
a sufficient display of gratitude for all of their indispensible work. I particularly thank Jeff Enders 
and Cody Goodwin for their sizeable contributions to this body of work, for their friendship, for 
their commiseration, and for their humor. To the many SyBBURE students who have endured 
working alongside me, burdened by my lofty expectations; I thank you for your hard work, for 
talking through problems, and for quitting on me or graduating when I needed you, forcing me 
to come to terms with my lack of knowledge. These projects also could not have been 
completed without the support and expertise of the VIIBRE scientists, engineers, and support 
staff. The opportunity to participate in this research was afforded to me at critical time in my 
graduate career and without it I would not have achieved this goal. I sincerely thank Kevin Seale, 
John Wikswo and John McLean for allowing me to work with SyBBURE and on these projects. 
Your continued support has and will continue to be appreciated on many levels. 
 Finally, I wish to acknowledge those who have supported this eight-year journey. I will 
show you my gratitude through my renewed presence in your lives.  
iv 
TABLE OF CONTENTS 
 
Page 
ACKNOWLEDGEMENTS .............................................................................................................. III 
LIST OF TABLES ......................................................................................................................... VII 
LIST OF FIGURES....................................................................................................................... VIII 
CHAPTER I ................................................................................................................................... 1 
1 INTRODUCTION .............................................................................................................. 1 
1.1 Objective ........................................................................................................... 1 
1.2 Specific Aims ...................................................................................................... 2 
1.2.1 Specific Aim 1 ........................................................................................ 2 
1.2.2 Specific Aim 2 ........................................................................................ 3 
1.3 Technology Innovation, Background and Significance......................................... 3 
1.3.1 Microfluidics for the Study of Cellular Response .................................... 3 
1.3.2 Mass Spectrometry for Cell State Assessment ..................................... 11 
1.3.3 Combining Microfluidics with Mass Spectrometry ............................... 14 
1.3.4 Computational Modeling of Complex Biological Systems ..................... 15 
1.3.5 Systems Biology Approach for Automated Science .............................. 17 
1.3.6 Summary ............................................................................................. 18 
1.4 Biological Background and Significance ............................................................ 19 
1.4.1 Cocaine Effects .................................................................................... 19 
1.5 References ....................................................................................................... 41 
CHAPTER II ................................................................................................................................ 60 
2 REAL-TIME CELLULAR EXOMETABOLOME ANALYSIS WITH A ......................................... 60 
MICROFLUIDIC-MASS SPECTROMETRY PLATFORM ................................................................ 60 
2.1 Abstract ........................................................................................................... 61 
2.2 Introduction ..................................................................................................... 62 
2.3 Methods .......................................................................................................... 69 
2.3.1 Microfluidic Bioreactor Design and Fabrication .................................... 69 
2.3.2 PDMS Surface Modification ................................................................. 69 
2.3.3 Cell Culture and “In Culture” Cocaine Exposure ................................... 72 
2.3.4 Metabolomics Sample Preparation and UPLC-ESI-IM-MS Analysis ....... 73 
2.3.5 Online Cell Loading and Experimentation ............................................ 74 
2.3.6 Solid Phase Extraction Desalter............................................................ 75 
2.3.7 Online Cell Effluent Desalting and Mass Spectrometry Analysis ........... 77 
2.3.8 Data Processing and Multivariate Statistical Analysis ........................... 78 
2.4 Results and Discussion ..................................................................................... 78 
2.4.1 Platform Integration and Evaluation .................................................... 78 
2.4.2 Cocaine Metabolism in Naïve and Experienced T cells ......................... 84 
2.5 Conclusions...................................................................................................... 90 
2.5.1 Platform Capabilities and Shortcomings .............................................. 90 
v 
2.5.2 Cellular Memory of Cocaine Experience............................................... 92 
2.6 References ....................................................................................................... 94 
CHAPTER III ............................................................................................................................... 97 
3 PROGRESS TOWARDS A HETERODYNE FRAMEWORK FOR THE GENERATION AND 
DETECTION OF OSCILLATORY CHEMICAL SIGNALS IN NONLINEAR LIGHT-PRODUCING SYSTEMS
 97 
3.1 Abstract ........................................................................................................... 98 
3.2 Introduction ..................................................................................................... 99 
3.3 Heterodyne Chemistry Theory ....................................................................... 100 
3.3.1 Heterodyne Models of Nonlinear Reactions....................................... 103 
3.4 Development of Hardware and Data Analysis Methods for Heterodyne 
Chemistry ................................................................................................................... 110 
3.4.1 Sinusoidal Concentration Generation ................................................ 111 
3.4.2 Chemical Signal mixing with a Microfluidic Reactor............................ 123 
3.4.3 Detection of Light as Reaction Products ............................................. 123 
3.4.4 Fourier Transform Analysis ................................................................ 128 
3.5 Nonlinear Chemical Reaction Exploration ....................................................... 129 
3.5.1 Fluorescence Quenching.................................................................... 129 
3.5.2 Peroxyoxalate Chemiluminescence.................................................... 137 
3.6 Summary, Pitfalls, and Problems .................................................................... 146 
3.7 Future Solutions............................................................................................. 150 
3.8 References ..................................................................................................... 152 
CHAPTER IV ............................................................................................................................. 156 
4 SUMMARY, FUTURE WORK AND ETHICAL IMPACT ...................................................... 156 
4.1 MF-SPE-nESI-IM-MS ....................................................................................... 157 
4.1.1 Microfluidic Device Design and Control ............................................. 158 
4.1.2 Online Desalting ................................................................................ 158 
4.1.3 Data Analysis ..................................................................................... 160 
4.1.4 MTNP-SPE-nESI-IM-MS ...................................................................... 161 
4.2 Heterodyne Framework ................................................................................. 162 
4.2.1 Sinusoidal Concentration Generation ................................................ 163 
4.2.2 Upstream Chemical Signal Mixing ...................................................... 165 
4.2.3 Downstream Chemical Signal Detection ............................................ 166 
4.2.4 Data Analysis Techniques .................................................................. 166 
4.2.5 Modeling Heterodyne Chemistry ....................................................... 167 
4.2.6 Probing Biochemical Reactions .......................................................... 167 
APPENDIX A  ALPHABETICAL LIST OF CONTRIBUTORS .............................................................. 168 
APPENDIX B  MTNP-SPED-NESI-IM-MS USE AND TROUBLESHOOTING GUIDE .......................... 169 
APPENDIX C  MEDI HEAT MAPS ............................................................................................... 197 
APPENDIX D  CHEMICAL REACTION MODELS ........................................................................... 200 
APPENDIX E  RPPM CODE ........................................................................................................ 219 
vi 
APPENDIX F  HETERODYNE DATA ANALYSIS CODE ................................................................... 227 
APPENDIX G  PUMP CALIBRATION ANOVA .............................................................................. 238 
APPENDIX H  HETERODYNE FREQUENCY TABLES ..................................................................... 241 
 
 
 
  
vii 
LIST OF TABLES 
 
Table Page 
1 Methods of Cellular Communication 8 
3.1 Methods of Cellular Communication 99 
3.2 Fluorescein Quenching Frequencies 106 
3.3 Peroxyoxalate Chemiluminescece Frequencies 109 
3.4 Input Speed and Average Resulting Flow Rates for Constant Speed Calibration 121 
3.5 Input and Output Parameters for Sinusoidal Calibration 121 
3.6 Fluorescein Quenching Experimental Variable Flow Frequencies 133 
3.7 Fluorescein Quenching Experimental Corrected Frequencies 135 
3.8 Reservoir Contents and Sample Input Parameters for Peroxyoxalate Reaction 138 
3.9 Pre- and Post-calibration Results for Peroxyoxalate Reaction 142 
3.10 Comparison of Model and Experimental Peroxyoxalate Reaction Frequencies 145 
3.11 Heterodyne chemistry hardware performance metrics 147 
  
viii 
LIST OF FIGURES 
 
Figure Page 
1.1 Device Fabrication, Design and Cell Loading  6 
1.2 Examples of Microfluidic Sinusoidal Concentration Generators  10 
1.3 Ion Mobility Mass Spectrometry  12 
1.4 Waters Synapt G2  13 
1.5 Conceptual Pathway from Experimental Data to Discovery of Conservation Laws  16 
1.6 A Comparison of Substances of Abuse  20 
1.7 Potential Mechanisms of the σ1 Receptor  26 
1.8 Summary of Effects of Cocaine on Immune Function 28 
1.9 Brain-immune Bi-directional Connections  37 
2.1 Cocaine Metabolic Pathways  67 
2.2 Experimental Scheme Showing the Potential Cell Fates  68 
2.3 Device Fabrication and Design 70 
2.4 PDMS Silanization 71 
2.5 Cocaine Exposure Scheme  72 
2.6 Solid Phase Extraction Desalter Setup 76 
2.7 MTNP-SPE-nESI-IM-MS Platform 79 
2.8 Insulin Treatment of Silanized PDMS Channels 83 
2.9 Walking Principal Component Analysis of Exometabolomic Profiles 85 
2.10 Benzoylecgonine Time Course and Fragmentation Spectrum 86 
2.11 Additional Metabolite Time Course Data 88 
2.12 Metabolite Expression Dynamics Inspector Heat Maps 89 
ix 
2.13 In Culture Principal Component Analysis of Exometabolomic Profiles 91 
3.1 Heterodyne Chemistry Basics 101 
3.2 Reaction Rate Equations for Fluorescein Quenching 104 
3.3 Fluorescein Quenching Model Data 105 
3.4 Reaction Rate Equations for Peroxyoxalate Chemiluminescence 107 
3.5 Peroxyoxalate Chemiluminescence Model Data 108 
3.6 Examples of Microfluidic Sinusoidal Concentration Generators 112 
3.7 Multiple Pump Sinusoidal Concentration Profile Generation 113 
3.8 Y-offset Contributions to Frequency Sprectrum 114 
3.9 Rotary Planar Peristaltic Micropump 116 
3.10 Single Pump Sinusoidal Flow Rate 118 
3.11 Pump Calibration 120 
3.12 Sinusoidal Pump Calibration 122 
3.13 Microfabrication Procedure 124 
3.14 Continuous Flow Photometer 125 
3.15 CFP Evaluation 127 
3.16 CFP Detection of Sinusoidal Concentration Profiles 128 
3.17 Experimental Setup for Fluorescein Quenching 131 
3.18 Fluorescein Quenching Sample Data Set 132 
3.19 Corrected Fluorescein Quenching Sample Data Set 134 
3.20 3D Plot of Varying FL Drive Frequencies 136 
3.21 Experimental Setup for Peroxyoxalate Chemiluminescence 139 
3.22 Pre- and Post-calibration Peroxyoxalate Chemiluminescence Experimental Data 141 
3.23 3D Plot of Varying H2O2 Drive Frequencies 143 
x 
3.24 Model versus Experimental Peroxyoxalate Chemiluminescence 144 
 
  
1 
CHAPTER I 
 
1 INTRODUCTION 
 
1.1 Objective 
The progression of science and medicine is often predicated by advancements in 
technology. Particularly, automation has played a large role in many of these technological 
advancements, allowing for progress to occur at a more rapid pace. For example, high impact 
technological driving forces, such as gene sequencing1,2, microarray technology3,4, and high-
throughput screening3,5, have led to a genomic revolution that has fueled not only the mapping 
of the human genome, but also drug discovery, epigenetics, biomarker discovery, systems 
biology and basic science research as a whole6–8. As popularity in approaching scientific issues 
from a systems biology perspective continues to grow, the need for new tools capable of rapidly 
producing data has become evident. The development of technology platforms for complex 
biological studies will be twofold. The first, a platform for assessing the metabolic state of a 
population of cells under highly controllable environmental parameters, could provide 
significant insight as to the underlying biological phenomenon leading to potential advancement 
in both clinical and academic systems biology research. This work, as described within, discusses 
a platform comprised of the Vanderbilt Institute for Integrative Biosystems Research and 
Education (VIIBRE) Multitrap Nanophysiometer (MTNP) paired with a solid phase extraction 
desalter (SPED), and an Ion Mobility-Mass Spectrometer (IM-MS). Through the use of this 
platform, it is hypothesized that new insight into cellular behavior, particularly under challenge-
based conditions such as cocaine exposure may result and potentially lead to the ability to 
predict and control cellular dynamics. The second technology framework developed will be for 
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the generation and receiving of oscillatory chemical signals and will consist of parallel Rotary 
Planar Peristaltic Micropumps (RPPMs) for the generation of sinusoidal concentrations of 
chemical signals, a microfluidic mixer for the combination the oscillatory signals, the Continuous 
Flow Photometer (CFP) for the collection of light from reaction products, and data analysis 
techniques for describing the frequency domain of the raw data. This framework stands to 
provide unique information regarding nonlinear reaction dynamics and is transferrable to more 
complex biochemical signaling pathways. 
 
1.2 Specific Aims 
 The following aims will lead to the creation and testing of these two novel platforms for 
real-time analysis of dynamic cellular exometabolomes and investigation of oscillatory chemical 
reaction networks. 
 
1.2.1 Specific Aim 1 
The development of an instrumentation platform for real-time systems biology 
measurements of small populations of cells will be carried out through the integration of 
microfluidic bioreactors, a solid phase extraction desalter and nano-electrospray ionization-ion 
mobility-mass spectrometry (nESI-IM-MS). Validation of this instrumentation platform will be 
carried out through assessing the exometabolomic profiles of naïve and cocaine-experienced 
Jurkat T cells through online cocaine challenge. Successful completion of this instrumentation 
platform with inaugural biological experimentation will include comparison of this platform to 
the current mass spectrometry standard for analysis of complex biological samples as well as 
principal component analysis of the resulting online biological data for the identification of 
differential exometabolomic profiles.  
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1.2.2 Specific Aim 2 
The complexities of biological regulatory networks provide motivation for the inclusion 
of advanced mathematical techniques and instrumentation for the investigation of nonlinear 
reaction dynamics. The development of instrumentation for producing oscillatory upstream 
signal generation and data analysis techniques for assessing downstream signaling could provide 
a means of more closely regulating and interpreting cell signal response. In order to validate this 
technique without the added complexity of a biological system, two non-cellular non-linear 
chemical reaction networks will be used, specifically Fluorescein quenching and peroxyoxalate 
chemiluminescence. Successful development of this framework will include the production and 
analysis of a sinusoidal concentration generator, signal mixer, reaction product receiver, and 
frequency domain data analysis techniques.  
 
1.3 Technology Innovation, Background and Significance 
The technology platform developed and integrated for the work described in the 
Specific Aims will be a joint microfluidics/mass spectrometry/computational modeling construct 
including the VIIBRE Multitrap Nanophysiometer, the Waters Synapt G2 HDMS and co-
evolutionary algorithms developed by the Cornell Computational Synthesis Laboratory. These 
technologies, while innovative in their own respect, will be incorporated to form a unique and 
technologically advanced approach for automated systems biology research. 
 
1.3.1 Microfluidics for the Study of Cellular Response 
Microfluidic devices are becoming increasingly popular and several designs have 
translated to market. The field of microfluidics incorporates skills and techniques from a variety 
of disciplines such as engineering, physics, chemistry, and biology. This technology is often 
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referred to as lab-on-a-chip (LOC) as it seeks to transform or often replicate the traditional 
experimental techniques of cell and molecular biology and biochemistry into small-scale on-chip 
experiments. Since there is a reduction in experimental scale, compared to traditional 
techniques, decreased reagent volume is necessary and is based on microfluidic device size and 
length of experiment. Microfluidic technology benefits from easier fluid handling, thus allowing 
for better control of experimental parameters and reduced sample loss. Experiments conducted 
with microfluidic devices are typically inexpensive not only due to the decreased cost of 
reagents, but also because of the low material cost as the devices are typically comprised of 
poly(dimethylsiloxane) and a glass slide or cover slip9,10. The design and fabrication procedures 
allow for meticulous control of the device features. Because devices can be designed on a 
smaller scale with less volume surrounding cells, extracellular contents, including autocrine and 
paracrine signaling molecules, are not diluted by the large volumes of traditional techniques 
such as cell culture and titer plates11. An important factor in working on the microscale is the 
physical phenomena that become influential on the experimental results. These factors include 
diffusion, laminar flow, and surface area-to-volume ratio, among others, and have significant 
repercussions in physiological processes and can greatly contribute to in vitro/in vivo 
correlation. By taking advantage of the numerous benefits of microfluidics many researchers 
have been able to make measurements at the micro scale that would otherwise not be 
possible12.  
Microfluidics and LOC techniques have shown remarkable promise in various biological 
measurements, such as immunoassays13–17, protein and DNA separations18–21, capillary 
electrophoresis22–26, and cell sorting27–29. There also exists a wealth of bioreactors designed to 
culture cells in an environment more closely replicating in vivo conditions11,30–36. Some 
microfluidic devices have also been combined with microfabricated multi electrode arrays for 
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electrochemical measurements of the metabolic activity of small numbers of cells and their 
rapid response to drugs and other perturbations. Combined optical and electrochemical 
technologies allowed for the recording of acidification rate, oxygen and glucose consumption, 
lactate release, intracellular calcium concentrations, transmembrane potentials and NADH 
concentrations with sensitivities to monitor single cells in nanophysiometers37–41. On-chip 
strategies for both cell culture and biochemical assays have taken great strides in the past 
decade, yet room for improvement of both on- and off-chip analysis techniques remains. 
The Vanderbilt Institute for Integrative Biosystems Research and Education (VIIBRE) 
Multitrap Nanophysiometer (MTNP), a microfluidic device used as miniature bioreactor, allows 
for studies on small populations of cells or simple organisms (<105). This is contrast to traditional 
cell biology techniques which often require populations several orders of magnitude larger. The 
MTNP has been used for long-term optical measurements of the dynamic behavior of cells, 
including fluorescent labeling of cells to determine type and activation state and detect signaling 
dynamics11,38,42. This device is ideally suited for studying immune cells, i.e., T cells, B cells, and 
natural killer cells as it traps non-adherent cells with structural barriers instead of with chemical 
surface modification that may allow cells to be exposed to higher shear stresses resulting from 
fluid flow. Design of the MTNP is done through the use of AutoCAD to create drawings of the 
device which will then be transferred to a chrome mask. Device parameters such as trap size, 
spacing and number, as well as chamber dimensions and inlet and outlet features, can be 
manipulated in AutoCAD for the optimization of devices as needed for specific experiments. 
Construction of microfluidic devices from these chrome masks occurs as previously 
described10,43 with photolithography performed to produce a silicon master from which 
numerous polydimethylsiloxane (PDMS) devices can be replica molded. After their inlet and 
outlet ports have been punched, the PDMS is plasma-bonded to glass cover slips. Prior to cell 
6 
loading, devices are primed with warmed culture media to prevent air bubble formation, a 
detrimental complication in any microfluidic device. As shown in Figure 1.1, cell loading is 
accomplished by first aspirating cells into a length of PEEK tubing using an automated Harvard 
Apparatus syringe pump and then, after inserting the tubing into the device inlet, reversing the 
direction of flow to pump the cells into then device. An alternate loading method that employs a 
manual or motorized rotary on-chip microfluidic pump44 is also permissible. The loading of cells 
is easily monitored with an inverted microscope, and once cells are loaded, the desired 
experiments can be performed. Visualization of the experiment can continue with microscopy, 
allowing for optical measurements to be conducted as needed.  
 
Figure 1.1 Device Fabrication, Design and Cell Loading A) PDMS device fabrication method 
involving photolithography and replica molding techniques. B) Design of the MTNP with (i) 
18µm x 12µm cell traps capable of (ii) trapping 2-3 cells each in a device with a 2nL volume 
and 7056 cells traps. C) Cell loading procedure using a Harvard Apparatus syringe pump to (i) 
first aspirate cells from a pellet in a microcentrifuge tube, then (ii) reverse the flow of the 
pump to push cells into the MTNP. 
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The MTNP is not only well suited to detect autocrine and paracrine signaling molecules 
in cellular effluent, but it is also unique in its ability to provide a system for investigating 
dynamic response of a cell population to a stimulus. The constant perfusion design of the 
experimental setup gives rise to platform capable of real time monitoring of alterations in 
species transport across the cell membrane, whether small molecule, protein, etc. Knowledge 
concerning changes in species transport provides information on the current state of the cell 
population which can lead to a more thorough understanding of the particular cell’s biology and 
the ability to control this cell’s behavior.  
 
1.3.1.1 Complex Cell Signaling Dynamics 
Central to the field of systems biology is the effort to both model and understand the 
complex cell signaling pathways that govern biological networks. Table 3.1 lists the various types 
of cellular signaling that comprise the breadth of response of a cell to its environment. 
Experimental and computational biologists alike often use wiring diagram analogies to represent 
these molecular interaction networks. Biological regulatory networks have been shown to be 
comprised of simple motifs, such as cycles and cascades, controlled by positive and negative 
feedback loops, described by linear, hyperbolic, sigmoidal, and oscillatory signal-response 
dynamics, which when taken together to form an integrated network, can drive the parametric 
state of the cell into one or more attractor states45,46. With such complexities in signaling 
systems, experimental determination of dynamical properties must be coupled with 
mathematical models to avoid error in the interpretation of the results. The dynamics of 
nonlinear biochemical networks under oscillatory stimulus conditions has been modeled by 
Ingalls as an extension of metabolic control analysis47. Tyson describes a means of combining 
simple signal-response elements consisting of sigmoidal switches, transient responses, 
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hysteretic switches and oscillators to computationally model any complex regulatory network46. 
Interested readers are directed towards numerous excellent reviews45,46,48–50 that have been 
written detailing the finer points of cell signaling, state stability and modeling of complex 
networks that are tangential to the scope of this work.  
 
Paramount to this work is in the exploration of sinusoidal signaling dynamics. Sinusoidal 
stimulus-response has been shown to provide valuable information in dynamical biological 
systems ranging from neuronal networks51–55 and the human visual response56–59 to insulin 
secretion in pancreatic islets60–62 and yeast regulation63–67. Oscillatory glucose levels have been 
shown to synchronize pancreatic islets in vitro68. Bird et al. report constant frequency sinusoidal 
calcium oscillations resulting from the stimulation of mouse lacrimal acinar cells with 
submaximal methacholine dose which are dependent on a negative feedback loop driven by 
protein kinase C69. Berthoumieux et al. reported oscillatory concentration dynamics on a three 
state enzyme system following Michaelis-Menten kinetics70. 
 
 
Table 1 Methods of Cellular Communication 
Intercellular Signaling 
Method 
Target Example 
Endocrine Distant cells Insulin on hepatocytes 
Paracrine Nearby cells Coagulation factors in 
platelets 
Juxtacrine Adjacent cells Membrane-bound growth 
factor 
Autocrine Emitting cell Interleukin-2 in T cells 
Intracrine Intracellular receptor Renin-angiotensin system in 
cardiac fibroblasts 
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1.3.1.2 Sinusoidal Flow Generation for Environmental Control in Microfluidic Devices 
 While much of the neuronal network studies are performed through the application of 
oscillatory electrical pulses, the generation of sinusoidal concentration gradients for simulating 
in vivo non-linear dynamics requires sophisticated and expensive flow systems. Several groups 
have pioneered work on producing microfluidic variable concentration generators, often 
incorporating valves and pumps (examples shown in Figure 1.2). Mosadegh et al. produced a 
microfluidic oscillator using switch valves and check valves to convert a constant infusion of fluid 
into an oscillating output71. Azizi and Mastrangelo created a microfluidic pulsed waveform 
generator capable of simulating rat striatum dopamine release, beta cell intracellular calcium 
oscillations and beta cell extracellular insulin secretion72. A microfluidic device for the 
production of sinusoidal glucose concentrations has been shown to allow for the entrainment of 
pancreatic islets68,73. The same research group has also produced a microfluidic multi-analyte 
gradient generator capable of independent sinusoidal control of up to four different chemical 
species74. Through the use of these or similar non-linear concentration generators, it is possible 
to more closely simulate upstream signaling dynamics, leading to a cellular response to stimulus 
that more closely mimics the in vivo response. With a sinusoidal concentration generator paired 
with a method of analyzing cell response data, the influence of the sinusoidal signal component 
could be revealed, providing another tool for describing, modeling and analyzing complex 
biological systems. 
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Figure 1.2 Examples of microfluidic sinusoidal concentration generators. (A) and (B) are 
designs from the same group incorporating pumps and a series of valves to produce 
independently controllable sinusoidal concentrations68,73,74. (C) employs a pulse code 
modulator comprised of a multiplexer with a low pass filter and digitally encoded clock 
signals to generate a variety of waveforms72. (D) depicts a design for a microfluidic oscillator 
capable of converting constant flow into an oscillating output through the use of both switch 
valves and check valves71. 
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1.3.2 Mass Spectrometry for Cell State Assessment 
The complexity of biological samples often exacerbates standard screening techniques 
to the detriment of most attempts to discover biomarkers of disease or to rapidly screen drug 
efficacy. This unique problem warrants an analytical technique capable of rapid, yet non-
destructive screening of samples. The need for sensitivity in this screening is an additional 
complicating factor characteristic of this type of experimental work as it is plagued by low 
abundance of analytes. The move towards mass spectrometry (MS) as the powerhouse of 
proteomic75, lipidomic76, glycomic77 and metabolomic studies has led to many advances in 
elucidating the complexity of the cell.  
Mass spectrometry is a technique for determining sample composition by using an ion 
source to create charged particles from the sample, separating those particles based on their 
mass to charge ratio (m/z) in a mass analyzer and then recording the relative abundance of ions 
of a particular m/z present in the sample through the use of a detector. Ion sources include 
electrospray ionization (ESI)78, which ionizes and volatilizes liquid sample, and matrix-assisted 
laser desorption/ionization (MALDI)79, which involves firing a laser at a dried sample co-
crystallized with an organic matrix molecule. While MALDI has the advantage of reducing issues 
caused by salts in biological samples and also gives a means of storing temporally resolved data 
when an immediate MS scan is unavailable, ESI can handle liquid samples and thus is capable of 
additional separation methods, rendering it preferred for more complex samples80. A variety of 
mass analyzers have been developed, such as ion trap (IT), time-of-flight (TOF), quadrupole and 
Fourier transform (FT), and are reviewed elsewhere80,81. MS is frequently coupled with 
chromatography techniques such as liquid chromatography (LC) and gas chromatography (GC) 
for additional separation of analytes. Recently, MS has also been paired with ion mobility (IM), a 
technology that separates ions in a drift tube, which is filled with a neutral gas and surrounded 
12 
 
Figure 1.3 Ion Mobility Mass Spectrometry (A) Schematic of IM-MS procedure, (B) Separation 
of classes of biomolecules based on collision cross section and m/z, (C) Sample combined IM-
MS spectra showing 3D information. Enders et al.75 
by parallel ring electrodes in series, connected by resistors. A voltage difference applied across 
the resistors produces an electrostatic field which causes ions to collide with the drift gas. Ions 
with a larger collision cross section move slowly through the drift tube, while those with a 
smaller collision cross section are able to pass quickly. This allows IM-MS to provide an 
additional dimension of information: relative abundance and collision cross section as a function 
of m/z, a distinct advantage over LC- or GC-MS (Figure 1.3). IM-MS has further benefits of 
separation speed (μs-ms), decreased chemical noise and enhanced peak identification82,83. 
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Because of these advantages, IM-MS is well suited for the rapid analysis of complex biological 
samples84,85.  
 The Waters SynaptTM G2 HDMS (Figure 1.4)86 is a state-of-the-art, commercially 
available IM-MS residing in the McLean Laboratory for Structural Mass Spectrometry. This 
instrument is outfitted with nano-ESI and is capable of direct fluid input, bypassing the built-in 
fluidics system. The ion mobility separation cell called TriwaveTM Technology contains three 
consecutive traveling wave ion guides to increase resolution: the ion trap in which ions are held 
and periodically released into the next region, the ion mobility separation (IMS) guide that 
exploits the mobility of the ions to achieve separation and the transfer region which maintains 
the ion separation and directs them to the analyzer. Once ions travel through these regions, 
 
Figure 1.4 Waters SynaptTM G2, a state of the art, commercially available IM-MS, showing 
external image (left) and internal details (right)86. This instrument is outfitted with ESI, nano-
ESI and MALDI sources. The ion mobility separation cell contains three consecutive traveling 
wave ion guides to increase resolution: the ion trap in which ions are held and periodically 
released into the next region, the ion mobility separation (IMS) guide that exploits the mobility 
of the ions to achieve separation and the transfer region which maintains the ion separation 
and directs them to the analyzer. Once ions travel through these regions, they move into the 
time-of-flight analyzer with a high field ion pusher, dual stage reflectron and ion detection 
system.  
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they move into the QuanTofTM time-of-flight analyzer with a high field ion pusher, dual stage 
reflectron and ion detection system. The Synapt G2 is managed through the use of MassLynxTM 
software and DriftScope™ Mobility Environment software is used for 2- and 3D visualization of 
data and peak labeling and identification.  
 
1.3.3 Combining Microfluidics with Mass Spectrometry 
Combining microfluidic constant perfusion bioreactors with mass spectrometry has the 
potential to rapidly screen cell effluent and even cell contents for proteins, lipids, carbohydrates 
and oligonucleotides. Several studies have taken on the challenge of the integration of these 
two technologies to produce a powerful analytical platform. In an early experiment, Chan et al. 
verified that using PDMS devices to transfer samples into the ESI-MS did not contaminate the 
samples87. On-chip ultrafiltration and analyte pre-concentration for high-throughput small 
molecule screening with ESI-MS were performed with the resulting detection sensitivity shown 
to increase by 1-2 orders of magnitude over off-chip screening strategies88. Kim and Knapp 
validated a fabrication method for producing on-chip ESI emitters, as opposed to direct spraying 
from channels ending at the edge of the device89. Silica capillaries were also used as on-chip 
electrospray nozzles and shown to be comparable to commercially available nanospray tips90. 
Huikko et al. used microfluidic channels and ESI-MS to analyze pharmaceuticals and amino acids, 
and based on these experiments, recommended a fabrication protocol for avoiding background 
noise caused by device fabrication procedures91. The development of an on-chip capillary 
electrophoresis device capable of direct ESI-MS from the channel edge was reported by Mellors 
et al92. The coupling of microfluidic devices for enzymatic protein digestions to MALDI- and ESI-
MS has seen success93,94. A significant impairment in coupling microfluidic devices with online-
MS is in the saturation of signals with salts present in biological samples. To avoid this issue, 
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MALDI-TOF MS was paired with a microfluidic bioreactor capable of trypsin digestion for 
proteomic analysis of Esherichia coli94. MALDI may provide a means of partially circumventing 
the issue caused by salts, but it is not a solution. While most of the work has just begun, many 
groups are poised to begin using these combined techniques for inspection of biological 
samples. 
1.3.4 Computational Modeling of Complex Biological Systems 
Modeling complex biological systems is a challenging task due to poor understanding of 
the biochemical pathways under investigation. Kitano describes biological systems as 
“functionally diverse, and frequently multifunctional, sets of elements [that] interact selectively 
and nonlinearly to produce coherent rather than complex behaviours”95. With the growing 
realization of complexity and amount of experimental biological data produced, many 
computational modeling methodologies have struggled to remain on the forefront of systems 
biology. 
 
1.3.4.1 Cornell Computational Synthesis Laboratory Co-evolutionary Algorithms 
One promising technique for the analysis of non-linear systems developed by the 
Cornell Computational Synthesis Laboratory (CCSL) is a co-evolutionary method combining 
symbolic regression algorithms (SRA) and estimation-exploration algorithms (EEA). The SRA, as 
shown in Figure 1.5, calculates partial derivatives for every combination of variables, searches 
for possible invariance, predicts and compares partial derivatives based on the invariance and 
generates candidate models along with the estimation phase of the EEA. The EEA compares the 
candidate models and proposes an experiment based on the extent to which it would cause 
disagreement between candidate models96. The benefit of symbolic regression lies in its ability 
to concurrently search for both forms of equations and parameters97. The data generated from 
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Figure 1.5. Conceptual pathway from experimental data to discovery of conservation laws. A) 
Shows the process of partial derivative calculation from which candidate functions are 
explored. B) List of mathematical operations as stored in the computer. C) Tree figure 
representing the equation in B. Schmidt and Lipson97. 
the proposed experiments would again be mined by the SRA, reducing the candidate models. 
The candidate model synthesis and experiment proposal eventually lead to model inference96. 
These algorithms display the capabilities of determining models of complex biological systems 
with model reduction.  
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1.3.4.2 Incorporation of Computational Modeling  
Modeling biological processes is a daunting task that can be overcome but often leaves 
the researcher with a purely theoretical, mathematical model that cannot be validated due to 
insufficient experimental data. While some experimentalists are dedicated to studying the 
cellular response one perturbation at a time, this method may not be capable of determining 
non-linear response, especially when a large number of variables is considered. Additionally, 
some experiments are capable of simultaneous adjustment of multiple experimental 
parameters, yet they may suffer from limitations in detecting cellular response as low sampling 
rates or signal amplitudes force the averaging of data over time or cell population98. Validating 
complex mathematical models with averaged, incomplete or biased data sets restricts model 
accuracy. Rapid detection of complex, dynamic biological response to multivariable 
perturbations will prove necessary to characterize the true cellular response. Since the fusion of 
microfluidics and mass spectrometry has the capability of detecting such responses, the use of 
these technologies for experimental data production is well suited. Spectral and optical data 
produced by this experimental platform is capable of being electronically transferred to Cornell 
for data mining and eventual model inference.  
 
1.3.5 Systems Biology Approach for Automated Science 
With the wealth of data the combination of microfluidics and mass spectrometry for the 
analysis of complex samples is likely to produce, taking a systems biology approach to the 
determination of biological models would be advantageous. Systems biology seeks to 
understand living organisms by studying the interactions of numerous levels of biochemical 
networks comprising that organism and does so frequently through the use of computational 
modeling to understand existing experimental results. The key innovation of the combined 
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MTNP – IM-MS – SRA/EEA approach lies in the opportunity for automation. In the matter of 
minutes, a population of cells can be exposed to a certain set of experimental conditions in the 
MTNP, effluent from these cells can be analyzed by IM-MS, spectral and optical data can be 
electronically transferred to Cornell for data mining and experimental parameters for a 
subsequent experiment on the same population of cells can be delivered and implemented. All 
of these steps can occur in the absence of the researcher and allows for the testing of a greater 
number of system variables than any human is able to control. Pioneers of automated science 
introduced the community of researchers to the possibilities of a robot scientist and tested its 
capabilities in functional genomics99–101. Our approach builds on this idea that the scientific 
process is capable of automation and, with the powerful data generation, analysis and 
computational modeling capabilities, extends this idea to experimental designs humans are 
unable to perform alone. 
 
1.3.6 Summary 
The microfluidic/analytical chemistry/model inference platform discussed applied to the 
problem of cocaine-induced immune suppression would serve to quickly and effectively discover 
any permanent or long-term changes in immune function. While technology resulting from the 
proposed work is poised to revolutionize basic science research on cellular or small organism 
populations, it may also result in a platform for developing personalized treatment strategies. 
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1.4 Biological Background and Significance 
Humans have the ability to fight off infections and disease with the aid of the immune 
system. When this vital component is diminished, a host of health problems can arise including 
cardiovascular disease and cancer. While some individuals are born with an immunodeficiency, 
others may acquire immune issues as a result of their lifestyle or exposure to hazardous 
substances. Many toxins and elicit substances are known to affect the immune system, leading 
to serious health complications. Cocaine, one such substance shown to suppress the immune 
system, will be discussed herein along with various biological toxins, T cell activators and basic 
factors in metabolic regulation. All effectors of cell state are experiments suited for analysis with 
the advanced technology platform discussed in the previous section to be developed for 
assessing and characterizing the effects drugs and toxins on the immune system. 
 
1.4.1 Cocaine Effects 
Drug use is widespread and is blind to cultural, societal, or economic diversity. Cocaine, 
isolated from the Erythroxylum coca plant, is a central nervous system stimulant that affects the 
reward center of the brain by blocking the reuptake of dopamine, norepinephrine and serotonin 
causing mood-stimulating effects, with chronic use leading to permanent changes in levels of 
certain uptake transporters102. The effects of cocaine reach far beyond the central nervous 
system, into the immune system through mechanisms not fully understood, resulting in a 
suppression of immune function discussed in more detail later in this proposal. Figure 1.6, based 
on the findings of Nutt et al., shows cocaine to be the second most harmful and addictive 
substance of those commonly abused103. In 2008, the National Survey on Drug Use and Health 
(NSDUH) estimates that 36.8 million Americans over the age of 12 have used cocaine at least 
once in their lives, with 1.9 million having done so in the previous month104. The prevalence of 
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use combined with the severe physical effects, including suppression of the immune system, 
make cocaine a worthy candidate for further investigation. A more complete understanding of 
the actions of this drug on the immune system can lead not only to potential testing methods, 
but also to more effective treatment strategies for addiction. 
1.4.1.1 Drug testing 
Exact statistics of a population’s cocaine use can be difficult to determine and are 
currently accomplished through surveys as mentioned previously. The accuracy of this method is 
questionable as no drug testing is performed on survey participants. Wastewater analysis using 
a gas chromatography-mass spectrometer for determining population use by amount of cocaine 
and its metabolites present has been suggested and tested in Belgium105 and in Florence, 
Italy106. While this method provides total amounts used, assumptions of amounts of individual 
 
Figure 1.6 A comparison of substances of abuse based on addictive quality and physical 
harm caused by use is shown. From Nutt et al.103 
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use would need to be made in order to determine percentages of the population using cocaine. 
The results from such testing are valuable in that they can be used to assess public tactics for 
reducing drug use in a population.  
Drug testing on an individual level is accomplished by analyzing bodily fluids and 
materials such as urine, blood, hair, sweat, and saliva with urine being the most commonly used 
based on ease of acquisition and cost of analysis. The initial urine screening is typically done 
with the enzyme-multiplied immunoassay technique and can be confirmed with gas 
chromatography-mass spectrometry (GC-MS)107 or liquid chromatography-mass spectrometry 
(LC-MS)108 for cocaine and/or its major metabolite, benzoylecgonine, with detection capabilities 
of 300 ng/mL, 1 ng/mL and 25 ng/mL, respectively. Since both substances are metabolized and 
cleared relatively quickly from the body (cocaine’s half-life is about an hour and 
benzoylecgonine’s is about 6 hours), the urine test would have to be performed soon after drug 
use109. Typical time limits for urine screening are on the order of days. Urine testing is also easily 
adulterated with the addition of bleach, vinegar, Visine and hand soap110,111. While urine testing 
is the standard, some aspects of other testing procedures are advantageous. For instance, the 
use of hair for drug testing allows for an extended time limit for detection and also provides 
information on use patterns based on hair growth rates. While adulterating hair samples is more 
complex, the removal of hair altogether is simple. Blood can also be tested, but due to the short 
half-life of cocaine, testing must be done within hours of drug use109. 
Significant advances in cocaine testing methods have not occurred in over 15 years as 
the tradeoff between cost and sensitivity has not been worthwhile. With just a few µL of blood 
from a finger stick, the proposed research could lead to a testing method rivaling a standard 
urine screening in cost, with none of the detection time limitations or sample adulteration 
issues, and with sensitivities on the order of those used in more expensive GC-MS or LC-MS 
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conformational analysis. Instead of testing directly for cocaine or its metabolites, the proposed 
method seeks to detect changes in metabolic dynamics of cells of the blood, particularly 
immune cells, as a result of in vivo cocaine exposure which could produce subsequent 
biomolecular signatures of drug use, thus detecting permanent changes in cellular biochemistry 
that may accompany single use, recreational use or chronic use of illicit drugs (John McLean, 
personal communication). 
 
1.4.1.2 Effects of Cocaine Use on the Central Nervous System 
Cocaine is a stimulant of the central nervous system, and as a result, most research on 
cocaine use and addiction in the past few decades has been focused on neurological effects, 
with less attention given to the more systemic physiological effects and the secondary effects of 
changes in neurobiology. Though many pharmacological actions of cocaine in the nervous 
system have been explored, not all are completely understood. A synopsis of the mechanisms of 
cocaine action in the nervous system will add to the classic view of cocaine and begin to 
associate the drug with its broad range of actions. 
 
1.4.1.2.1 Monoamine Reuptake Inhibition 
The most well-known and studied action of cocaine is its role in blocking the reuptake of 
monoamine (norepinephrine, serotonin and dopamine) neurotransmitters. As a small xenobiotic 
molecule exhibiting both lipophilic and hydrophilic properties, cocaine, upon administration, can 
cross the blood-brain barrier. Much of the cocaine localizes to areas of the brain that are rich in 
neurotransmitter transporters, such as the nucleus accumbens, ventral tegmental area, and 
amygdala112,113, where it becomes concentrated in the synapses between neurons and binds to 
these transporters, which are responsible for the recycling of the transmitters back into the 
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presynaptic neuron where they are stored in vesicles. This blockade increases levels of 
monoamines (norepinephrine, serotonin, and dopamine) in the synaptic cleft, allowing greater 
ligand binding to their respective receptors on the postsynaptic neuron. With increased 
dopamine signaling and subsequent binding to the G-protein-coupled dopamine receptor, 
comes an increase in cyclic AMP in postsynaptic neurons114, leading to increased neuronal firing 
and maintenance of an activated state in the pleasure center of the brain, perpetuating the 
euphoric feeling of the user112,115. Prolonged exposure to cocaine leads to a downregulation in 
postsynaptic receptors for dopamine that causes desensitization to the effects of the drug, and 
thus a higher dose is required to achieve the same results116. Upregulation of dopamine 
transporters is evident up to 30 days post-cocaine use; however, results also show that these 
levels return to normal after 90 days, indicating that monoamine reuptake inhibition is not 
permanently modified117. Dopamine signaling plays a fundamental role in learning and memory 
systems, and as such, cocaine addiction is hypothesized to result from adaptations in these 
systems as a result of Pavlovian and operant conditioning114,118,119. In a recent review, Wise and 
Kiyatkin discuss the ultra-fast rewarding action associated with cocaine use in chronic users: a 
spike in dopamine that occurs prior to cocaine reaching the brain120. This pre-use stimulus 
represents evidence of a conditioned response caused by release of glutamate and 
acetycholine120–122. Reuptake inhibition, however, is not the only method of cocaine 
neuromodulation, as is evident by the fact that many medications designed to block monoamine 
reuptake do so without the psychotic and depressive effects linked to repeated cocaine 
stimulation123. Thus, cocaine must interact with other receptors to elicit these additional effects. 
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1.4.1.2.2 Non-monoaminic Nervous System Substrates: Sigma-1 Receptor 
Dopamine reuptake inhibition has received great attention from the scientific 
community as it is the main pathway leading to the reward associated with cocaine use. 
Investigation of the role of cocaine binding to additional neural substrates also has the potential 
to contribute to our understanding of cocaine’s complex pharmacological actions. For example, 
although it is still unidentified, an additional neuronal receptor was discovered by Rothman et 
al. to be a potential binding site for cocaine, as the binding affinity of the drug to this receptor is 
within the concentration range of cocaine found in brain membrane preparations post-
administration123. Smirnov et al. have implicated peripheral non-monoamine neural substrates 
in the immediate physiological response (EEG and EMG changes) to cocaine prior to stimulation 
of the central nervous system124. Secondary effects of increased dopamine signaling may also 
occur. For instance, prolonged cocaine administration leads to upregulation of μ opioid 
receptors in the nucleus accumbens and κ opioid receptors in the olfactory tubule, caudate 
putamen, and cingulate cortex as a result of increased dopamine transmission125. The sigma-1 
(σ1) receptor is one of the more extensively studied of the additional substrates for cocaine and 
will be reviewed here in greater detail. 
As mentioned above, cocaine has complex mechanisms of action, some of which are a 
direct result of receptor-mediated binding to the σ1 receptor, which is found in high density in 
the central nervous system, and also throughout peripheral organs, tissues, and even immune 
cells. While the existence of this receptor as an opioid receptor was first suggested in 1976126 
and subsequently reclassified upon discovery of the lack of naloxone or naltrexone binding 
affinityto this receptor127, a complete understanding of the σ1 mechanism of action has 
remained elusive. It has, however, been implicated in addiction, cognition, pain, depression and 
a wealth of human diseases, including cancer and cardiovascular disease128. This receptor is an 
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endoplasmic reticulum (ER) ligand-gated molecular chaperone129, also associated with the 
control and modulation of voltage-regulated and ligand-gated ion channels, such as Ca+2, K+, Na+, 
and Cl- channels, as well as NMDA and IP3 receptors, thus playing a role in Ca+2 signaling130,131. 
Through these actions, it is postulated that σ1 receptors control neuronal firing and 
neurotransmitter release132 and play a role in the behavioral and locomotor stimulus response 
associated with cocaine use133. 
The affinity level of cocaine for the σ1 receptor is 2-10µM, which is within typical blood 
concentrations of cocaine users128,132. Cocaine also augments the expression of the immediate 
early gene fos-related antigen 2 (fra-2), which in turn potentiates the gene expression of the σ1 
receptor and its subsequent protein expression134,135. As a σ1 agonist, cocaine is capable of 
inhibiting voltage-gated ion channels while enhancing the ligand-gated ion channels130. Hayashi 
and Su give evidence that stress to the endoplasmic reticulum causes σ1 receptors to 
redistribute to the entire ER and postulate that they may play a role in the suppression of 
misfolded proteins that leads to or is part of the unfolded protein response (UPR)129. Recently, 
some advances have been made that give insight into the workings of this complicated receptor 
chaperone. These results suggest that the concentration of agonists may cause the σ1 receptor 
to leave the endoplasmic reticulum and translocate to the cell membrane, where it can 
potentially alter the function of the ion channels (Figure 1.7)129,136–139. NMDA receptors, ion 
channels involved in memory and learning, were one of the first cell membrane receptors to be 
associated with the σ1 receptor, and although discrepancies exist between studies
140–142, the 
interaction between these two receptors is evident. Regardless of the suggested membrane-
translocation, the σ1 receptors regulate neighboring ion channels in the endoplasmic reticulum 
as well. For instance, σ1 agonists administered in neural cell lines caused a rise in Ca
+2 flux 
through the IP3 receptor (IP3R) even in the presence of an IP3R inhibitor143. Sigma-1 receptors 
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have been shown to regulate the interorganelle Ca+2 signaling between the mitochondria and 
the ER129. The relationship between calcium and cocaine is far from new information; however, 
the details of the relationship, beyond that of cocaine causing a decrease in mobilized cytosolic 
Ca+2, potentially through a mechanism involving the σ1 receptor, are unclear.  
These studies of both monoamine and non-monoamine targets for cocaine binding give 
rise to the complex nature of the drug’s pharmacological and behavioral effects. While many of 
these substrates, such as dopamine transporters, are well characterized, others are still in the 
early stages of identification and characterization. Understanding the diverse actions of cocaine 
will allow for the development of innovative methods for treatment of addiction or cocaine 
 
Figure 1.7 Representations of the potential mechanisms by which the σ1 receptor mediates 
both ER and plasma membrane (PM) ion channels: A) Steroids binding to σ1 receptors cause 
translocation to the PM. From Monnet et al.138 B) High concentrations of N,N-
dimethyltryptamine (DMT) causes signaling in neurons leading to σ1 receptor translocation. 
From Su et al.139 
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toxicity, yet investigating only the nervous system effects of the drug leaves an untapped 
resource for potential treatment strategies. One must also consider the immune effects of 
cocaine, as well as how the immune and nervous systems interact to truly understand the 
complete physiological reaction to the drug. 
 
1.4.1.3 Immunological Effects of Cocaine Use 
Investigation of the effects of cocaine on immune response began slowly in the 1980s 
with a study showing the suppressive effects of cocaine on the immune response of mice to 
sheep red blood cells144, followed by 10-15 studies published per year from the early 1990s 
through the present day. As the link between cocaine use and immune function has become 
stronger, the expectation of permanent immune changes grows more plausible, but it has not 
yet been investigated directly. Extensive research on the role of cocaine in the susceptibility to 
and progression of HIV, cancer, and cardiovascular diseases has been conducted and will be 
reviewed here alongside general immune function changes due to cocaine exposure.  
 
1.4.1.3.1 Direct Immunomodulatory Effects 
Cocaine is described as an immune suppressor that acts directly on the σ1 receptor in a 
wide range of leukocyte populations, including T cells, B cells, and natural killer (NK) cells. 
Numerous peripheral mechanisms of action via the neuro-immune connection that result in 
immune function changes are also suspected (Figure 1.8). In one of the earliest studies of the 
effects of cocaine on the immune system, Watson et al. described a suppression of the immune 
system following cocaine administration in mice as measured by ear swelling and plaque-
forming cell (PFC) splenic assay144. As time progressed, more direct measures of immune 
function were incorporated. Change in white blood cell count post cocaine exposure was one of 
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these more direct immune differences, although there is some discrepancy in the nature of that 
change, with some reports of decrease145 and even no change146,147 in cell count or viability. 
When exposed to cocaine, and to a greater degree when incubated with cocaine for 24 hours, 
phytohemagglutinin (PHA)-induced proliferation of T cells is suppressed and associated with a 
decrease in the cytosolic free Ca+2 and diminished production of IL-2 148, although other studies 
show no link between decreased T cell proliferation and Ca+2 flux or IL-2 production 149. 
Disagreement between findings suggests a more complex signaling cascade, with Ca+2 most 
likely playing a critical role in need of further investigation. Faraj et al. report that lymphocytes 
possess a high affinity dopamine uptake process that cocaine blocks in a concentration-
dependent manner150. Cytokine secretion has been shown to be altered in response to cocaine 
 
 
Figure 1.8. Summary of effects of cocaine on immune function, both up and down arrows 
indicate mixed results. Cocaine also alters antibody and cytokine production, though it is not 
clear by which route these alterations occur. Adapted from Pellegrino and Bayer.154 
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exposure in various leukocytes, including NK cells, T cells, neutrophils and macrophages151,152. 
Specifically, cocaine may increase T helper type 1 (Th1) cytokines and decrease T helper type 2 
(Th2) cytokines, and thus promote Th1-mediated immune responses and degrade Th2-mediated 
responses152,153. This range of results is perhaps a result of varying exposure parameters (chronic 
and acute administration are known even to cause differential effects in the central nervous 
system), experimental model or cell population, and potential tolerance to cocaine154,155. 
Pellegrino et al. released a compelling study on lymphocyte proliferation after exposure to 
cocaine and demonstrated that suppression of proliferation occurred as a result of peripheral 
activities of cocaine156. They additionally report that the need for high dose cocaine in vitro in 
order to elicit a decrease in immune function, points to indirect methods of immune 
modulation, potentially through alterations on neurotransmitters or the neuroendocrine 
system. Disagreement between results from numerous studies indicates the complexity of this 
biological system and drives the need for a more systematic approach that includes studies on 
both the humoral and cell-mediated immune responses in single and mixed immune cell 
populations from various animal models, and especially from humans, under tightly controlled 
and easily adjustable experimental conditions.  
 
1.4.1.3.2 Serum Protein Alteration and Resulting Immune Response 
The body’s responses to any foreign substance include non-specific innate immune 
responses and primary and secondary adaptive immunological responses. These will occur if the 
foreign body, in this case cocaine, elicits an immune response. Upon entry into the bloodstream, 
non-specific esterases in the plasma of the blood, part of the humoral immune system, 
hydrolyze cocaine to two primary metabolites: benzoylecgonine and ecgonine methyl ester157. 
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As a result, cocaine has been found to be detectable in blood for only 4-6 hours after 
ingestion158.  
Immunological responses to antigen presentation should not occur in response to 
cocaine alone as it is a small molecule. However, cocaine can elicit an immune response when 
attached to a large carrier molecule, such as a protein. Cocaine has been shown to covalently 
modify endogenous proteins (e.g., albumin) present in the plasma through the acylation of the 
ε-amino group of the protein lysine residues through a nucleophilic attack by 
benzoylecgonine159. These modified proteins are recognized as foreign antigens through binding 
with major histocompatibility complexes (MHC) located on antigen-presenting cells (e.g., 
macrophages, dendritic cells). Binding, depending on whether the proteins are endogenous or 
exogenous, will occur on either MHC class I or MHC class II, respectively, for any antigen that is 
recognized. The modified proteins that have been documented are treated as exogenous, as 
they are highly abundant plasma proteins, such as albumin and IgG proteins. The exogenous 
modified proteins are endocytosed by antigen-presenting cells (APCs). This endocytosis occurs 
either non-specifically by dendritic cells whose primary job it is to scavenge and present any 
protein they encounter, by receptors on macrophages, or through surface IgM antibodies on B 
cells. These endosomes are digested through the fusion with lysosomes, which contain 
proteases and an acidic medium. Meanwhile, MHC II complexes are synthesized in the ER of the 
APC and combined with an invariant chain that allows for the transportation of the MHC 
molecule to the endolysosome, while preventing any binding in the antigen binding region prior 
to reaching the endolysosome. The resultant digested peptides from the endolysosome have a 
high affinity for the binding region of the MHC II. These are conjugated with class II MHC 
molecules through vesicle fusion, as the invariant chain is degraded by proteases in the 
endolysosome. This MHC:peptide complex is then shipped to the plasma membrane for 
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presentation to CD4+ T cell recognition. Upon recognition, the CD4 cells are activated by the 
antigen-presenting cell, and they then stimulate B cells to produce neutralizing antibodies 
against the cocaine-acylated proteins. 
The antigen-presenting cell and the CD4+ T cell adhere through interaction of the MHC 
class II molecule and the T cell receptor (located on the T cell surface). For activation to occur, 
antigen-specific recognition, along with co-stimulatory molecules, must be present (e.g., B7 on 
the antigen-presenting cell interacts with cluster of differentiation 28, or CD28, on T cells). Once 
the CD4+ T cell is activated, it produces IL-2, along with an increased expression of IL-2 receptor, 
essentially resulting in self-activation through IL-2:IL-2R interaction. This promotes T cell growth 
and proliferation. These T cells differentiate into T helper cells, which then differentiate into Th1 
cells through IL-12 promotion, or Th2 cells through IL-4 promotion. For this discussion, Th2 cells 
are most important, as they promote the production of antibodies through the activation of B 
cells.  
To accomplish this, the antigen-presenting cell and the CD4+ T cell adhere through 
interaction of the MHC class II molecule and the T cell receptor (located on the T cell surface). 
For activation to occur, antigen-specific recognition, along with co-stimulatory molecules, must 
be present (e.g., B7 on the antigen-presenting cell interacts with cluster of differentiation 28, or 
CD28, on T cells). Once the CD4+ T cell is activated, it produces IL-2, along with an increased 
expression of IL-2 receptor, essentially resulting in self-activation through IL-2:IL-2R interaction. 
This promotes T cell growth and proliferation. These T cells differentiate into T helper cells, 
which then differentiate into Th1 cells through IL-12 promotion, or Th2 cells through IL-4 
promotion. For this discussion, Th2 cells are most important, as they promote the production of 
antibodies through the activation of B cells.  
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B cell activation occurs through a similar antigen recognition procedure: a specific 
antigen binds to B cell surface antibodies (IgM and IgD antibodies), is endocytosed and 
presented as a MHC class II complex. This MHC class II complex must then be recognized by an 
antigen-specific Th cell, which then activates the naïve B cell through cytokine secretion. This Th 
cell also expresses a CD40 receptor, which binds with the CD40 produced by the antigen-
presenting B cell. These B cells then proliferate and differentiate into antibody secreting B cells. 
As such, both memory T and B cells specific to the modified proteins are present in the body, 
along with antibodies for their neutralization in the plasma. 
After the initial recognition, activation, and antibody-forming cascade, cocaine-modified 
proteins in the bloodstream are recognized by IgM or IgG antibodies, resulting in an 
immunological cascade. The cocaine modified proteins are bound to extracellular IgM or IgG 
antibodies, which in turn activate the complement system. This is considered the classical 
pathway of activation and results from an antigen:antibody complex. These antibodies are 
produced by B-cells, each having a single specificity for a modified protein dictated by the 
variable region of the antibody. The activation of complements results in the opsonization of the 
antigen and the recruitment of inflammatory cells. 
Opsonization serves to mark the complex for phagocytosis, produced through the 
covalent binding of complement components to the modified proteins. The binding of 
complements results in conformational changes that activate specific cleavages within the 
complement system (i.e., C1s as a serine protease), which generates C3 convertases that bind to 
the cocaine-modified proteins. C3 convertase is further cleaved into C3b, which serves as the 
opsonization agent, and C3a, which is a small peptide involved in inflammation. Phagocytes (i.e., 
neutrophils, monocytes, macrophages, and dendritic cells) are recruited using these chemokines 
produced from this complement cleavage (i.e., C3a, C4a, and C5a). These phagocytes serve to 
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recognize, contain, and destroy the modified protein. Macrophages recognize conjugated 
complement with complement receptors, which induce the phagocytosis of complexed antigen. 
Specifically, the binding of the C3b complement, which is covalently bound to the 
antibody:antigen complex, to its respective receptor (i.e., CR1 on macrophages), is the first step 
to phagocytosis. Phagocytosis then occurs when the inflammatory chemokine C5a activates the 
macrophage. This results in the formation of a phagosome in the macrophage through 
engulfment, bringing the modified protein into the macrophage in a vesicle, which is then fused 
with a lysosome. Within the phagolysosome, degradation of the protein occurs via acidification 
and lysing enzymes. In this manner antibody:antigen complexes are cleared from the system in a 
specific fashion. 
Activated macrophages also secrete cytokines and other signaling factors, such as 
leukotrienes and prostaglandins in response to antigen recognition. These recruit and alert 
lymphocytes that an antigen is present, eliciting an adaptive response. As a result of activation, 
a cocktail of interleukins (i.e., IL-1, IL-6, IL-8, IL-12), in addition to tumor necrosis factor alpha 
(TNF-α), are produced by macrophages. Important for this discussion is the production of IL-6, 
IL-8, and IL-12, as IL-6 activates lymphocytes and stimulates further antibody production, IL-12 
activates Th 1 cells, and IL-8 recruits neutrophils, basophils, and T cells. Hence, as a result of 
cocaine’s permanent covalent modification of plasma proteins, an immunological response that 
ultimately includes both innate and adaptive immune systems is mounted. 
 
1.4.1.3.3 Progression of Diseases and Aging 
Immune suppression as a result of cocaine administration leaves the user with an 
increased susceptibility to infection. The relation of cocaine use and prevalence of HIV and AIDS 
has frequently been studied, with reports indicating that increased susceptibility to HIV infection 
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among cocaine users is not a result of intravenous drug use alone but of the changes in the 
immune system caused by cocaine154. Baldwin et al. report an increase in infectivity or HIV 
replication in human cells when exposed to cocaine in vitro151. A decrease in CD4+ counts, lower 
CD4:CD8 ratio, and marked increase in viral load upon cocaine administration were found in 
mice implanted with HIV-infected human peripheral blood leukocytes160. In a supplementary 
study by the same investigators of the various mechanisms through which viral load was 
increased 150-fold, it was shown that cocaine both increases expression of HIV chemokine 
coreceptors and directly binds the σ1 receptor of leukocytes, causing an increase in IL-10 and 
TGF-β – both significant factors in the progression of HIV146. The striking impact of cocaine 
administration on risk and progression of HIV, along with the evidence of numerous 
mechanisms of action leading to these issues, necessitates further work before effective HIV 
treatment and prevention strategies can be developed. 
HIV and other infections are not the only conditions worsened by cocaine use. Cancer 
progression has also been shown to be associated with the binding of cocaine to σ1 receptors, 
which alters chemokine production, specifically IL-10, leading to suppression of the antitumor 
response152,161. It has also been reported that macrophage inhibition of tumor growth is 
diminished when exposed to cocaine in vitro162. As the antitumor response is a feature 
associated with the immune system, it follows that the suppression of the immune system by 
cocaine would also hamper the response to tumor formation. 
Cocaine use is a culprit in many cardiovascular complications, including myocardial 
ischemia, apparent myocardial infarction, hypertrophy, myocarditis, thrombosis, stroke and 
sudden cardiac death, among others. Although the mechanisms by which cocaine plays a role in 
cardiovascular disorders remain to be determined, many studies investigate the connection163–
168. A thorough review of the role of cocaine use in cardiovascular disorders has been conducted 
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elsewhere169–171. It is, however, important to realize the broad range of physical effects caused 
by cocaine use.  
In a related study on drug-induced accelerated aging, Reece reports that addicted 
populations of patients show higher erythrocyte sedimentation rate (ESR), C-reactive protein 
(CRP), globulins, globulin/albumin ratio, and lymphocyte count when compared with non-
addicted medical patients and that since many of these factors are considers biomarkers of 
aging, it is possible that aging of addicted individuals follows a contracted time course172. 
 
1.4.1.3.4 Current Strategies of Immune Modulation Research 
 Much of the research to determine the effects of cocaine on immune function discussed 
above was performed using immune cell lines and blood samples from animal models. The 
assessment of immune status is typically performed by quantifying parameters such as 
lymphocyte proliferation, cell count, cytolytic activity, plaque-forming activity, antibody titer, 
cytokine production, and corticosterone levels, to name a few. Immunoassays such as enzyme-
linked immunosorbent assay (ELISA) and immunohistochemistry combined with flow cytometry 
are the current techniques used in these types of studies. These techniques have their 
downfalls, though. For example, ELISA is plagued by potential complications of cross-reactivity 
and poor sensitivity, although digital ELISA might increase the sensitivity by orders of 
magnitude173. Flow cytometry, while fast and capable of detecting multiple wavelengths at a 
time, reports only population-based information, missing any variation between cell phenotypes 
and not allowing sequential measurements on individual cells. Further complicating such 
measurements in cultured lymphocyte cell lines are the large volumes associated with cell 
culture known to dilute paracrine and autocrine signaling factors that provide critical 
information concerning the status of the immune system42. These concerns in the determination 
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of immune status bring to light the need for additional analytical techniques and 
instrumentation to delve further into these biological matters. 
 
 
1.4.1.4 Neuroimmune Connection and its Role in Potential Long-Term Effects of Cocaine 
It is widely accepted that drug use, especially when repeated, leads to long-lasting 
behavioral sensitization in the form of psychosis or craving for the drug, which is thought to 
arise from potentially permanent174–177 neuroplastic changes in certain areas and circuitry of the 
brain as a result of increased dopamine transmission178. De Vries et al. report that reinstatement 
of drug-seeking behavior after withdrawal is associated with this long-term behavioral 
sensitization179. Activation of the σ1 receptor has been implicated in drug-seeking relapse in 
mice as determined through the use of the conditioned place preference (CPP) behavioral 
assessment180. Ecke et al. link long-term alterations in genes typically viewed as stress- or 
immune-related to cocaine use and the levels of cAMP response element-binding protein 
(CREB), a factor in stress-induced reinstatement181. The evidence of long-term effects in the 
nervous system shows that permanent changes could be taking place that may have a 
subsequent effect on immune function either through the brain-immune communication 
network (Figure 1.9)182–184 or by some other means. Brain-mediated immune responses involve 
not only neuroendocrine, neurochemical, metabolic and autonomic responses, but also changes 
in mood, motivational state, sleeping patterns, eating behavior, and social and locomotor 
activities185. 
Cocaine has long been shown to increase levels of adrenocorticotropin hormone (ACTH), 
β-endorphin, and corticosterone in rats in a manner dependent upon cocaine or dopamine 
regulation of corticotropin-releasing hormone (CRH), the initiator of hypothalamic-pituitary-
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adrenal (HPA) axis activation186–188. Likewise, cocaine use is associated with the maintenance of 
increased cortisol levels189. Upregulation of these stress hormones leads to alteration in gene 
expression and potentiates cocaine self-administration190. HPA axis activation, along with the 
increased secretion of these signaling molecules, leads to modulation of the immune system. 
Most investigations into the combined modulation of the immune system through the brain 
signaling in addition to cocaine are relatively short-term studies, and their findings have mixed 
responses due to the difficulty of controlling studies with collective cell-mediated immunity 
alterations and peripheral effects relating to the humoral immune response. In one of the few 
 
 
Figure 1.9 A) Brain-immune bi-directional connections: the vagus nerve, the hypothalamic–
pituitary–adrenal (HPA) axis, the sympathetic nervous system (SNS) and the peripheral 
nervous system (PNS). B) Glucocorticoids' mechanisms of action on immune cells resulting in 
alteration of function. From Sternberg et al.184 
A B
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long-term studies, Avila et al. suggest several valid explanations for prolonged immune 
suppression after withdrawal from chronic cocaine use that imply long-term or even permanent 
alterations in the immune system191. They discuss how the immune system vulnerability caused 
periodic release of corticosteroids initiated by cocaine administration, the sustained stress 
response release of corticosteroids during withdrawal, or the combination of the two as 
potential mechanisms of sustained T cell suppression after withdrawal191. In separate studies by 
the same group, the activated neuroendocrine stress response was implicated in the alteration 
of cellular immunity during the early withdrawal period192,193. Johnson et al. investigated the 
immune markers during acute cocaine withdrawal in pregnant women, and over this short 
period of data collection saw significant changes in complement receptor expression, which 
plays a role in the host-pathogen response194. 
The interaction between the brain and the immune system is bidirectional, resulting in 
the brain interpreting immune cell activation as a stressor through signaling of cytokines182,183. 
Since cocaine is capable of eliciting an immune response by binding to serum proteins and 
thereby activating the release of cytokines, the effects of cocaine may be potentiated through 
the HPA axis.  
A recent review published on the neuroimmunopharmacology of opioids provides an in-
depth discussion of the role of the central immune system – i.e., astrocytes and microglial cells, 
which exhibit behaviors of both neural cells and immune cells – in this interconnection of the 
neurological and immunological systems195. Hutchinson comments that “[c]entral immune 
signaling cannot be thought of as a parallel system separate from that of neuronal synaptic 
transmission and neuronal communication,” which, taken together with the research findings of 
the neuro-immune connection, can be extended to include the peripheral immune signaling. 
Cocaine has been found to further potentiate the neuro-immune connection by serving as an 
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inflammatory stressor that causes leukocytes to adhere to endothelial cells of the blood-brain 
barrier, which leads to leaking of the tight junctions and allows leukocytes to traverse the 
barrier196. This connection complicates the determination of potential mechanisms of 
immunosuppressive effects of cocaine, but further establishes the likelihood of both direct and 
peripheral mechanisms of action, the interactions of which may serve as a feedback system that 
could lead to prolonged and long-term effects in both the immune and nervous systems. 
Experienced researchers in the field of drug-modulated immunology also speculate on 
the matter of long-term immune effects. For instance, Pacifici et al. comment that “. . . the 
possibility that some kind of immune memory mechanism could also play a role cannot be 
discarded”197. Evidence of these potential sustained effects, however, may lie in the neuro-
immune communication, including the HPA axis and the autonomic nervous system. With the 
increasing attention toward psychoneuroimmunology and the link between the brain and the 
immune system, in addition to the continuing quest to understand addiction, future studies may 
be able to bring to light any long-term or permanent immune effects and the connection 
between those of the long-lasting or permanent behavioral changes in the nervous system.  
 
1.4.1.5 Cocaine Effects Summary 
Cocaine, while often considered to plague a single physiological system, is capable of 
eliciting a range of effects on both the nervous and immune systems, thereby creating a cascade 
of physiological responses. Many of the effects on the nervous system are due to modifications 
of dopamine signaling, though there is evidence of additional actions through the σ1 receptor, as 
well as receptors that are still to be identified. The modulation of the immune system by cocaine 
is highly dependent on dose and administration frequency, and although cocaine alone does not 
elicit an immune response, it may lead to activation of the immune system and production of 
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cytokines through alterations in serum proteins. When viewing the modulations of both the 
immune and nervous systems in light of the bi-directional communication network, it is likely 
that further regulatory interactions occur, specifically through stress hormones and immune-
signaling molecules, producing a complex interaction network that leads to adaptations in gene 
transcription. While there is no published evidence of a permanent change in immune function 
as a result of either chronic or acute cocaine use, the long-lasting or permanent behavioral 
changes, in addition to the link between the brain and the immune system, lead one to 
speculate regarding this possibility. Immune adaptations could further explain the relationship 
between cocaine use and diseases and aging.  
In order to best treat addiction, it is important to understand how drugs of addiction 
affect not only the brain, but also the immune system. Though the recent advances in 
developing vaccines against cocaine addiction198 could serve to benefit many individuals, they 
focus on preventing the neural effects of the drug, ignoring the immune response to the drug-
modified serum proteins (which begins as soon as cocaine enters the bloodstream) and 
subsequent neuro-immune signaling capable of perpetuating addictive effects. Yet these 
endeavors may serve to propel interest in the effects of cocaine on the immune system in 
addition to the neurological effects. Continuing to look at cocaine modulations on a systems 
level, thus further investigating the neuro-immune connection, could lead to additional 
treatment strategies that ameliorate the long-term or permanent changes associated with 
chronic drug use. 
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2.1 Abstract 
 The inherent complexity of biological systems inhibits predictability, and therefore 
understanding, on levels ranging from cells to systems and even to whole organisms. This 
complexity presents challenges to the study of systems at the cellular level that lead to 
conflicting and often unexplainable results. For significant progress in the biological revolution 
to endure, technological innovation must precede and stimulate biological advancement. Herein 
is described such a technological progression capable of expanding the palette of cell biology 
techniques. Using a combination of microfluidics, online desalting, and nanoelectrospray 
ionization-ion mobility-mass spectrometry (nESI-IM-MS) technologies, a platform adept at the 
sampling of the cellular microenvironment with robust temporal specificity has been 
constructed. The cellular response to stimuli in the microenvironment, in conjunction with the 
cell’s metabolic processes, results in the secretion and excretion of a suite of biomolecules, 
known as the exometabolome, for the purpose of communication with other cells or tissues and 
elimination of waste materials. Naïve and cocaine-experienced T cell metabolism of cocaine is 
used as an exemplary system to confirm the capability of the platform, highlight its potential for 
metabolite discovery applications, and explore immunological memory of T cell drug exposure. 
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2.2 Introduction 
Cellular response is a complex phenomenon that manifests both physically and 
chemically. While physical responses can most often be analyzed visually, chemical responses 
are difficult to characterize even with modern detection methods. Adding to the difficulty is the 
influence of timing when dealing with cellular response. When responding to a biochemically 
altering stimulus, such as naïve T cell response to an antigen presented by a dendritic cell, a cell 
undergoes a series of biochemical pathway shifts that allow it to adapt to its new conditioned 
state. The cell’s temporal response, therefore, provides insight into the interspersed pathway 
shifts that occur throughout the various stages of stimulus exposure. Temporal response is 
especially relevant to toxicology, where, despite experiencing a toxin and undergoing numerous 
metabolic shifts, an organism may not show observable external symptoms until much later, 
when effective treatments are no longer as useful. 
Nonetheless, time remains a largely underappreciated or neglected variable in most 
comprehensive cellular response experiments, not as much for its perceived lack of value as for 
its difficulty of precise temporal resolution and control of measurements. Biological 
measurements typically take one of two forms; either they sample a small number of targets 
very frequently (as in immunoassay or fluorescence measurements, e.g.) or they sample a 
plethora of targets over a broad time span (e.g., proteomic workup). The limitations of current 
methodological strategies and detection technologies stymie the combination of these two 
approaches. The most comprehensive analysis would track as many analytes as possible and 
sample these analytes as frequently as possible to capture the truly dynamic properties of 
metabolic responses. As the frequency of sample collection is increased, previously unidentified 
patterns in signal response may begin to emerge, according to the Shannon-Nyquist theorem, 
which states that in order to properly characterize a pattern containing a frequency of Y, the 
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sampling must occur at an interval greater than 1/(2Y). Also, increasing the sampling frequency 
may reduce the possibility of aliasing, wherein rapidly varying phenomena are undersampled in 
violation of the Shannon/Nyquist theorem to produce misleading results. 
With the approach in place, a major logistical problem still remains: how does one 
sample a biological system multiple times over the course of an experiment without destroying, 
or even perturbing, that system? The exometabolome, or suite of biomolecules that are 
secreted or excreted from a cell into the surrounding matrix, represents a promising target. The 
exometabolome has been demonstrated as a viable indicator of internal cellular processes and 
can be easily assessed without any disturbance of the system from which it originates1. Changes 
in exometabolomic species transport provide information on the current state of the cell 
population, which can lead to a more thorough understanding of the particular cell’s biology and 
to the ability to control the cell’s behavior. 
The cell is constantly surveilling the surrounding environment. Perceived changes in this 
microenvironment lead to alterations of intracellular and intercellular signaling, which in turn 
lead to shifts in gene regulation and modifications in protein and metabolite production. 
Depending on the signal received, the intracellular processes enacted may lead to the secretion 
of another signaling factor to extend the complex web of communication. These signaling 
factors are produced by a given cell for communication with 1) nearby cells of the same type 
(autocrine signaling), 2) adjacent cells (juxtacrine signaling), 3) nearby cells of a different type 
(paracrine signaling), and 4) distant cells (endocrine signaling). The exometabolome not only 
includes traditional signaling molecules, but also enzymatically produced metabolites of 
xenobiotics (i.e., drugs, toxins) introduced to cells. 
 The Vanderbilt Institute for Integrative Biosystems Research and Education (VIIBRE) 
Multitrap Nanophysiometer (MTNP) is a polydimethylsiloxane (PDMS) microfluidic device that 
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functions as a miniature bioreactor. In contrast to traditional cell biology techniques that often 
require cellular populations on the order of >108, the MTNP allows for studies on small 
populations of cells or simple organisms (<105). The MTNP has been used for long-term optical 
measurements of the dynamic behavior of cells, including fluorescent labeling of cells to 
determine type and activation state and detect signaling dynamics2–4. This device provides a 
framework on which to study numerous cells, i.e., T cells, beta cells, and breast cancer cells, as it 
traps both non-adherent and adherent cells with structural barriers instead of with chemical 
surface modification that may cause cells to be exposed to higher shear stresses resulting from 
direct contact with fluid flow. The MTNP is well suited to detect secreted molecules in cellular 
effluent, and it is also unique in its ability to provide a system for investigating the dynamic 
response of a cell population to a stimulus. The constant perfusion design of the microfluidic 
bioreactor gives rise to a platform component capable of real-time alteration and control of the 
cellular microenvironment, in addition to providing an opportunity for monitoring the effluent 
output from the device. 
The use of a biological model for testing the instrumentation platform does have a 
major downside in the form of potential loss of metabolite signal due to adsorption to PDMS 
bioreactor surfaces. Rectification of these types of issues requires changing the microfluidic 
device material or modification of PDMS surface properties. Switching device materials, and 
thus the techniques for producing such devices, often requires substantial changes in 
infrastructure as well as loss of desirable PDMS properties such as optical clarity and low feature 
size. Surface modification is more plausible, as procedures can be added onto existing 
fabrication or experimental methods. A variety of types of surface modification of PDMS 
microfluidic devices have been investigated, such as chemical vapor deposition, sol-gel coating, 
silanization, surfactant coating and dynamic coating (reviewed elsewhere5,6). Due to the nature 
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of this combined technology platform with mass spectrometry downstream of the microfluidic 
device, care must be exercised in the selection of a surface modification method. The presence 
of species in the bioreactor effluent necessary for the alteration of the PDMS surface can lead to 
complications in the detection of desired cell secretions due to issues of dynamic range. 
Instability of species used in surface modification can additionally lead to adsorption of secreted 
cellular materials to PDMS. A stable, inert coating is crucial for downstream mass spectrometry. 
Surfactants and dynamic coating methods are not appropriate for this application as the 
presence of electrostatically bound polymer or added analytes to the solution are not compliant 
with detecting low levels of cellular signals. One method leading to a covalently bound surface 
modifier is silanization. Though silanes are often deposited on surfaces through chemical vapor 
deposition and can result in the production of chlorine gas, ethoxy- and methoxy-silanes can be 
purchased in a liquid form, resulting in ease of application to PDMS surfaces for the prevention 
of non-specific adsorption. 
 The complexity of biological samples often overwhelms standard screening techniques 
seeking to discover biomarkers of disease or rapidly assess drug efficacy. This unique problem 
warrants an analytical technique capable of both rapid screening of samples and sufficient 
sensitivity to account for the many analytes in low abundance that typically comprise 
metabolomic and signaling experiments, which often either defy detection or appear collectively 
as chemical noise. The use of mass spectrometry (MS) as the leading detection method of 
proteomic7, lipidomic8, and glycomic9 studies has led to many advances in elucidating the 
complexity of the cell. 
 The combination of constant microfluidic perfusion bioreactors with mass spectrometry 
has the potential to rapidly screen cell effluent for secreted species indicative of internal 
metabolic perturbations. Several studies have taken on the challenge of integrating these 
66 
technologies to produce a powerful analytical platform. In an early experiment, Chan et al. 
verified that using PDMS bioreactor devices to transfer samples into the electrospray ionization 
mass spectrometer (ESI-MS) did not contaminate the samples10. On-chip ultrafiltration and 
analyte pre-concentration for high-throughput small molecule screening with ESI-MS were 
performed with the resulting detection sensitivity shown to increase by one to two orders of 
magnitude over off-chip screening strategies11. A significant impairment in coupling cellular 
bioreactor microfluidic devices with online-MS is in the suppression of signals of interest by salts 
present in biological samples. To combat this problem, some form of desalting is typically 
performed offline, using either a solid phase extraction (SPE) column and vacuum manifold or 
some form of liquid chromatography. These techniques desalt samples by providing a 
functionalized surface for which salts and analytes have differing affinities. For example, liquid 
chromatography (LC) typically uses C18 columns, which provide good affinity binding sites for 
non-polar molecules but lack sufficient interaction prospects for salts, thereby allowing for an 
aqueous rinse to clear the column of salts and a subsequent organic elution of analytes without 
the suppressing contributions from salts. These methods, while providing an efficient means of 
desalination, come at the expense of temporal resolution, and they are not designed for online 
analysis. One recent development in the online desalting of effluent from a microfluidic 
bioreactor is the work of Chen et al., which incorporates a packed micro-solid phase extraction 
column12. 
 We have previously demonstrated the ability to rapidly desalt a continuous sample 
stream using online SPE13. This work directly translates to the processing of continuous sample 
streams originating from a MTNP. Using online SPE for such applications provides a surface for 
which analytes of interest have affinities but unwanted salts do not. This allows for variable 
duration periods of pre-concentration of the analytes. 
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 As an initial proof of concept experiment for this integrated platform, we selected 
cellular memory of drug exposure, specifically Jurkat T cell memory of cocaine, for ease in 
identification of known drug metabolites and for its unique biological information. The choice of 
cell type was based upon cocaine’s classification as an immunosuppressive agent, whether by 
mechanisms of direct and/or indirect actions on immune cells. Findings from experiments tying 
cocaine to immune function suppression have been contradictory at times14–18, most likely 
because of the complex biological systems under investigation and wide variety of experimental 
procedures. A major hurdle in determining these mechanisms is the lack of an assay capable of 
tightly controlled environmental parameters, temporal robustness to avoid loss of intermittent 
 
 
Figure 2.1 Cocaine metabolic pathways. Each compound is labeled with name, abbreviation 
and molecular weight.  
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changes, and multi-parameter sampling for unique evidence of experimental variable 
interconnection. The platform proposed herein allows for such an assay to be conducted. 
Through the comparison of naïve Jurkat T cells and those with prior cocaine exposure on this 
platform, differences in cocaine metabolism (general pathways shown in Figure 2.1) may be 
detected. Figure 2.2 demonstrates the experimental concept. Exposure of a naïve cell to cocaine 
may lead to a certain exometabolomic profile which defines the state of the cell. However, 
when a cell with prior cocaine experience receives a subsequent dose, the exometabolomic 
profile may either be identical to that of the naïve cell under exposure or distinguish the cell as 
unique. With a near real-time readout of cellular metabolic events on our integrated 
 
 
Figure 2.2 Experimental Scheme showing the potential cell fates (in terms of 
exometabolomic profiles) demonstrated as color change in the above image for naïve and 
cocaine-experienced cells upon exposure to cocaine in a microfluidic bioreactor.  
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microfluidic-solid phase extraction-ion mobility-mass spectrometry platform, it may be possible 
to determine variations in exometabolomic profiles that will provide evidence of cellular 
memory of cocaine exposure. 
 
2.3 Methods 
 
2.3.1 Microfluidic Bioreactor Design and Fabrication 
 The VIIBRE Multitrap Nanophysiometer (MTNP) was previously designed in AutoCAD 
and converted to a chrome mask on glass (Advance Reproductions, North Andover, MA). A 
silicon master was produced through photolithography methods which include spinning a 
negative photoresist, SU-8, onto silicon wafers, exposing them to UV light through the desired 
mask to crosslink the SU-8, then developing to remove non-cross-linked polymer19. 
Polydimethylsiloxane (PDMS) (Sylgard 184 Elastomer Kit, Dow Corning, Midland, MI) was then 
cast onto the silicon and SU-8 master, cured, and removed from the master. Inlet and outlet 
ports were punched and PDMS replicas were bonded to glass coverslips by O2 plasma treatment 
(Harrick Plasma Cleaner, Ithaca, NY). A representation of this fabrication method is shown in 
Figure 2.3.  
 
2.3.2 PDMS Surface Modification 
 Liquid 2-[methoxy(polyethyleneoxy)6-9propyl]trimethoxysilane (PEG-silane) was 
obtained from Gelest (Morrisville, PA). Immediately following plasma treatment, devices were 
intubated and a 2% solution of PEG-silane in 95% ethanol, 5% H2O, and 11mM acetic acid was 
injected until the device interior was filled. Devices were allowed to site at room temperature 
for 10 minutes followed by a rinse with ethanol, then water. A final incubation on a hot plate at 
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110°C for 10 minutes was then performed to evaporate any remaining solvent and complete the 
surface modification. Figure 2.4 portrays the steps in the covalent surface modification of PDMS. 
 After at least 24 hours at room temperature, each device was perfused with 
fluorescently labeled insulin at a rate of 500 nL/min for 30 minutes and then rinsed with Ringer’s 
buffer (118 mM NaCl, 5.4 mM KCl, 2.5 mM CaCl2, 1.2 mM MgSO4, 1.2 mM KH2PO4, 20 mM 
HEPES) for another 30 minutes. Images were collected every 15 seconds during the perfusion 
and rinsing stages with an inverted Nikon Eclipse Ti-e fitted with a 495 nm/521 nm 
excitation/emission filter set for fluorescent imaging of adsorbed insulin. Images were aligned 
and processed with Image J for comparison of total fluorescence intensity. 
 
Figure 2.3 A) Microfluidic device fabrication procedure involving photolithography and 
replica molding techniques. B) Design of the MTNP (i) with 18 µm x 12 µm cell traps (ii) 
capable of trapping 2-3 cells each (iii) in a device with a 234 nL volume and 7056 cells traps. 
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Figure 2.4 PDMS Silanization scheme showing hydrolysis of methoxy group from PEGn 
trimethoxysilane to form silanol groups (A) and the steps of PDMS activation (B(i)), silane 
deposition (B(ii)), condensation of the silane into chains (B(iii)), hygrogen bond formation 
between silanol and oxidized PDMS surface (B(iv)) and covalent bond formation between 
silane and PDMS surface (B(v)).  
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2.3.3 Cell Culture and “In Culture” Cocaine Exposure 
 Jurkat T cells (clone E6-1, TIB-152) (ATCC, Manassas, VA) were cultured in 90% RPMI 
1640, 10% fetal bovine serum (FBS, heat inactivated) (Lonza, Allendale, NJ) at 37°C, 5% CO2 
according to the manufacturer’s instructions. 
 In-culture cocaine exposure experiments were performed as follows (Figure 2.5). Two 
populations of Jurkat T cells (passage 6, 2 million cells/ml, 500 µL, in biological triplicate) from 
the same culture flask were added to two separate microcentrifuge tubes. Both tubes were 
centrifuged at 200 × g for 2 minutes and supernatant was removed. Cells in tube one were 
 
Figure 2.5 Cocaine exposure scheme for both in culture and online cell experiments showing 
the time course of cocaine administration to naïve (blue) and experienced (green) T cell 
populations. Experienced cells received a pre-exposure dose of cocaine for 4 hours while the 
naïve cells did not. 
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resuspended in 500 µL of RPMI 1640 and incubated for 54 minutes at 37°C, 5% CO2. The cells 
were then centrifuged as above and resuspended in RPMI with cocaine at 60 µg/ml, then 
incubated for another 54 minutes. This cell population received two more steps of media 
switching, RPMI then cocaine, for a total of four 54-minute exposure periods. Each time the cells 
were centrifuged, the supernatant was reserved for protein precipitation and metabolomic 
analysis. Since these cells lacked pre-exposed to cocaine, they were termed “naïve.” 
 Cells in the second tube were resuspended in 500 µL of cocaine in RPMI 1640 (60 µg/ml) 
and incubated for 216 minutes at 37°C, 5% CO2. After this period, cells were again centrifuged 
and then exposed in the same manner as tube one with alternating exposure to plain RPMI 1640 
and cocaine. Supernatant from these samples was also kept for metabolomic analysis. Since 
these cells had an extended cocaine pre-exposure period, they were termed “experienced.” 
 In order to investigate the cocaine degradation over the time course of the experiment, 
samples of cocaine in RPMI were incubated in the same conditions as the cells and sampled at 
each 54-minute time point starting at time zero and ending at 10.5 hours. 
 
2.3.4 Metabolomics Sample Preparation and UPLC-ESI-IM-MS Analysis 
 As each 54-minute time point was taken, supernatant was placed on ice to halt any 
continued metabolite modifications and immediately processed for protein removal with cold 
methanol. To each 300 µL supernatant sample, 900 µL of cold methanol was added, vortexed, 
allowed to sit for 10 minutes at 4°C and then centrifuged at maximum speed for 10 minutes in a 
Heraeus Fresco 21 temperature-controlled centrifuge (Thermo Scientific). Supernatant was 
transferred to a new microcentrifuge tube and kept at 4°C until all samples were collected and 
processed. All samples were then dried down in a Savant DNA 110 Speedvac overnight with low 
heat and reconstituted in 300 µL 5% methanol/95% water (0.01% formic acid). 
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 Samples were placed in the sample tray of the nanoAcquity UPLC with autosampler 
(Waters, Milford, MA), which remains cooled to 4°C to prevent sample degradation. 
Ultraperformance liquid chromatography was performed on 1 µL samples loaded on a HSS C18, 
1.8 µm particle size column with mobile phase A (0.1% formic acid in H2O) by ramping from 
100% mobile phase A to 100% mobile phase B (0.1% formic acid in MeOH) over 11 minutes, 
then holding at 100% mobile phase B for 2 minutes. Ion mobility-mass spectrometry and MSe 
were then performed on the eluted analytes using the Synapt G2 ion mobility-mass 
spectrometer (Waters, Milford, MA). Quality control samples were dispersed every 10 samples 
in the Waters Masslynx v4.1 software sample list among technical triplicates of each biological 
sample. 
 
2.3.5 Online Cell Loading and Experimentation 
 Prior to experimentation, 500-1000 µL of cell suspension was removed from culture 
flasks. Cells at passage 6 were used for experiments. Cells were then gently pelleted and 
aspirated into polyether ether ketone (PEEK) tubing connected to pump-controlled syringes. The 
flow direction of the pump was reversed upon intubation of the MTNP and cells were collected 
into microfluidic traps for experimentation. Cell-loaded devices were then perfused with 
selected media components and bright-field images were collected by an inverted Nikon Eclipse 
Ti-e (Nikon Instruments, Melville, NY). Cells in the MTNP were maintained at 37°C and 5% CO2 
during experimentation. 
For T cell cocaine metabolism studies, populations of naïve T cells and experienced T 
cells (exposed to cocaine at 60 µg/mL in RPMI 1640 for 4 hours) were stimulated with either 
cocaine (60 µg/ml in RPMI 1640) or RPMI 1640. Cells were initially exposed to plain RPMI media 
for 54 minutes, followed by exposure to cocaine at 60 µg/mL in RPMI for 54 minutes. Both steps 
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were repeated for a total of four steps. Experiments with naïve and experienced cells were 
performed on the same day, in series, to exclude any variation in cell population from day to 
day. The cocaine exposure scheme is the same as the in-culture exposure, shown in Figure 2.5. 
 
2.3.6 Solid Phase Extraction Desalter 
Columns are made of 360 µm OD/100 µm ID fused silica tubing and are bomb-loaded in 
house with 3 μm, 300 Å, C18 phase Jupiter Bulk Packing (Phenomenex, Torrance, CA) using a 
PIP-500 Pressure Injection System (New Objective, Woburn, MA). Three 10-port Nanovolume 
UPLC Valves with 360 µm fittings, C72MH-4690ED (VICI Valco Instruments Co. Inc., Houston, TX) 
were used for the valve arrangement (Figure 2.6). The aqueous solvent and both organic solvent 
lines, running at 500 nL/min, were supplied with an Eksigent Nanoflow Metering System (AB 
SCIEX, Framingham, MA), which has four independent flow channels. The output lines from the 
two downstream valves were connected with a micro-T junction and fed directly into the mass 
spectrometer via a nano-electrospray ionization (nESI) source. Cheminert 360 µm unions (with 
100 µm bore) were used for all tubing-to-tubing connections (not shown). Only fittings for 360 
μm OD tubing were used as the more popular 1/16” fittings requiring sleeves to connect to 
smaller bore tubing instigated leakage at high backpressures. Other than the columns, which 
were made of fused silica, 360 µm/50 µm PEEK tubing was used. Prior to experimental use a 2 
μg/mL solution of polyarginine was run through the system to bind all non-reversible interaction 
sites. Elution cycles were then run overnight to ensure all reversibly bound material was 
removed before experimentation. Sample loops were added to the system (as seen in Figure 
2.6) to reduce backpressure buildup. 
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Figure 2.6 Solid phase extraction desalter setup starting from initial sample effluent flow 
incorporates 2 sample loops, 3 valves, and 2 C18 columns. During (A), sample effluent fills 
sample loop 2 for 9 minutes, while the aqueous solvent flows through sample loop 1, over 
column 1 and to waste. The organic solvent flows over column 2 and to the mass 
spectrometer. B) Upon switching of the valves, the sample effluent fills sample loop 1 for 9 
minutes. Aqueous solvent forces the 1.5 µL head of aqueous solvent, the 4.5 µL of sample 
effluent, and an additional 2.1 µL of aqueous solvent over column 2 to equilibrate the 
column, load the sample, and rinse away the salts. Organic solvent runs through column 1 
and to the detector. C) The next valve switch again exchanges the sample loop filled by 
effluent, while column 1 is equilibrated, loaded, and rinsed. The analytes captured on column 
2 are eluted by the organic solvent and sent to the detector. D) When the valves switch 
again, the sample effluent fills the opposite loop, column 2 is equilibrated, loaded, and 
rinsed, and column 1 is eluted with organic solvents and those analytes are sent to the 
detector. The pattern repeats until the experiment is completed. 
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2.3.7 Online Cell Effluent Desalting and Mass Spectrometry Analysis 
 All online cell effluent experiments were conducted using PDMS MTNP devices. Cellular 
effluent from the device was processed online prior to mass spectrometry analysis using the 
online SPE desalter in Figure 2.6. Cell effluents, driven by syringe pumps upstream of the 
bioreactor, were filtered with an inline filter (1 µm stainless steel frit, followed by a 0.5 µm 
polymer mesh, IDEX Health & Science, Oak Harbor, WA) and loaded into each sample loop. 
Sample loops, which were made of 360 µm OD/250 µm ID tubing, were 12.2 cm long, providing 
a sample loop volume of 6 μL. The continuous sample stream was diverted into each sample 
loop for exactly 9 minutes at 500 nL/min, thus filling the sample loop to 75% capacity. Because 
water was always flowing through these sample loops immediately prior to sample flow, a plug 
of 1.5 μL of water preceded each sample effluent plug. This plug served to quickly and roughly 
equilibrate the column with an aqueous solvent. Once the loop was filled to 75% with online 
sample effluent, the small water plug and sample effluent were passed over the column, using 
the aqueous solvent line to generate the necessary backpressure. Once the effluent had cleared 
the sample loop and had been entirely passed over the column, an additional 2.3 minutes or 2.1 
μL of aqueous solvent (H2O with 0.1% formic acid) was run over the column to serve as the 
rinsing/purging step to remove residual salts. Following the salt purge, the column was eluted 
with organic solvent (90% methanol, 10% H2O, 0.1% formic acid). Each step of this process from 
the initial effluent flow through the SPE desalter is illustrated in Figure 3. Data were collected 
using MassLynx software (Waters Corp., MA) by Data Dependent Analysis (DDA) method cycle 
files, where each column elution was collected as an individual file. Collecting each column 
elution as individual data files aided sample analysis, as explained later. 
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2.3.8 Data Processing and Multivariate Statistical Analysis  
 Resulting data sets from both online and in-culture experiments were processed using 
Waters MarkerLynx software along with Umetrics Extended Statistics software for multivariate 
statistical analysis (Waters Corp., MA). All spectra were corrected to sodiated HEPES buffer 
([M+Na]+ exact mass 261.0888), centroided, and peaks were normalized to 10,000 counts per 
sample. Only spectra from samples analyzed through UPLC were deisotoped and underwent 
chromatographic peak detection. Data from online experiments were processed by a combined 
scan range. An intensity threshold was set for all data at 1000. Principal component analysis 
(PCA) with Pareto scaling was performed to verify initial sample grouping. Further statistical 
analysis with orthogonal partial least squares-discriminate analysis (OPLS-DA) was performed to 
identify significant contributors for group separation. 
 Metabolite Expression Dynamics Inspector (MEDI), a free java-based program, was used 
to create metabolite expression profiles from the raw metabolite data obtained from the online 
experiments. Respective media standard profiles (cocaine in RPMI and plain RPMI) were 
subtracted from each experimental profile. Naïve profiles were subtracted from the experienced 
profiles according to their experimental timing to produce a difference map of metabolite 
expression unique to the experienced cell population. 
 
2.4 Results and Discussion 
2.4.1 Platform Integration and Evaluation 
 Successful integration of the platform has been achieved as shown in Figure 2.7. The 
microfluidic bioreactor (MTNP) is controlled upstream by Harvard Apparatus syringe pumps and 
viewed under the Nikon Eclipse Ti-e, for optional fluorescent and brightfield imaging acquisition, 
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and outfitted with a stage incubator for control of temperature, gas and humidity. The effluent 
exiting from the MTNP flows through two inline filters for catching cell debris (1 µm stainless 
steel frit, followed by a 0.5 µm polymer mesh, IDEX Health & Science, Oak Harbor, WA). Once 
through the filters, the effluent fills one of the two sample loops vented to open air to avoid 
high backpressures in series with the compliant microfluidic device. After the effluent undergoes 
salt removal by the solid phase extraction desalting system, it is directed into the nESI source 
and sprayed into the Waters Synapt G2 nESI-IM-MS. A complete use and troubleshooting guide 
is available in Appendix B. 
 Initial work, which paired a previous arrangement of the online SPE design20 with 
MTNPs, resulted in ruptured devices. When LC pumps were used to rinse and elute the SPE 
 
Figure 2.7 MTNP-SPE-nESI-IM-MS platform with Harvard Apparatus syringe pumps, Nikon 
Eclipse Ti-e inverted fluorescence microscope with stage incubator, solid phase extraction 
desalter with Eksigent and nanoAcquity pumps for solvent flow control, nanoelectrospray 
ionization source for continuous flow sample analysis in the Waters Synapt G2 ion mobility-
mass spectrometer. Beyond the initial experimental setup, all components are fully 
automated and capable of running multi-hour experiments limited by the lifetime of cells in 
the MTNP. 
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columns, pressure would build up behind the column. When the valve was switched so that the 
MTNP was directly in series with the column, this high backpressure (>200psi), would cause 
massive flow reversal and induce the PDMS device to physically delaminate from the glass to 
which it was bonded. This problem was mitigated by altering the valve arrangement to 
incorporate sample loops. By cutting off the direct pathway between the columns and the 
microfluidics, the buildup of pressure that occurred during rinsing/eluting was unable to take 
the least resistive path to the compliant microfluidic device and would instead be vented to the 
waste port, as shown in Figure 2.6. Although in extreme cases the inline filters downstream of 
the microfluidic device may become clogged with cells, thus interfering with effluent flows, this 
is a rare occurrence and can be prevented by using new filters for each experiment in addition 
to open-outlet cell loading (allowing cells to exit the device during loading before attaching to 
the downstream components). 
 The sample loop addition to the valve arrangement allowed for a two-step valve 
configuration, a simplification of the previous version. The new two-step arrangement 
generated a saw-toothed pattern as opposed to the rise-and-fall delta-function pattern 
observed with previous arrangements20. In this 180-minute experiment, an 18-minute-long cycle 
was used, producing an elution peak every 9 minutes. The sample loop volume was designed 
specifically to hold 9 minutes of sample effluent (4.5 µL at 500 nL/min flow rate). This cycle 
duration was determined to be optimal based on analyte concentrations. The file acquisition 
was set to account for the delay time from the device to the nESI source such that one column 
elution was captured per file while accounting for the roughly 12-second software delay 
between file acquisitions. Pump switching for control of the MTNP perfusion media was also 
timed with the SPE desalter valve switching. 
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 Removal of salts in an online manner greatly increases signal-to-noise ratio. Yet with the 
low number of cells and high concentration of media components, detecting low concentrations 
of analytes is challenging. The signals are also affected by the dynamic range (~105) of the mass 
spectrometer21. Presumably, post-desalting, and given cellular utilization of nutrients in the 
media, HEPES at 10 mM is the analyte of greatest concentration. The high concentration of this 
species limits the lower range of detection of exometabolomic contents to roughly five orders of 
magnitude lower. This HEPES concentration can be reduced if necessary, but as its purpose is to 
buffer the media to maintain a physiological pH, there could perhaps eventually be a tradeoff. 
While detection of low concentration species remains a challenge, the ongoing advances in mass 
spectrometry technology will increase the detection capabilities of this system.  
 
2.4.1.1 PDMS Surface Passivation for Increased Signal-to-Noise Ratio 
 Using fluorescently labeled insulin, the adsorption of insulin to the surface of PDMS 
could be visualized. Figure 2.8 provides both pictorial and graphical representations of the 
adsorption of insulin to PDMS and PEG-Si-PDMS. During the 30 minutes of fluorescent insulin 
exposure, the intensity increases drastically for the control PDMS and less drastically for the 
silanized PDMS with a relative maxima of 4:1.  
 While insulin is not necessarily a prime target of these experiments, it serves as an 
example of the potential complications from non-specific adsorption. Though high sensitivity is 
characteristic of mass spectrometry, this system seeks to identify secreted molecules from 
roughly 105 cells. Detecting these low-level signals becomes a greater challenge when a portion 
of the signal is lost due to interactions with seemingly inert materials. Although the PDMS 
passivation schemes returned positive results, some metabolite, peptide or protein species, 
such as insulin, are particularly “sticky” to most polymer and glass. In testing the capabilities of 
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the system, we have noticed drastic reduction in and even absence of signal from insulin 
standards over time, even at low temperatures. Additionally, insulin hysteresis in the combined 
platform has been discovered after as long as 4 days of continuous perfusion of the SPE desalter 
tubing and columns. While the columns may be a source of insulin retention, this particular 
hysteresis occurred with freshly made columns, pointing to an alternate source of 
contamination as the culprit. The remaining sources of contamination could be from insulin 
retention in the PEEK and/or fused silica tubing lines, the valve rotors, or even on the source 
block or cone of the mass spectrometer. Insulin adsorption does not merely lead to a 
contamination problem; it also leads to reduction in the overall insulin signal. 
 
2.4.1.2 Comparison of UPLC-ESI-IM-MS to MTNP-SPE-nESI-IM-MS 
 A significant reduction in time is among the benefits of continuous sample flow from the 
microfluidic bioreactor to the solid phase extraction desalter and into the nESI-IM-MS. This 
integrated platform allows for the setup (~2-3 hours), execution (~4-8 hours), and data 
collection (no additional time) in the course of a day. Traditional in-culture experiments with 
UPLC-ESI-IM-MS analysis possibly require less initial setup (~1 hour), roughly the same execution 
time (~4-8 hours), significant additional sample processing time (~15-20 hours including 
overnight sample evaporation), and data collection (~50 hours for 120 samples with a 25-minute 
UPLC time per sample) for a total of about 4 days until data are ready for processing compared 
to 1 day for the platform developed in this work. 
 Another advantage of the integrated platform compared to in-culture experiments is in 
the ease of obtaining mass spectra at multiple time points. Our process is automated with 
constant media perfusion control timed with the switching of the SPE desalter valves as well as 
the data file collection timing. With the in-culture experiments, a lengthier process is required to 
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Figure 2.8 Insulin treatment of silanized PDMS channels. PDMS channels were perfused FITC-
insulin for 30 minutes (green), followed by 30 minutes of rinsing with Ringer’s solution (blue). 
The top three fluorescent images show the surface bound insulin at 1 min, 31 min and 60 
min, with the bottom three images corresponding to the surface modified channels. Silanized 
PDMS channels (purple line) retain (at maximum) only 25% of the total insulin retained by 
untreated PDMS. 
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collect a time point. The cell suspension must be centrifuged for 2 minutes, the supernatant 
removed, and the cell pellet resuspended in new media. The length of time required for this 
media change is on the same order of the time points taken with the integrated platform. 
Repeated centrifuging and pellet aspiration can introduce unnecessary stress to the cells, which 
may produce an exometabolomic profile resulting from both the media exposure and additional 
cell stress. 
 One downside compared to liquid chromatography data is the absence of retention 
time information. While the solid phase extraction desalter uses a column similar to those found 
in an LC system, any slight timing discrepancy from one file collection to the next prevents the 
use of any retention time data. Confounding this issue is the fact that processing data within the 
Waters Masslynx software without retention time data available prevents the option for the 
removal of isotopes from the data. While this is a hindrance in some respects (roughly 3 times 
more peaks, redundant data, etc.), it can prevent the accidental removal of isobaric peaks of 
interest from the study. 
 
2.4.2 Cocaine Metabolism in Naïve and Experienced T cells 
2.4.2.1 Online Cellular Analysis  
 Two populations of Jurkat T cells were compared in this study: naïve T cells that had 
never been exposed to cocaine and experienced T cells that had been incubating in cocaine at 
60 µg/ml in RPMI 1640 for 4 hours prior to online experimentation. As shown in Figure 5, a high 
degree of variance was observed based not only on what type of media was present in the 
bioreactor (i.e., plain RPMI media or cocaine RPMI media), but also whether the cells 
experienced cocaine earlier in the day (i.e., whether the cells were experienced or naïve to 
cocaine exposure). The major unique contributors to group separation between naïve and 
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experienced exometabolomic profiles included m/z 283, m/z 187, m/z 399, m/z 157, and m/z 
337 (all at elevated abundance in the experienced group compared to the naïve group). The 
metabolites contributing to group separation between type of media to which cells were 
exposed in the MTNP consisted of m/z 312, m/z 182, m/z 304, m/z 290, and m/z 150. Though 
 
Figure 2.9 Walking principal component analysis of exometabolomic profiles of naïve (shades 
of yellow) and cocaine-experienced (shades of turquoise) Jurkat T cells obtained with on-line 
cellular analysis. Each numerically labeled data point represents a 9-minute column elution, 
with 6 data points collected per step (all marked with the step number and connected in 
order of collection with the dotted line). In steps 1 and 3, both cell populations received plain 
RPMI. In steps 2 and 4, both received cocaine in RPMI at 60 µg/ml. As profiles switch from 
RPMI to cocaine exposure, the data points move towards the right and vice versa, with the 
exception of naïve cell step 4, which stays closer to step 1. Further analysis of the data 
reveals this inconsistency may be explained by the death of the cells. Data were grouped not 
only based on the experimental step, but also by the experience level of the cells, as the cells 
receiving a 4-hour pre-incubation in cocaine group separately from those that did not receive 
this dose. 
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the data analysis pipeline prevented removal of isotopes, any m/z present in the list of top 
contributors negated the inclusion of their respective isotopes from these lists. 
 Benzoylecgonine (m/z 290 as [M+H]+, m/z 312 as [M+Na]+), a primary metabolite of 
cocaine, was identified as a contributing factor to the separation between the cocaine exposure 
steps and plain RPMI steps as well as to naïve cells and experienced cells. Analysis of this 
 
Figure 2.10 Top: Benzoylecgonine (BE) time course data for experienced (blue) and naïve 
(purple) cells. While data were gathered sequentially, plots are overlaid to highlight the 
increased abundance of BE in experienced cells. The absence of the expected increase in BE 
corresponding to step 4 (the last step of cocaine exposure) provides further evidence of cell 
death due to lack of cocaine metabolism. Bottom: The fragmentation spectra of BE are 
shown with parent ion of m/z 290. 
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metabolite over the time course of the experiment revealed an expected increase during 
cocaine exposure steps, but also showed a significant increase from naïve to experienced cells (p 
value = 5.7E-4) (Figure 2.10). Fragmentation spectra revealed fragment ions m/z 82, m/z 91, m/z 
105, m/z 150, m/z 168, m/z 182 and m/z 272, as shown in Figure 6. Analysis of the remaining 
top three contributors to separation based on media revealed cocaine at m/z 304, 
anhydroecgonine methyl ester (AEME) at m/z 182 (produced from dehydration of ecgonine 
methyl ester (EME) rather than the pyrolysis of cocaine), and ecgonine aldehyde, the 
decomposition product of EME, at m/z 150. 
 To verify that this increased BE abundance was not purely a result of non-enzymatic 
hydrolysis of cocaine to BE in aqueous solutions over the time course of the experiment, an 
experiment replicating the naïve and experienced cell experimental time course was performed 
with the omission of the Jurkat T cells. In order to compare the experiment with cells to that 
without cells, we normalized the BE intensity to the cocaine intensity. On average, the percent 
of the total normalized BE from non-enzymatic hydrolysis was 34.1% in step 2 of the naïve cell 
experiment while the corresponding percentage for step 2 of the experienced cell experiment 
was 34.5%. 
 The time course of additional metabolites is provided in Figure 2.11, including cocaine 
metabolites anhydroecgonine (AHE) (m/z 168) and hydroxybenzoylecgonine (HOBE) (m/z 306), 
as well as several unknown metabolites (m/z 330, m/z 475, m/z 678). Some of these additional 
metabolites have higher abundance in the cocaine-experienced population while others have no 
overall change in abundance. Overall, BE, AHE, and m/z 645 show significant increases from 
naïve to experienced cell population (p- values = 5.7E-4, 1.12E-3, and 1.60E-3 respectively). While 
AHE is a typical product of AEME (the pyrolysis product of cocaine), some reports have shown 
the metabolic pathway from cocaine into AEME and AHE could result from loss of water of EME 
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or ecgonine (EG)23. While there is much evidence that AEME and AHE can form as a result of the 
analysis technique, this is typical of gas chromatography separations that require vaporization of 
compounds, thus risking alteration of thermolabile compounds such as cocaine and its 
 
Figure 2.11 Additional metabolite time course data are shown compared to BE. Experimental 
conditions for each group of cells are shown above the graph with solid black lines indicating 
exposure to cocaine media. Anhydroecgonine (AHE) and hydroxybenzoylecgonine (HOBE), 
two additional metabolites of cocaine, provide examples of both variation between naïve 
and experienced cell groups in the case of AHE and consistency between these two groups in 
the case of HOBE. The increases in BE and AHE from naïve to experienced groups are 
statistically significant with respective p values of 5.7E-4 and 1.12E-3. Three unidentified m/z 
645, m/z478, and m/z 330 that contribute to the separation between media exposure groups 
are also shown. m/z 330 and m/z 478 show no statistical significance between naïve and 
experienced cell groups while the increase in m/z 645 is statistically significant (p = 1.6E-3). 
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metabolites24. Electrospray ionization is utilized when this type of compound is under 
investigation.  
 Exometabolomic profiles in the form of differential heat maps, created by the 
Metabolite Expression Dynamics Inspector, were created to demonstrate the temporal 
distinctions present between the naïve and experienced T cells. 30917 metabolites (including 
isotopes) were organized by random tile assignment into heat maps corresponding to each 9 
min data file. After the respective media background peaks were subtracted, the naïve time 
 
Figure 2.12 Metabolite Expression Dynamics Inspector heat maps demonstrating grouping of 
metabolites with similar trends in each of 2550 tiles. A) Each heat map represents a time 
point in the middle of the time course for each experimental step (RPMI or cocaine 
exposure). For instance, step one of RPMI exposure resulted in heat maps corresponding to 
data files 1 through 6, with the heat map corresponding to data file 3 shown. The difference 
between the experienced cells profiles (red) and naïve cells profiles (green) is calculated in 
the blue column. B) The color scale for the map ranges from -20.5 (showing a decrease in 
abundance of a particular group of analytes) to 26.69 (for an increased abundance of other 
analytes). C) The metabolite density map shows the distribution of 30917 metabolites.  
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course data was subtracted from the experienced time course. A sample of these differential 
metabolic profiles denoting the middle time point in each media exposure step is shown in 
Figure 2.12. A full set of time course heat maps for both the naïve and experienced groups are 
available in Appendix C.  
 
2.4.2.2 In Culture Cellular Analysis 
 To compare this instrumentation platform, as well as the resulting biological data of 
naïve and cocaine-experienced T cells, with the current standard in mass spectrometry analysis 
of biological samples, the online experiment was replicated in culture and samples analyzed 
with UPLC-ESI-IM-MS. Figure 2.13 shows the PCA plot demonstrating sufficient variance when 
comparing steps 1 and 3 (plain RPMI 1640 exposure) with steps 2 and 4 (cocaine exposure). 
Unlike the online experiment, separation between cocaine experienced cells and naïve cells is 
not achieved with exception of the initial RPMI exposure of the naïve cell populations. While 
once major difference is the number of time points per step of media exposure, as discussed 
previously, replicating the 9 minute time point sampling of the online system would confound 
the length of time needed for media switching, as well as add unnecessary stress to the cells.  
 
2.5 Conclusions 
2.5.1 Platform Capabilities and Shortcomings 
 We have described the analysis and proof of concept of a technology platform for near 
real-time detection of the cellular exometabolome based on the combination of a microfluidic 
bioreactor, an online SPE desalting arrangement, and mass spectrometry. A great strength of 
this platform is in its adaptability to different cell types and experimental conditions. 
Microfluidic cell trapping devices can be customized to the size of any adherent or non-adherent 
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cell type. In this work, we demonstrate cell trapping and experimentation on naïve and cocaine-
experienced Jurkat T cells. While this work shows only one model system based around cocaine 
exposure, the environmental stimuli are limited only by the number of pumps one has available 
for providing variable perfusion conditions and the temperature change and gas exchange rates 
an incubator is capable of generating. The online SPE desalting arrangement allowed for 
sufficient desalting to permit a temporal resolution of 9 minutes. While this temporal resolution 
 
Figure 2.13 In-culture principal component analysis of exometabolomic profiles of naïve 
(shades of yellow) and cocaine experienced (shades of turquoise) Jurkat T cells. Each 
numerically labeled data point represents the end point of a 54 minutes exposure to the 
indicated media. As with the online experiment, during steps 1 and 3  both cell populations 
received plain RPMI, while during steps 2 and 4 both received cocaine in RPMI at 60 µg/ml. 
Variance between step1 and 3 and steps 2 and 4 result in unsupervised grouping according 
to media exposure type. Separation between naïve and experienced cell groups, particularly 
when under cocaine exposure, does not occur to the same degree as yellow and turquoise 
points corresponding to steps 2 and 4 are heavily intermixed. 
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is not by any means a significant advance for cellular chemical detection methods, because it is 
dictated by the analyte abundance and detection capabilities of the TOF mass analyzer, it is 
(depending on the mass analyzer) the best resolution possible for this biological system using 
mass spectrometry. Because it is trivial to scale the loading time in this arrangement based on 
detection power, we believe a technology platform of this general system will be of 
considerable utility to the biological community, particularly as mass analysis detectors improve 
in the coming years. 
 
2.5.2 Cellular Memory of Cocaine Experience 
 Cocaine metabolism in naïve and experienced Jurkat T cells was investigated with this 
near-real time platform developed for the study of the cellular exometabolome. While it is well 
known that cocaine has an effect on immune cells, there has been no prior demonstration 
(though the idea has been suggested)25 of even a short-term immune cell memory of prior 
cocaine exposure. With the advent of this innovative platform, unique metabolic profiles are 
obtained that are absent from the “in-culture” data or perhaps lost due to the increased sample 
processing and UPLC analysis time. Upregulation of cocaine metabolism into benzoylecgonine in 
experienced cells demonstrates one contributor to the unique exometabolomic profile resulting 
from previous cocaine experience. Anhydroecgonine, as well as unknown metabolites m/z 645 
and m/z 478, are also upregulated in cell populations with prior cocaine exposure, leading to the 
possibility of indicators of immune cell memory of cocaine other than cocaine metabolites 
alone. 
 While there is a previously reported non-enzymatic degradation rate of cocaine into 
benzoylecgonine at physiological temperatures and pH22, we were able to confirm a rate specific 
to this platform. Through comparison of the BE to cocaine ratios from naïve and experienced 
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cell experiments, as well as the platform absent of cells, it is evident that the portion of BE 
abundance from non-enzymatic degradation does not entirely explain the significant increase in 
BE during the cocaine exposure steps in the experienced cells, indicating the response is due to 
a unique exometabolomic profile of T cells with prior cocaine exposure. Further analysis of 
cellular memory of cocaine exposure is warranted based upon these findings. 
  
94 
2.6 References 
1. Kell, D. B. et al. Metabolic footprinting and systems biology: the medium is the message. 
Nature Reviews Microbiology 3, 557–565 (2005). 
2. Faley, S. et al. Microfluidic platform for real-time signaling analysis of multiple single T cells 
in parallel. Lab Chip 8, 1700–1712 (2008). 
3. Warnement, M. R., Faley, S. L., Wikswo, J. P. & Rosenthal, S. J. Quantum Dot Probes for 
Monitoring Dynamic Cellular Response: Reporters of T Cell Activation. NanoBioscience, 
IEEE Transactions on 5, 268–272 (2006). 
4. Faley, S. L. et al. Microfluidic single cell arrays to interrogate signalling dynamics of 
individual, patient-derived hematopoietic stem cells. Lab Chip 9, 2659–2664 (2009). 
5. Zhou, J., Ellis, A. V. & Voelcker, N. H. Recent developments in PDMS surface modification 
for microfluidic devices. Electrophoresis 31, 2–16 (2010). 
6. Wong, I. & Ho, C.-M. Surface molecular property modifications for poly(dimethylsiloxane) 
(PDMS) based microfluidic devices. Microfluid Nanofluid 7, 291–306 (2009). 
7. Yates, J. R. Mass spectrometry: from genomics to proteomics. Trends in Genetics 16, 5–8 
(2000). 
8. Han, X. & Gross, R. W. Global analyses of cellular lipidomes directly from crude extracts of 
biological samples by ESI mass spectrometry: a bridge to lipidomics. J. Lipid Res. 44, 1071–
1079 (2003). 
9. Zaia, J. Mass spectrometry of oligosaccharides. Mass Spectrometry Reviews 23, 161–227 
(2004). 
10. Chan, J. H., Timperman, A. T., Qin, D. & Aebersold, R. Microfabricated Polymer Devices for 
Automated Sample Delivery of Peptides for Analysis by Electrospray Ionization Tandem 
Mass Spectrometry. Analytical Chemistry 71, 4437–4444 (1999). 
11. Jiang, Y., Wang, P.-C., Locascio, L. E. & Lee, C. S. Integrated Plastic Microfluidic Devices with 
ESI-MS for Drug Screening and Residue Analysis. Analytical Chemistry 73, 2048–2053 
(2001). 
95 
12. Chen, Q., Wu, J., Zhang, Y. & Lin, J.-M. Qualitative and Quantitative Analysis of Tumor Cell 
Metabolism via Stable Isotope Labeling Assisted Microfluidic Chip Electrospray Ionization 
Mass Spectrometry. Anal. Chem. 84, 1695–1701 (2012). 
13. Enders, J. R. et al. Towards monitoring real-time cellular response using an integrated 
microfluidicsmatrix assisted laser desorption ionisation/ nanoelectrospray ionisation-ion 
mobility-mass spectrometry platform. IET Systems Biology 4, 416–427 (2010). 
14. Bagasra, O. & Forman, L. Functional analysis of lymphocytes subpopulations in 
experimental cocaine abuse. I. Dose-dependent activation of lymphocyte subsets. Clinical 
and Experimental Immunology 77, 289–293 (1989). 
15. Roth, M. D., Whittaker, K. M., Choi, R., Tashkin, D. P. & Baldwin, G. C. Cocaine and {sigma}-
1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-
SCID model. J Leukoc Biol 78, 1198–1203 (2005). 
16. Chao, C. et al. Recreational drug use and T lymphocyte subpopulations in HIV-uninfected 
and HIV-infected men. Drug and Alcohol Dependence 94, 165–171 (2008). 
17. Pellegrino, T. & Bayer, B. M. In vivo effects of cocaine on immune cell function. Journal of 
Neuroimmunology 83, 139–147 (1998). 
18. Kubera, M. et al. The effect of cocaine sensitization on mouse immunoreactivity. European 
Journal of Pharmacology 483, 309–315 (2004). 
19. Duffy, D. C., McDonald, J. C., Schueller, O. J. A. & Whitesides, G. M. Rapid Prototyping of 
Microfluidic Systems in Poly(dimethylsiloxane). Analytical Chemistry 70, 4974–4984 
(1998). 
20. Enders, J. R., Marasco, C. C., Wikswo, J. P. & McLean, J. A. A Dual-Column Solid Phase 
Extraction Apparatus for the Online Collection and Preparation of Continuously Flowing 
Effluent Streams for Mass Spectrometry.  
21. Anderson, N. L. & Anderson, N. G. The Human Plasma Proteome: History, Character, and 
Diagnostic Prospects. Mol Cell Proteomics 1, 845–867 (2002). 
22. Warner, A. & Norman, A. B. Mechanisms of cocaine hydrolysis and metabolism in vitro and 
in vivo: a clarification. Ther Drug Monit 22, 266–270 (2000). 
96 
23. Xia, Y., Wang, Bartlett, M. G., Solomon, H. M. & Busch, K. L. An LC−MS−MS Method for the 
Comprehensive Analysis of Cocaine and Cocaine Metabolites in Meconium. Anal. Chem. 
72, 764–771 (2000). 
24. Fandiño, A. S., Toennes, S. W. & Kauert, G. F. Studies on Hydrolytic and Oxidative 
Metabolic Pathways of Anhydroecgonine Methyl Ester (Methylecgonidine) Using 
Microsomal Preparations from Rat Organs. Chem. Res. Toxicol. 15, 1543–1548 (2002). 
25. PACIFICI, R. et al. Cell-Mediated Immune Response in MDMA Users After Repeated Dose 
Administration. Annals of the New York Academy of Sciences 965, 421–433 (2002). 
 
  
97 
CHAPTER III 
 
3 PROGRESS TOWARDS A HETERODYNE FRAMEWORK FOR THE GENERATION AND DETECTION 
OF OSCILLATORY CHEMICAL SIGNALS IN NONLINEAR LIGHT-PRODUCING SYSTEMS 
 
 
Christina C. Marasco1,2,3 , Madeleine S. Durkee1,2,3, Ayeeshik Kole4, Loi Hoang1,2, Jie Zhou1,5, Ryan 
Planchard3, Ron Reiserer1, Philip C. Sampson1, and John P. Wikswo1,2,3,5,6 
 
 
1Vanderbilt Institute for Integrative Biosystems Research and Education, Vanderbilt University, 
Nashville, TN 
2The Searle Systems Biology and Bioengineering Undergraduate Research Experience, Vanderbilt 
University, Nashville, TN 
3Department of Biomedical Engineering, Vanderbilt University, Nashville, TN 
4Indiana University School of Medicine, Purdue University, Bloomington, IN 
5Departments of Physics & Astronomy, Vanderbilt University, Nashville, TN 
6Molecular Physiology & Biophysics, Vanderbilt University, Nashville, TN 
  
98 
3.1 Abstract 
The complexities of biological regulatory networks (oscillations, feedback loops, etc.) 
provide motivation for the development of mathematical and physical models for the 
exploration of nonlinear reaction dynamics. When considering even single biochemical reactions 
comprising these networks, simplifications of the reaction mechanism are often unavoidable or 
even made out of ignorance as nonlinear production of potentially unstable chemical 
intermediates potentiates a problem that may be nearly impossible to overcome. Within this 
work we present a novel analytical method based on the radio signal processing technique 
‘heterodyning’ to explore the existence and rate of generation of previously undetectable 
chemical intermediates. We have developed instrumentation for sinusoidal concentration 
generation, a microfluidic mixer for the combination of two or more unique chemical 
frequencies, a detector for quantifying the generation of reaction products, and a data analysis 
technique for processing the output signal into the frequency domain. This work will describe 
the heterodyne technique, detail the initial efforts in developing the hardware framework, show 
preliminary results from the use of the technique on nonlinear chemical reactions, and detail 
further experiments needed to fully benchmark the heterodyne framework. The development 
of these methods and their application to biological regulatory networks could provide a means 
of more closely regulating and interpreting complex cell signaling and metabolic response. 
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3.2 Introduction 
Central to the field of systems biology is the effort to both model and understand the 
complex cell signaling pathways that govern biological networks. Table 3.1 lists the various types 
of cellular signaling that comprise the breadth of response of a cell to its environment. 
Experimental and computational biologists alike often use wiring diagram analogies to represent 
these molecular interaction networks. Biological regulatory networks have been shown to be 
comprised of simple motifs, such as cycles and cascades, controlled by positive and negative 
feedback loops, described by linear, hyperbolic, sigmoidal, and oscillatory signal-response 
dynamics, which when taken together to form an integrated network, can drive the parametric 
state of the cell into one or more attractor states1,2. With such complexities in signaling systems, 
experimental determination of dynamical properties must be coupled with mathematical 
models to minimize error in the interpretation of the results. The dynamics of nonlinear 
biochemical networks under oscillatory stimulus conditions has been modeled by Ingalls as an 
extension of metabolic control analysis3. Tyson describes a means of combining simple signal-
Table 3.1. Methods of Cellular Communication 
Intercellular Signaling 
Method 
Target Example 
Endocrine Distant cells Insulin on hepatocytes 
Paracrine Nearby cells 
Coagulation factors in 
platelets 
Juxtacrine Adjacent cells 
Membrane-bound growth 
factor 
Autocrine Emitting cell Interleukin-2 in T cells 
Intracrine Intracellular receptor 
Renin-angiotensin system in 
cardiac fibroblasts 
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response elements consisting of sigmoidal switches, transient responses, hysteretic switches 
and oscillators to computationally model any complex regulatory network2. Interested readers 
are directed towards numerous excellent reviews1,2,4–6 that have been written detailing the finer 
points of cell signaling, state stability and modeling of complex networks that are tangential to 
the scope of this work.  
Paramount to this work is in the exploration of sinusoidal signaling dynamics. Sinusoidal 
stimulus-response has been shown to provide valuable information in dynamical biological 
systems ranging from neuronal networks7–11 and the human visual response12–15 to insulin 
secretion in pancreatic islets16–18 and yeast regulation19–23. Oscillatory glucose levels have been 
shown to synchronize pancreatic islets in vitro24. Bird et al. report constant frequency sinusoidal 
calcium oscillations resulting from the stimulation of mouse lacrimal acinar cells with 
submaximal methacholine dose which are dependent on a negative feedback loop driven by 
protein kinase C25. Berthoumieux et al. reported oscillatory concentration dynamics on a three 
state enzyme system following Michaelis-Menten kinetics26. 
 
3.3 Heterodyne Chemistry Theory 
Heterodyning is a radio frequency processing technique developed within the 
telecommunications industry for the shifting of signals from one frequency to another through 
nonlinear mixing in a diode or transistor. When two or more signals at unique frequencies 
(Figure 3.1A) are combined in a linear manner, the resulting frequencies include only the input 
frequencies (Figure 3.1B). In contrast, when these same input signals are combined in a 
nonlinear fashion, new frequencies are generated, called heterodynes, that correspond to the 
summation and differences of the input frequencies (Figure 3.1C-E). These heterodynes are 
similar to musical “beats”. As the complexity of the nonlinear signal combination varies 
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Figure 3.1 Heterodyne chemistry basics. A) contains two simulated signals a(t) and b(t) with 
periods of 223 seconds and 269 seconds. B) When these signals are combined linearly and 
analyzed in the frequency domain only the two input frequencies are seen. C), D), and E) 
When nonlinear combinations of these same two frequencies (fa and fb) occur, the 
production of additional frequencies, as annotated, are seen. These new frequencies are 
referred to as heterodyne frequencies. 
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the number of heterodyne frequencies also varies. For instance, nonlinear mixing resulting in 
the product of the two input signals (a(t) x b(t)) results in the formation of two heterodyne 
frequencies: the summation and difference, while a(t)2 returns only one heterodyne and a(t)2 x 
b(t) returns five heterodyne frequencies: fa-fb, 2fa-fb, fa+fb, 2fa, and 2fa+fb. Through the 
knowledge of the particular heterodyne frequencies present, one can potentially infer the 
combination of the input signals, though contributing system nonlinearities may complicate this 
analysis. It should also be possible to learn even more through the analysis of the spectral 
amplitudes. 
 When considering the application of this technique to chemical reaction schemes, the 
mixing of radio or television signals translates to the mixing of chemical species. If the reaction is 
nonlinear (i.e. second order or higher reaction kinetics), the mixing of reactants will result in the 
production of heterodyne frequencies. Discrepancies between previously determined reaction 
models and experimental data arising from this technique, in terms of the presence or absence 
of certain heterodyne frequencies, might illuminate any disagreements in the kinetics 
controlling the reaction and the presence of formerly unknown reaction intermediates. This 
technique, therefore, has the potential to clarify chemical reaction schemes, as well as the 
kinetics governing those reactions.  
While the application of this signal elucidation technique to the analysis of oscillating 
chemical signals in a biological network may be tantalizing, the complexities of the response 
may produce unexplainable, contradictory data without the a priori knowledge of oscillatory 
chemical signals on a simplified chemical reaction. In order to validate this platform and analysis 
technique on a chemical reaction, two non-cellular reaction networks will be used, specifically 
heavy metal quenching of fluorescein and peroxyoxalate chemiluminescence. As the product of 
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both of these reactions is light, an optical read-out can be used, thus avoiding any intrusive 
reaction monitoring methods. 
The basis for this heterodyne technique lies in the conversion of time domain data into 
the frequency domain, which can be done through a Fourier transform. For the analysis of 
discrete data sampled from a continuous source, such as light emission, the Fast Fourier 
transform (FFT) is used, specifically with the Cooley-Tukey algorithm27–29. With the powerful 
capabilities of the FFT, it is possible to assess reaction product data in the frequency domain.  
 
3.3.1 Heterodyne Models of Nonlinear Reactions 
Chemical reaction models for both fluorescein quenching and peroxyoxalate 
chemiluminescence were created in Matlab for verification of data analysis techniques and 
experimental data comparison. 
 
3.3.1.1 Fluorescence Quenching Model 
 Fluorescence excitation, emission, non-radiative decay and quenching are regularly 
represented with the set of equations shown in Figure 3.2. With low concentrations of the 
quenching agent, the reaction has been shown to follow the Stern-Volmer relationship 
 
  
 
                                                                                  
 
where kQ is the rate constant of the quenching reaction, I is the fluorescence intensity under 
steady-state conditions, I0 is the fluorescence intensity in absence of the quencher, τ0 is the 
fluorescence lifetime, and [Q] is the quencher concentration. This relationship indicates a linear 
correlation between quencher concentration and fluorescence intensity, providing kQ is not 
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dependent on the quencher concentration. However, fluorescence quenching has been shown 
to behave nonlinearly under circumstances with high concentrations of the quencher30. While 
several mechanisms of fluorescence quenching have been described31,32, including collisional 
electron transfer, excited complex formation, and static quenching, a method of fully describing 
the complex reaction kinetics of fluorescence quenching has not yet been developed.  
Heavy metal quenching of fluorescein with iodide was selected as the specific quenching 
relationship to inspect33,34. Matlab was utilized to create a model of fluorescein quenching with 
iodide based on the equations shown in Figure 3.2 (excitation was not included) along with rate 
constants kf and knr as described by Arik et al.,
35 and kQ approximated as 
 
         
     
    
                                                                 
 
 
Figure 3.2 Reaction Rate Equations for fluorescein excitation, emission, non-radiative decay 
and quenching. 
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Figure 3.3 Fluorescein Quenching Model A) Input sinusoidal concentration profiles for 
fluorescein (green) and potassium iodide (grey). The periods of KI and FL were 223 seconds 
and 269 seconds. B) Display of simulated raw data for a fluorescein quenching reaction with 
the frequency domain of this simulated raw data set revealing the drive frequencies as well 
as a few summation and difference frequencies (values with assignments appear in Table 3.2.  
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where R is the sum of the molecular radii of the fluorophore and quencher, N is Avogadro’s 
number, and D is calculated from the sum of the diffusion coefficients of the fluorophore and 
quencher35. Each concentration vector was specified by a sinusoidal concentration wave, either 
according to non-constant flow or constant flow. The amplitude, frequencies, y offset and phase 
offset were modeled to replicate the experimental conditions. The resulting simulated data for 
the rate of light emittance over time for a two pump, variable flow setup is displayed in Figure 
3.3A. The FFT of this simulated raw data was taken and peaks were annotated as shown in 
Figure 3.3B and Table 3.2. While this model only considers the reaction kinetics and thus, does 
not incorporate the channel dimensions or diffusion of chemical species, it does provide 
theoretical verification of the heterodyne technique. 
 
 
Table 3.2 Fluorescein quenching drive and heterodyne frequencies corresponding to the data 
shown in Figure 3.3. 
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3.3.1.2 Peroxyoxalate Chemiluminescence Model 
 Peroxyoxalate chemiluminescence can be described with the equations shown in Figure 
3.4 in which hydrogen peroxide (H2O2) reacts with bis(2,4,6-trichlorophenyl) oxalate (TCPO) to 
produce an intermediate (D), which then dissociates further into intermediates C and E. 
Intermediate E transfers electrons to a fluorophore, Rubrene (Rub), causing it to become excited 
and emit light. This reaction is the basis for glow sticks. Peroxyoxalate chemiluminescence has 
been defined by second order chemical kinetics for both reaction 1 and 2 and would be 
expected to produce a complicated frequency spectrum of heterodynes based upon the 
summations and differences of the three reactants. 
 A Matlab model of the peroxyoxalate chemiluminescence reaction was created based 
on the equations in Figure 3.4, along with rate constants as described by Comstock et al.36. 
Sinusoidal concentration profiles for Rubrene, TCPO and H2O2 were specified with parameters 
consistent with those of the physical experiment. The periods of Rubrene, TCPO, and H2O2 were 
set as 223 seconds, 269 seconds, and 307 seconds to mimic the physical experiment as well. The 
 
Figure 3.4 Reaction rate equations for peroxyoxalate chemiluminescence in which species C, 
D and E are reaction intermediates. 
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Figure 3.5 Peroxyoxalate Chemiluminescence Model. A) Input sinusoidal concentration 
profiles for Rubrene, TCPO, and H2O2 oscillating at periods of 223, 269, and 307 seconds. B) 
The simulated raw chemiluminescence data is shown with the fluorescence signal scale 
inverted to adhere to the experimental data convention of increase in signal intensity in the 
downward direction. Exploring the frequency domain returns many heterodyne frequencies 
as listed in Table 3.3. The amplitude of the drive frequency of H2O2 is much lower than 
expected. Drive frequencies are labeled with an asterisk. 
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Table 3.3 Peroxyoxalate chemiluminescence drive and heterodyne frequencies 
corresponding to the data shown in Figure 3.5. 
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resulting simulated raw data along with the FFT of this data is shown in Figure 3.19. The drive 
(bold) and heterodyne frequencies are labeled. As this model requires three reactants compared 
to the two for the fluorescein quenching model, the data has an added degree of complexity as 
three drive frequencies combine to produce the frequency spectrum (sum and difference 
frequencies are a combination of a, b, and c instead of just a and b).  
 This model, like that of the fluorescein quenching, lacks the added complexity of 
diffusion and laminar flow in the serpentine mixer used for the physical experiment. Though 
only concerned with the reaction itself, the model does provide insight into the heterodyne data 
analysis techniques for nonlinear chemical reactions with three reactants. Further model 
manipulations including varying the reaction rate constants and the initial concentrations are 
available in Appendix D along with the Matlab code for the models. We find that alterations in 
the reactant concentrations and reaction rate constants demonstrate a change in peak 
amplitude in the frequency domain, though no shift in peak frequencies are seen. Further 
analysis of these and additional simulations should be completed to fully understand the 
dependence of the peak amplitudes on the concentrations and rate constants. 
 
3.4 Development of Hardware and Data Analysis Methods for Heterodyne Chemistry 
The heterodyne-based platform developed herein for the study of these oscillatory 
chemical signals must include instrumentation for modulating sinusoidal concentration via flow 
rate, a microfluidic mixer for the combination of two or more unique chemical frequencies, a 
detector for acquiring reaction product data, and a data analysis technique for processing the 
output signal into the frequency domain. 
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3.4.1 Sinusoidal Concentration Generation 
 The generation of sinusoidal concentration profiles is paramount to this work. While a 
variety of options is possible, in theory, a low-volume, low-cost, highly adaptable option is 
desirable. To achieve these desired criteria, we turn to microfluidic-based approaches. 
 
3.4.1.1 Literature Examples 
The generation of sinusoidal concentration profiles for simulating in vivo non-linear 
dynamics requires sophisticated and expensive flow systems. Several groups have pioneered 
work on producing microfluidic variable concentration generators, often incorporating valves 
and pumps (examples shown in Figure 3.6). Mosadegh et al. produced a microfluidic oscillator 
using switch valves and check valves to convert a constant infusion of fluid into an oscillating 
output37. Azizi and Mastrangelo created a microfluidic pulsed waveform generator capable of 
simulating rat striatum dopamine release, beta cell intracellular calcium oscillations and beta 
cell extracellular insulin secretion38. A microfluidic device for the production of sinusoidal 
glucose concentrations has been shown to allow for the entrainment of pancreatic islets24,39. 
The same research group has also produced a microfluidic multi-analyte gradient generator 
capable of independent sinusoidal control of up to four different chemical species40. Through 
the use of these or similar non-linear concentration generators, it is possible to more closely 
simulate upstream signaling dynamics, leading to a cellular response to stimulus that more 
closely mimics the in vivo response. With a sinusoidal concentration generator paired with a 
method of analyzing cell response data, the influence of the sinusoidal signal component could 
be revealed, providing another tool for describing, modeling and analyzing complex biological 
systems. 
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3.4.1.2 Ideal Pumps 
 While the production of sinusoidal concentration profiles, as described above, has been 
described by a number of different groups, an additional means of generating these 
 
 
Figure 3.6. Examples of microfluidic sinusoidal concentration generators. (A) and (B) are 
designs from the same group incorporating pumps and a series of valves to produce 
independently controllable sinusoidal concentrations24,39,40. (C) employs a pulse code 
modulator comprised of a multiplexer with a low pass filter and digitally encoded clock 
signals to generate a variety of waveforms38. (D) depicts a design for a microfluidic oscillator 
capable of converting constant flow into an oscillating output through the use of both switch 
valves and check valves37. 
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concentration gradients could be done solely through the use of pumps, thereby preventing 
limitations on the downstream applications of these variable flows.  
 Sinusoidal flow alone does not produce sinusoidal concentration profiles. Predicted 
speeds of a two pump system (blue and gold curves), with each pump running at a different 
frequency, can be seen in Figure 3.7A. The total speed calculated as the summation of the two 
sinusoidal speeds is variable (yellow curve) and will, as a result, fail to produce true sinusoidal 
 
Figure 3.7 Multiple Pump Sinusoidal Concentration Profile Generation. A) Predicted 
individual (blue and gold) and pumps speeds (yellow) for a 2 pump setup driven sinusoidally 
at different frequencies with an amplitude of 30 rpm, y offset of 30 rpm. y1 (blue) has a 
period of 223 seconds, while y2 has one of 269 seconds. The total speed (yellow) is calculated 
from the sum of the individual speed profiles, indicating a non-constant total speed. B) The 
concentration profiles resulting from variable total flow rates are predicted for fluorescein 
and Iodide based on initial concentrations of 100 µM and 1 M, respectively. C) Using two 
pumps per reactant (red and green) run 180 degrees out of phase (with y offset = amplitude 
= 30 rpm), a constant total flow can be achieved. D) The resulting simulated concentration 
profiles for fluorescein and iodide are sinusoidal. 
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concentration profiles. Variable flow concentration profiles are predicted for fluorescein and 
iodide as shown in Figure 3.7B.  
 In order to generate sinusoidal concentration profiles, two pumps are required per 
reactant with these pairs of pumps run with the same sinusoidal flow parameters, but 180 
degrees out of phase from each other. Figure 3.7C predicts the speeds of two pumps (red and 
green curves) run in this manner, with the resulting summation of the speeds (blue curve) a 
constant. To achieve a sinusoidal concentration profile with this two-pump per reactant setup, 
one pump should contain the actual reactant, while the other should contain the solvent of the 
reactant. The resulting concentration profiles, predicted for fluorescein and iodide, with two 
pumps per reactant (a total of four pumps needed), are shown in Figure 3.7D. Both the variable 
total flow and constant total flow assume the need for a y offset preventing the theoretical 
 
Figure 3.8 Y offset contributions to frequency spectrum. A) Simulated signal for y(t) = sin 
2πft, with f = 0.004484 Hz, along with the frequency domain data showing the drive 
frequency. B) Simulated signal for y(t) = 1 + sin 2πft, with f = 0.004484 Hz. The frequency 
domain data reveals no change upon the use of a y offset. The magnitude of the drive 
frequencies are also the same (0.9973). 
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production of negative concentrations. By selecting a y offset equal to or greater than the 
amplitude, negative flows can be avoided. This y offset addition does not lead to any unforeseen 
discrepancy when analyzing the data in the frequency domain as evidenced by Figure 3.8. The 
FFT of a single sinusoidal signal with and without a y offset was performed, resulting in identical 
peaks at 0.004486 Hz (with identical magnitudes 0.9973) in the frequency domain. 
 Variable flow concentration profiles (Figure 3.7B) can be corrected to true sinusoidal 
profiles (Figure 3.9D) by adjusting by the total variable flow rate divided by a constant flow rate. 
 
                                 
                         
  
                   
 
where A is the amplitude of the speed profile (assuming A = y offset) and f1 and f2 are the 
frequencies of the pump driving fluorescein and the pump driving iodide. This correction factor 
can convert a single reactant’s concentration profile. Correcting resulting light emission based 
on a second-order kinetic model, requires a slightly different application of this factor 
 
                                        
                         
  
          
 
with variables as described above and a square of the correction factor to account for [light](t) = 
f[FL][I]. This correction factor allows data to be collected from variable flow conditions with one 
pump per reactant as described in Figure 3.7A (with subsequent correction) in addition to 
constant flow conditions described by Figure 3.7C with two pumps per reactant. 
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3.4.1.3 Rotary Planar Peristaltic Pumps 
Rotary Planar Peristaltic Pumps (RPPM, VIIBRE, Vanderbilt University), as previously 
described41, are comprised of a NEMA-17 stepper motor, shaft collar, PDMS washer, thrust 
bearing, 5-channel PDMS device, and polycarbonate plate as shown in Figure 3.9. Pump 
construction begins with fabrication of silicon masters through photolithography techniques 
according to the manufacturer’s specifications. 1) SU-8 2010 resist (MicroChem) was spun on a 
clean silicon wafer; 2) the wafer with resist was then soft baked; 3) the edge bead was removed; 
4) the resist was exposed to UV light through the desired mask; 5) the wafer was again baked to 
finalize the crosslinking; 6) the patterned wafer was developed until non-cross-linked resist was 
fully removed; 7) then a final bake was performed to reduce stress in the remaining SU-8. PDMS 
(Sylgard Elastomer 184, Dow Corning, Midland, MI, in a 10:1 polymer to curing agent ratio) was 
spun onto the silicon master at 500 rpm for 1 minute and cured on a hot plate at 110°C. To 
 
Figure 3.9 Rotary planar peristaltic micropump, shown in side view on the right is comprised 
of a stepper motor with its shaft coupled through a collar to a PDMS washer and thrust 
bearing that drive fluid flow through a PDMS device with 5, 50µm W x 20µm H channels. 
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create a thicker region for punching inlet and outlet ports, a 2 mm x 7 mm x 13.5 mm solid 
PDMS punch layer was bonded to the cured, spun on PDMS channel layer by treating both 
surfaces with O2 plasma (Harrick Plasma Cleaner, Ithaca, NY) and baking for 10 minutes at 110°C 
to complete the PDMS-PDMS bond. The channel and punch layer were cut and removed from 
the master and inlet and outlet ports created with a sharpened 25 gauge blunt tip. The device 
was then bonded to a 2 mm x 13.5 mm x 27 mm solid PDMS base layer by O2 plasma treatment 
followed by baking for 10 minutes at 110°C and overnight at 70°C. 6 mm biopsy punches were 
used to create holes in the microfluidic device for the motor shaft. Devices were aligned to the 
polycarbonate plate and then assembled onto the stepper motor with shaft collar, PDMS 
washer and thrust bearing through the application of four screws to the top of the 
polycarbonate plate. Channels were aligned overtop of the ball bearings with the aid of a 
microscope. A compression trapeze was used to apply 3.9 N (400 g with gravity) to the area in 
contact with the ball bearings. Alignment was reconfirmed post-compression. Inlet and outlet 
ports were intubated with polyether ether ketone tubing (PEEK, 150 µm ID, 360 µm OD, 
Upchurch Scientific). 
 RPPMS were controlled with a custom stepper motor driver platform, consisting of an 
Arduino Duemilanove capable of controlling up to four Schmalzhaus EasyStepper boards, thus 
providing an integrated module capable of driving up to four RPPMs. In-house developed 
Arduino code allows for the generation of sinusoidal flow rates through the specification of the 
direction, half maximum speed in RPM (or half amplitude), y offset, phase offset, period and 
duration. Annotated code can be found in Appendix E. For verification of sinusoidal flow and 
calibration to overcome pump-to-pump variability, the Upchurch Scientific Nano Flow Sensor 
and software package was used. 
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3.4.1.4 Problems and Solutions 
To provide verification for the sinusoidal concentration generation, the predicted speed 
profile, based on the Arduino stepper motor code, when driven sinusoidally was produced 
(Figure 3.10A). A noticeable discrepency in the period was produced, resulting in the input 
frequenciy to predicted output frequency calibration curve in Figure 3.10B revealing a 0.56% 
error between the frequency input to the code and the predicted output. An RPPM was then 
driven with the same input parameters and the resulting flow rate was measured with the 
NanoFlow sensor (shown in Figure 3.10C). In addition to a larger period discrepency, the 
 
Figure 3.10 Single pump sinusoidal flow rate. A) One period of predicted sinusoidal pump 
speed profile with an amplitude of 30 rpm, y offset of 30 rpm and an input period of 223 
seconds. The resulting output period is 224.24 seconds. B) Predicted output frequency based 
on 0.56% timing discrepancy in the Arduino code. C) Actual flow sinusoidal flow profile of a 
single pump with an input amplitude of 30 rpm, input y offset of 30 rpm and input period of 
223 seconds. The resulting flow measured with the NanoFlow sensor indicates an amplitude 
of 1.051 µL/min, a y offset of 0.9421 µL/min and a period of 209.44 seconds. 
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amplitude and y offset drift apart leading a brief time of negative flow. While the NanoFlow 
sensor has a notoriously difficult time with calibration to zero flow, the negative speed leading 
to the negative flow rates can be observed by eye as the motor will reverse direction for a very 
brief time. To avoid this region of negative flow, the y offset can be adjusted 3 or 4 intergers 
above the set amplitude.  
 
3.4.1.4.1 Inter-pump Variation 
Pump assembly, alignment and compression were highly scrutinized under 
magnification to achieve the most consistent results. Flows from seven RPPMs (1, 2a, 2b, 3a, 3b, 
4a, 4b) were monitored with the NanoFlow sensor and software. Pumps are numbered as such 
indicating that, for example, the fluidic component of pump 2a and 2b are true replicates with 
precise dimensional control; likewise are pump fluidics 3a and 3b and 4a and 4b identical. This 
matching of pump fluidics is intended for reducing variation between pairs of pumps, though 
there are still differences as evidenced by Figure 3.11A. Table 3.4 shows the average output flow 
rates for each pump run at a constant speed of 79 rpm, as well as the resulting standard 
deviations. Resultant Analysis of Variance (ANOVA, single factor) performed on this pump data 
demonstrates statistically significant differences between pumps (results can be found in 
Appendix G). From the average output flow rate data, it is in theory possible to calibrate the 
pumps in order to control the output flow rate. Figure 3.11B displays the flow rates of six 
sinusoidally driven pumps with input amplitude of 41 rpm, y offset of 43 rpm and period of 37 
seconds. The input and output parameters are shown in Table 3.5. The amplitude is calculated 
as half the peak to trough and reveals that the pumps do not trend in perfect agreement with 
the constant flow rate calibration scheme.  
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Figure 3.11 Pump Calibration. A) The variation in flow rate (as recorded by the NanoFlow 
sensor) between seven pumps set at the same constant speed (79rpm) is shown with 
average flow rates listed in Table 3.3. B) Six pumps driven sinusoidally each with an 
amplitude of 41 rpm, y offset of 43 rpm, and period of 37 seconds Pump 1 in this 
experimental setup always runs at a constant speed and was not analyzed for sinusoidal 
flow. The peak and trough flow rates, along with the output amplitude and y offset are 
reported in Table 3.4. 
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3.4.1.4.2 Matched Pump Pair Calibration 
As mentioned previously, flow must be kept constant to produce a sinusoidal 
concentration profile. Figure 3.12A depicts a two pump setup in which both pumps run with the 
same amplitude, y offset and period, but one pump has a phase offset of 180 degrees. The 
Table 3.5 Input and output parameters for sinusoidal calibration corresponding to Figure 3.11 
B. 
 
 
Table 3.4 Input speed and average resulting flow rates for constant speed calibration 
corresponding to Figure 3.11A. 
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summation of these two speed profiles (blue and gold) produce a constant speed output 
(yellow). This sum of sinusoidal flows can be utilized in the calibration method as well. In order 
to calibrate sinusoidally driven pumps, flows from pairs of pumps with matching fluidic 
components were mixed together prior to entrance into the NanoFlow sensor. The expected 
flow rate is constant, providing the pumps are of the same flow rate. Figure 3.12B-D show an 
initial flow summation for each pair of pumps in which oscillations occur (left half of each 
 
Figure 3.12 Sinusoidal Pump Calibration. A) The predicted speed profile in a 2 pump setup 
with pump b (blue) running 180 degrees out of phase from pump a (gold) with an amplitude 
of 30 rpm, a y offset of 30 rpm and a period of 223 seconds for both pumps. The summation 
of these two speed profiles produces a constant total speed. B), C) and D) show the pump 
calibration under sinusoidal control for each pair of pumps. For instance, pump 2a and 2b 
have the same input conditions, except 2b is offset by 180 degrees. The total theoretical flow 
rate produced should be constant. Yet the left half of B) shows oscillations. Pump 2a was 
adjusted to reduce the oscillations (right). The same procedure was used with pumps 3a and 
3b and 4a and 4b, though the latter set was problematic in that the oscillations could not be 
alleviated entirely. 
123 
subplot). Once the amplitude and y offset are tuned properly, the oscillations diminish (right half 
of each subplot). Pump pair 4a and 4b, Figure 3.12D, was problematic as the oscillations could 
not be completely reduced.  
 
3.4.2 Chemical Signal mixing with a Microfluidic Reactor 
Microfluidic reactors were designed with AutoCAD 2004lt and sent to Infinite Graphics 
(Minneapolis, MN) for production of a mylar mask bearing the designs. Silicon masters were 
created by standard photolithography procedures. SU-8 2010 resist (MicroChem) was spun on a 
clean silicon wafer and baked. It was then exposed to UV light through a mask to crosslink the 
resist in the desired pattern. After baking again, the coated wafer was developed to remove any 
un-cross-linked resist. The finished master was then poured with Sylgard Elastomer 184 (Dow 
Corning, Midland, MI) in a 10:1 polymer to curing agent ratio and allowed to cure at 60°C. Cured 
polydimethylsiloxane (PDMS) was cut and removed from the wafer and inlet and outlet ports 
created. After treatment with O2 plasma (Harrick Plasma Cleaner, Ithaca, NY), the PDMS was 
permanently bonded to glass cover slips. This process is shown pictorially in Figure 3.13. 
 
3.4.3 Detection of Light as Reaction Products 
 A detection strategy similar to that of flow injection analysis was designed to pair with 
continuous flow through a microfluidic reactor and the subsequent generation of light from the 
test chemical reactions chosen. While flow injection setups utilize a valve to control the 
introduction of a sample into a reagent flow stream for subsequent detection with or without 
reaction with the reagent, the desired design for the current analysis technique controls 
multiple reactant flow streams with pumps alone. This provides a means of controlling each 
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individual reactant separately. Once reactants are mixed, the light produced can be detected.  
 The experimental setup as shown in Figure 3.14 includes a 20x objective (LD A-Plan 
20x/0.3 Ph1, Zeiss) coupled to a photomultiplier tube (PMT, H5784-20, Hamamatsu). PMT 
output was amplified (20 dB boost, gain of 7-8), filtered (low pass at 20Hz) and collected for 
analysis by a USB data acquisition card (NI USB-6009, National Instruments). Labview 10 
(National Instruments) was used for acquiring data. Fluorescence excitation was accomplished 
through the use of a 440 nm Solid State, Diode Pumped, Continuous Wave 25 mW Laser (Crystal 
 
Figure 3.13 Microfabrication procedures for the production of microfluidic reactors involving 
photolithography and replica molding techniques. 
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Laser) coupled with a narrow band 442 nm excitation filter set with bandpass emission (Chroma 
Z442BP). Control of the flow of reactants through the microfluidic reactor was achieved by 
computer controlled microfluidic Rotary Planar Peristaltic Pumps (RPPM, VIIBRE, Vanderbilt 
University). Flow was conducted through polyether ether ketone (PEEK, 150 µm ID, 360 µm OD, 
Upchurch Scientific) from reservoirs, through the RPPMs and into the microfluidic reactor. Pump 
flow rates were under sinusoidal control to vary the concentrations of reactants in the device. 
Prime number sine wave periods were selected to minimize overlap of the harmonics during the 
course of the experiment. 
The Continuous Flow Photometer (CFP) was successfully developed for both 
fluorescence and chemiluminescence applications. The fluorescence applications involved the 
 
Figure 3.14 Continuous Flow Photometer (CFP) for both chemiluminescence and 
fluorescence studies with the inclusion of excitation laser and filter set specific to 
fluorescence measurements of fluorescein.  
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use of a filter set and excitation laser specific for fluorescein, while the chemiluminescence 
applications do not. To investigate the capabilities of the CFP for detecting varying 
concentrations of fluorescent signal, several fluorescein standards (0 µM, 50 µM, 66.7 µM, 80 
µM and 100 µM) were run at a constant rate to produce a standard curve (shown in Figure 
3.15A). To test the CFP for sinusoidal fluorescence applications, a single RPPM was sinusoidally 
driven with a period of 269 seconds or 223 seconds and the FFT was taken of resulting raw data 
to produce frequency spectra (Figure 3.15B, C respectively). The output drive frequency is 
bolded and errs from the input frequency according to the calibration plot in figure 3.15E. The 
ability of the CFP to determine inter-pump variability by means of the drive frequency output 
was investigated. Upon performing an FFT on the raw voltage time series data produced by 
driving two pumps under the exact same conditions, a greater shift from the expected output 
frequency is revealed perhaps as a result of inter-pump variability. The data analysis techniques 
are robust in that regardless of the shift in output frequency, the harmonics calculated based 
upon this output drive frequency are exact matches (0.06% error based on the peaks in B-D) for 
those found in the spectra (Figure 3.15D).  
To further investigate the discrepency with the period, the experimental data from the 
fluorescein quenching experiments incorporating the use of the CFP were used to produce a 
curve of input frequencies and actual output frequencies (Figure 3.15E). This data reveals an 
even greater discrepency in pump period at 5.83%. Since the periods are selected as prime 
numbers between 3 and 6 minutes to avoid overlapping harmonics, the actual value of these 
numbers lacks significance beyond this. Adjusting the input frequency based on this curve is 
futile to a certain extent as the Arduino stepper motor code requires intergers, preventing the 
production of an actual 223 second period. To test for the CFP’s performance with sinusoidal 
concentration profiles, a pair of pumps was driven with amplitudes and y offsets based upon the 
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calibration work. One pump was set to run out of phase from the other. The raw data and 
resulting frequency spectrum of a very short data set are show in Figure 3.16.  
 
 
Figure 3.15 CFP evaluation. A) Standard curve for varying concentrations of fluorescein (0 
µM, 50 µM, 66.7 µM, 80 µM and 100 µM) run at constant flow rates. B) and C) show single 
pump sinusoidal flow (constant concentration) frequency spectra with periods of 269 
seconds and 223 seconds and input parameters as indicated. D) Two non-calibrated pumps 
were run under identical parameters (sinusoidal flow, constant concentration), including the 
periods, to determine differences in the frequency spectrum as a result of inter-pump 
variability. The output drive frequency has shifted from that of the-input frequency data 
(from 0.004888 Hz to 0.004745 Hz). E) Actual output frequencies based on experimental data 
showing a 5.83% discrepancy between input frequency parameters and resulting frequencies 
in the experimental data. 
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3.4.4 Fourier Transform Analysis 
In order to achieve sufficient resolution of the frequency spectra, experiment durations 
were selected so as to collect at least 100 periods of the reactant driven at lowest frequency. 
Raw voltage data collected by the PMT and read and digitized by Labview (as a 63 bit .tdms file) 
was converted to Matlab with an in-house developed TDMS reader capable of down-converting 
the data into 16 bits without decimation and loss of resolution. Data were detrended (or zero 
 
Figure 3.16 CFP detection of sinusoidal concentration profiles. A) The frequency output 
expected from a 37 second period of oscillations produced an output frequency of 0.02747 
Hz (error of 1.6% from the theoretical value). B) shows the raw data of the 400 second data 
acquisition.  
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meaned) and a fast Fourier transform was then performed using Matlab’s built in FFT function. 
All Matlab data analysis scripts are available in Appendix F. Resulting frequency domain data 
were processed for peaks at least three times greater than the noise level and assigned a peak 
descriptor as matched to calculated values in the McLaurin series expansion of nonlinear mixing 
(addition of multiple sin waves) based on the two or three output drive frequencies. 3D and 
surface plots of swept frequencies were constructed for data visualization. All errors reported 
were calculated based on the following equation. 
 
 
 
3.5 Nonlinear Chemical Reaction Exploration 
 Two chemical reactions were utilized to test the hardware system described in the 
previous section: fluorescence quenching and peroxyoxalate chemiluminescence. As this system 
is in its infancy, this data is considered highly preliminary and at most qualitative comparisons 
can be made between the model data and this experimental data. 
 
3.5.1 Fluorescence Quenching 
3.5.1.1 Experimental Parameters and Setup 
 Fluorescence quenching was accomplished with 1 M potassium iodide (KI) and 100 µM 
fluorescein (FL) in water (all chemicals from Sigma Aldrich). Two RPPMs connected to a 
microfluidic reactor housed in the CFP were first primed with ethanol and a background file with 
the laser engaged at 10 mW was collected. Reservoirs were replaced with the reactants, which 
were allowed to flow through at constant rates. Data sets for fluorescein quenching were 
        (        –      
      
)  100  (5) 
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collected with the pump speeds of KI and FL sinusoidally varying from 0 to 60 rpm with an 
amplitude of 30 rpm (to prevent negative speeds) and periods ranging from roughly 3 to 6 
minutes. Data was collected for 7-10 hours.  
 A two pump sinusoidal flow setup was used on all the fluorescein quenching 
experiments. As indicated previously, this type of two pump sinusoidal flow addition produces a 
variable total flow rate leading to a concentration profile as shown in Figure 3.18A. However, 
the correction methods described in section 3.4.1.2 can be applied to transform the data into 
those produced by concentration profiles that were true sinusoids. Pump one drew fluid from a 
reservoir of 100 µM fluorescein in water, while pump 2 drew fluid from a reservoir of 1 M KI in 
water. After the two sinusoidal flows combine in the mixer (a 500 µm W x 100 µm H x 2 cm L 
microfluidic channel), the laser excitation and fluorescence detection occur within the same 
field of view of the objective (~1 mm x 1 mm) (as shown in Figure 3.17). The time delay for this 
setup with two pumps running at 1 µL/min each is 11 minutes from the pump to the 
measurement point. 
 
3.5.1.2 Data 
 Fluorescein was run with a period of 269 seconds, while KI was run with a period of 223 
seconds. Both had an amplitude of 30 rpm and y offset of 30 rpm. The oscillatory concentration 
profiles of both fluorescein and KI are shown in Figure 3.18A. The full time course of the 
experiment was 8 hours, though only a 1.4 hour section of the full time course data in shown to 
demonstrate the trends in the fluorescence signal (Figure 3.18B). After importing the raw data 
into Matlab, detrending and performing the FFT, the drive frequencies and heterodyne 
frequencies were annotated as shown in Figure 3.18B and Table 3.6 based on McLaurin series 
expansion. Both sum and difference frequencies are detected. Tabular forms of the theoretical 
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heterodyne sum and difference frequencies specific to these experimental output frequencies 
are available in Appendix H. Comparing the actual heterodyne frequencies to those calculated 
based on the output drive frequencies results in a 0.03% average error. 
 Correction of this fluorescence data produced in a variable flow setup by means 
discussed in section 3.4.1.2 (equation 4) provides a method of converting the variable total flow 
results to constant total flow ones, and thus producing data corresponding to that collected in 
experiments with constant total flow. The corrected data set analogous to Figure 3.18 is shown 
in Figure 3.19. The annotated drive frequencies (bold) and heterodyne frequencies (Table 3.7) 
do not change upon data correction. Though the time-dependence of the raw data amplitudes 
are adjusted by this correction, the overall heterodyne and drive frequencies remain unaltered. 
 
Figure 3.17 Experimental setup for fluorescein quenching with two RPPMs pumping FL and KI 
at a sinusoidal speed into a mixer (a 500 µm W x 100 µm H x 2 cm L microfluidic channel) that 
combines the flows into a variable total flow. The reaction mixer device is held in place on 
the CFP as shown in Figure 3.14. Laser excitation occurs through the objective on the CFP and 
fluorescence emission travels through the objective and the filter cube to the PMT for 
detection. The signal is converted to a voltage and is recorded in Labview 10 Signal Express. 
132 
 
Figure 3.18 Fluorescein quenching sample data set with sinusoidal flow A) Fluorescein at 100 
µM was run with a period of 269 seconds, while KI at 1 M was run with a period of 223 
seconds. Variable flow concentration profiles result. B) A portion of the raw fluorescence 
data from an 8 hour fluorescein quenching experiment with a two pump, sinusoidally driven, 
variable total flow setup is shown. After performing the FFT of the raw data, resulting 
heterodyne frequencies can be annotated as shown in Table 3.6 based on calculated values 
from the output driving frequencies with McLaurin series expansion. Drive frequencies are 
labeled with an asterisk. 
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Table 3.6 Fluorescein quenching experimental variable flow drive and heterodyne 
frequencies corresponding to the data shown in Figure 3.18. 
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Figure 3.19 Fluorescein quenching sample data set corrected to correspond to sinusoidal 
concentration inputs. A) The input concentration profiles for FL and KI (periods of 269 and 
223 seconds) shown in Figure 3.18A were corrected using equation (3) to show the 
conversion of oscillatory concentration profiles to sinusoidal ones. B) The data shown in 
Figure 3.18 was corrected using equation (4). The frequency domain of the corrected raw 
data reveals heterodyne and drive frequencies analogous to the non-corrected data set 
(Table 3.7). A large amplitude artifact of the DC offset appears, overshadowing the expected 
difference frequencies. Drive frequencies are labeled with an asterisk. 
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Table 3.7 Fluorescein quenching experimental corrected drive and heterodyne frequencies 
corresponding to the data shown in Figure 3.19. 
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As the frequencies are unchanged upon correction, the same average error of 0.03% describes 
the accuracy of the corrected data set as with the uncorrected spectrum. 
 Fluorescein quenching experiments with the two pump setup were explored with 
periods of fluorescein ranging from 179 seconds to 331 seconds, while keeping the period of KI 
constant at 223 seconds. The FFT frequency and amplitude are plotted against the swept 
frequencies of FL as shown in 3.20. As the data correction left the heterodyne and drive 
frequencies unchanged, the uncorrected data was used to construct the 3D plot to avoid the 
large amplitude DC offset component present after correction.  
 
 
 
 
Figure 3.20 3D plot of varying FL drive frequencies from 0.005587 Hz to 0.003021 Hz with KI 
drive frequency held constant at 0.004484 Hz. The largest amplitude peaks represent the 
drive frequencies of FL and KI. The color scale bar is available on the right. 
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3.5.1.3 Interpretation, Problems, and Solutions 
Fluorescein quenching, though modeled as a more simplistic model of higher order 
chemical kinetics, reveals heterodyne frequencies indicative of chemical intermediates in both 
the experimental data and the simulated data. Though these experiments were performed with 
a two pump setup incapable of producing constant flow rates, even upon correction of this data 
to mimic constant flow, the heterodyne frequencies remained unchanged; a phenomenon also 
verified through the same correction method utilized on the simulated variable flow data. As the 
experimental fluorescein quenching data reveals a richer frequency domain spectrum than the 
simulated data, it is possible that the model created was oversimplified and further exploration 
into this occurrence should be conducted. This may also indicate that the nonlinear dynamics of 
fluorescein quenching are more complex than initially expected. Regardless, the presence of the 
heterodyne frequencies in these variable flow experiments with non-calibrated pumps 
demonstrates the robustness of the platform for heterodyne analysis, in general, as the inherent 
noise generated by pump inconsistencies and non-sinusoidal waveform concentration profiles, 
does not interfere with the detection of heterodyne frequencies. 
 
3.5.2 Peroxyoxalate Chemiluminescence 
3.5.2.1 Experimental Conditions and Setup 
For the peroxyoxalate chemiluminescence reaction, seven reservoirs were filled with 10 
mM Bis(2,4,6-trichlorophenyl) oxalate (TCPO) in Diethyl Phthalate (DEP), 0.56 mM Rubrene 
(Rub) in Dimethyl Formamide (DMF), 0.98 M H2O2, 0.8 M Imidazole with 2% Pluronic F-68 in 
water, DEP, DMF, and H2O (all chemicals from Sigma Aldrich) as shown in Table 3.8. Seven 
pumps were used to drive fluids from these seven reservoirs. The RPPMs and the microfluidic 
reactor were primed with ethanol and a background file was collected. The reservoirs were 
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switched to those with the reactants and allowed to flow at a constant rate to flush the reactor 
of ethanol. The pump driving the flow of pluronic and imidazole was held constant at 59 rpm, 
while the remaining six pumps were driven sinusoidally based on their calibrated values (sample 
input parameters shown in Table 3.8). The periods of TCPO and Rub were held constant while 
that of H2O2 was varied over the course of separate experiments from 3 to 6 minutes. Data for 
each experiment was collected for 7-10 hours.  
With pairs of pumps used to define the concentration profile for each of the three 
reactants (0.98 M H2O2, 0.56 mM Rubrene and 10 mM TCPO), sinusoidal concentration profiles 
were possible and no post-collection data correction techniques were necessary. Each pump 
conducted the flow of fluid from its respective reservoir and the sinusoidal variable flows from 
each pair of pumps were summed in the pump mixers (a 100 µm W x 70 µm H x 12.8 cm L 
microfluidic serpentine channel) producing a constant total flow rate with a sinusoidal 
concentration profile for that reactant. This process was performed for each pair of pumps. The 
flow from the three pump mixers, along with the constant flow catalyst and pluronic mixture 
Table 3.8 Pump Reservoir Contents and Sample Input Parameters for Peroxyoxalate Reaction 
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were combined in the reaction mixer (100 µm W x 70 µm H x 12.8 cm L microfluidic serpentine 
channel) and chemiluminescence detection occurs within the field of view of the objective (~1 
mm x 1 mm). This experimental setup is as depicted in Figure 3.21. 
 
3.5.2.2 Data 
Figure 3.22 compares raw time-domain data and frequency domain data for the seven-
pump setup before (orange) and after (green) calibration. The period of Rubrene, TCPO, and 
H2O2 were 223, 269, and 307 seconds in both sets of data. The pre-calibration setup used a y 
offset and an amplitude of 30 rpm for all pumps, with half the pumps run with a phase offset of 
 
Figure 3.21 Experimental setup for seven pump sinusoidal concentration chemiluminescence 
reactions. Each pump drives the flow of one of the three reactants, three solvents, or catalyst 
with pluronic (details shown in Table 3.7). With two pumps running 180 degrees out of phase 
controlling the concentration profile of the reactant through their combination in the pump 
mixers, it is possible to achieve both constant flow and sinusoidal concentrations. 
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180 degrees. In the post calibration experiment, each pump pair was calibrated to its pair such 
that the total flow rate remained constant while each individual pump ran at a variable flow 
rate. The length of the data sets was equalized prior to FFT analysis to prevent any unnecessary 
modifications to the data due to differences in experiment duration. A side-by side comparison 
of the drive frequencies and heterodyne frequencies, as shown in Figure 3.22B and C and Table 
3.9, revealed subtle distinctions in the raw data pattern between the pre-calibration experiment 
and the post-calibration experiment. Both raw data sets are on the same scale. The respective 
frequency domain data comparison provides a richer source of variation between pre- and post-
calibration data. While the same drive frequencies were employed for Rubrene, TCPO and H2O2 
(as well as for their respective 180 degree out of phase solvent pump counterpart), the output 
frequencies vary. For example, the input drive frequency for Rubrene is 0.004484 Hz (223 
second period), however, the pre-calibration data returns a Rubrene drive frequency of 
0.004745 Hz (5.8% error) while the post-calibration data returns a frequency of 0.004506 Hz 
(0.5% error). Pump calibration affords a 10% reduction in error from the theoretical frequency 
values. Pump calibration can take up to 30 minutes per pair of pumps, so a trade-off in this 
reduction in error exists.  
Aside from the accuracy of the frequency values, the post-pump calibration data has 
reduced noise compared to the pre-calibrated data, allowing for the detection and identification 
of a greater number of heterodyne frequencies. The error in the location of the heterodyne 
frequencies for both the pre- and post-calibration data is on average 0.10% and 0.15%, 
respectively, indicating that, though the accuracy of the frequency values in the pre-calibration 
data is lower that of the post-calibration data, the heterodyne frequencies remain accurate 
within a given experiment when compared to the heterodyne frequencies calculated from the 
actual output drive frequencies. It is also worth noting that the pattern of the annotated 
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Figure 3.22 Pre- and post-calibration peroxyoxalate chemiluminescence experimental data. 
An experiment was performed prior to calibration of the seven pump setup for the purposes 
of comparison to data post-calibration. A) Rubrene, TCPO and H2O2 were driven with 
constant flow, sinusoidal concentration with periods of 223 seconds, 269 seconds and 307 
seconds. B) A portion of the raw data set (full time course was 6.8 hours) as well as the 
frequency spectrum for the pre-calibration experiment is shown adjacent to the analgous 
experiment performed post-pump calibration along with the respective frequency spectrum 
(C). The resulting frequencies for each experiment are compared in Table 3.9. Drive 
frequencies are labeled with an asterisk. 
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Table 3.9 Side-by-side pre- and post-calibration results for peroxyoxalate reaction 
heterodyne and drive frequencies with assignments, corresponding to the experimental data 
in Figure 3.22B and C. 
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heterodyne frequencies is the same, even if the frequency values differ, between the pre- and 
post-calibrated data as noticeable by examination of Table 3.9. The distinction between the pre- 
and post-calibration data is evident from inspecting Figure 3.22B and C as well as Table 3.9. The 
frequencies detectable in the post-calibration set that are not detectable in the pre-calibration 
set include: 2fH2O2 - fTCPO, fRub + fTCPO - fH2O2, 2fRub – fH2O2, 3fH2O2, 3fRub- fH2O2, 2fTCPO + fH2O2, fRub+ 2fH2O2, 
fRub + fTCPO +fH2O2, fRub + 2fTCPO, 2fRub + fH2O2, and 2fRub + fTCPO.  
 The seven pump peroxyoxalate reaction was conducted with varying periods of H2O2 
from 179 seconds to 331 seconds, while maintaining the periods of rubrene (223 seconds) and 
TCPO (269 seconds). Data were collected for the same length of time and analyzed in the 
frequency domain for detection of heterodyne frequencies. The resulting 3D plot sweeping the 
H2O2 frequency is shown in Figure 3.23.  
 
 
Figure 3.23 3D plot of varying H2O2 drive frequencies from 0.005587 Hz to 0.003021 Hz with 
Rubrene and TCPO drive frequencies held constant at 0.004484 Hz and 0.003719 Hz. With 
this view it is possible to see the repeating frequency patterns. The color scale bar is available 
on the right. 
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3.5.2.3 Interpretation, Problems, and Solutions 
For the peroxyoxalate chemiluminescence reaction utilizing calibrated RPPMs in pairs 
driven 180 degrees out of phase from one another (to accurately generate a sinusoidal 
concentration profile for each reactant), heterodyne frequencies were also detected in 
abundance and are comparable to those produced in the simulated data (Figure 3.24). As this 
reaction is comprised of three reactants, the McLaurin series expansion becomes more rigorous 
and peak assignments a lengthier process. However, the accuracy of the assignments of the 
detected frequencies withstands regardless of the difficulty in making the assignments. Table 
3.10 compares the detected frequencies in the simulated and experimental data sets and 
reveals differences between the model and experimental. This indicates that the model does 
not completely predict the physical experiment; though deciphering this discrepancy produces 
additional challenges. A possible explanation for these differences is that the reaction rate 
 
Figure 3.24 Model versus experimental peroxyoxalate chemiluminescence A) Simulated light 
emission data and frequency domain data for the same parameters used in the experiment 
producing the data and resulting frequency spectrum in B). Tabular comparison of model and 
experimental frequencies are available in Table 3.10. Drive frequencies are labeled with an 
asterisk. 
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Table 3.10 Side-by-side comparison of frequencies detected from model and experimental 
peroxyoxalate reaction corresponding to the data in Figure 3.24A and B. 
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equations, based on the chemical equations, do not adequately predict the physical 
phenomenon. However, to make this claim, further experimentation is required to rule out 
additional causes first. Alternate explanations could include nonlinear mixing contributions from 
the RPPMs and insufficient mixing. As this reaction combines reactants dissolved in both organic 
and aqueous solvents, even in the presence of pluronic, the mixing is imperfect. Adaptations to 
the model equating to lower reaction efficiency, as an approximation of insufficient mixing, 
should be performed. The nonlinear contributions of the pumps should also be explored 
through further modeling and experimentation. 
 
3.6 Summary, Pitfalls, and Problems 
The work described herein demonstrates progress toward the development of a robust 
technique for the investigation of oscillatory chemical signals in the form of light produced by 
reactions (fluorescein quenching and peroxyoxalate chemiluminescence) with sinusoidal 
reactant concentration profiles. It has involved the incorporation of 1) instrumentation for 
modulating sinusoidal concentration through flow rate as driven by the rotary planar peristaltic 
micropumps, 2) a microfluidic mixer for the combination of two or more unique chemical 
frequencies, 3) a detector for acquiring data from the light producing reactions in the form of 
the Continuous Flow Photometer, and 4) a data analysis technique involving Matlab’s Fast 
Fourier Transform for translating the raw data into the frequency domain where heterodyne 
frequencies are able to be detected. In order to assess the progress in the development of this 
heterodyne chemistry hardware framework, a set of metrics were developed as shown in Table 
3.10 along with comments regarding the status of each metric. The following discussion 
provides additional commentary regarding the performance metrics. 
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Table 3.11 Heterodyne chemistry hardware performance metrics 
 
System Component Metric Status 
Rotary Planar Peristaltic 
Micropumps 
Long-term functionality with 
two pump setup 
Maintained continuous experimental 
data collection for 20 days with three 
pump fluidic changes. 
Long-term functionality with 
seven pump setup 
Maintained continuous experimental 
data collection for 11 days with four 
pump fluidic changes. 
Increased frequency domain 
resolution with pump 
calibration 
Post-calibration data contained more 
significant (> 3x noise) heterodyne 
frequencies than analogous pre-
calibration data. 
Microfluidic Mixers 
Microfluidic device stability 
Minimal device changes required with no 
device clogging or delamination events. 
Mixing efficiency 
Peroxyoxalate reaction mixing increased 
with the addition of 2% pluronic solution 
in a serpentine mixer. Fluorescein 
quenching may need additional mixing 
time. 
Continuous Flow 
Photometer 
Calibration curve for four 
fluorescein concentrations 
Completed with concentrations tested in 
the linear region of the detector. 
Long-term fluorescence 
and/or chemiluminescence 
acquisition 
Continuous data collection possible with 
no discernible time limit. 
Data Collection and 
Analysis 
Long-term data collection 
with Labview 10 
Labview failed three times over three 
months as a result of too many data logs 
saved to the project. 
Rapid conversion (less than 5 
seconds)of large Labview 
data files into Matlab 
Conversion of >3million point .tdms data 
sets achieved in under 5 seconds with 
Matlab file converter and a 1.73GHz, 
4GB, 32-bit i7 processor. 
Fast Fourier transform in 
Matlab of large data files in 
less than 5 seconds 
Matlab processed the FFT of >3million 
data points in under 5 seconds with a 
1.73GHz, 4GB, 32-bit i7 processor. 
Data correction for variable 
total flow conditions 
Data correction completed successfully 
with sample pre- and post-correction 
data provided. 
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 The validation of this platform involved assessing the sinusoidal concentration 
generation with the RPPMs, verifying the fluorescence and chemiluminescence detection 
capabilities of the CFP, and confirming the data analysis techniques through comparison with 
expected heterodyne frequencies calculated from McLaurin series expansion. The use of models 
of the chemical reactions was also utilized for comparison to the experimental data and for 
testing variable flow data correction methods. Finally, the platform was utilized to collect swept 
frequency data of fluorescein for the fluorescein quenching reaction and H2O2 for the 
peroxyoxalate chemiluminescence reaction.  
 Assessments indicated the need for pairs of pumps running 180 degrees out of phase 
from one another in order to generate a sinusoidal concentration profile. Inter-pump variable 
led to the incorporation of pump calibration schemes. Constant flow pump calibration of 
matched fluidic pumps pairs reveals issues beyond channel dimensional differences that are 
contributing to the statistically significant inter-pump variation. The assembly, alignment and 
compression processes are highly subject to the user’s discretion, particularly during the 
alignment procedure. Further, alignment, even under magnification, can be problematic due to 
the tolerance of the thrust bearing cage (machined in house out of Teflon) which leads to the 
misalignment of less than half of the thrust bearings. (Misalignment of half of the ball bearings 
or greater is due to insufficient alignment of the channels and rarely an issue with the thrust 
bearing.)  
 Discrepancies were found when attempting to convert the constant flow calibration to 
sinusoidal pump rates, necessitating the need for pumps intended to be run sinusoidally, to be 
calibrated under such conditions. However, a multipoint constant flow calibration was not 
performed and may provide results in agreement with the sinusoidal flow calibration. 
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 Comparing data sets of pre- and post-pump calibration experiments revealed that pump 
calibration in the seven pump setup provides reduced noise in the frequency domain, allowing 
for enhanced heterodyne frequency determination and minimized error compared to 
theoretical frequency values. The benefits of pump calibration come at the expense of time as 
the current calibration procedures can take up to 30 minutes per pair of pumps. Additionally, 
extreme care must be taken while calibrating to minimize the stopping of the pumps controlled 
by the same Arduino board, but yet are not the object of the current calibration. While the 
calibration of the pumps allows for the detection of an increased number of heterodyne 
frequencies, the lack of a calibration does not invalidate the data as the values of the 
frequencies detected are highly accurate when compared to those calculated from the output 
drive frequencies for that experiment. 
The detection of these heterodyne frequencies under known reactant profile conditions 
allows for the verification of the analysis technique. Though the output drive frequencies err 
from the input frequencies, even without prior knowledge of the driving frequencies of the 
reactants, it is possible to assign identities with high accuracy to each frequency detected (i.e. 
(a+b), (2a-c), (a+b+c)) based on the most abundant peaks in the spectrum. Through this method, 
it is possible to extrapolate the frequencies with which the reactants were run. 
 While this work may appear to be oriented towards chemical kinetics, this strategy has 
potential applicability to a variety of complex nonlinear biological networks including those 
characterized by oscillatory chemical signals. Through the extension of these techniques into 
biochemical signaling networks, a new level of understanding may arise and lead to the 
discovery of unknown upstream chemical interactions as detected by the frequency domain 
pattern of downstream products. 
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3.7 Future Solutions 
 While this work represents a significant amount of progress in the development of a 
heterodyne technique, additional work must be completed to accurately ascertain the cause(s) 
of the discrepancies between the model frequency spectra and the experimental frequency 
spectra. The Arduino code driving the motors needs to be refined to eliminate any internal 
delays or frequency discrepancies. Suggestions for tests to determine the cause of the observed 
heterodyne frequencies include the following. 1) Further calibration of the detector response 
under constant flow of only fluorescein, in particular low flow conditions may allow for 
visualization of any photo-bleaching that may occur. 2) Next, pump pairs driven with water and 
fluorescein with the same frequency, so as to produce a sinusoidal concentration profile of 
fluorescein, can be utilized to view the resulting oscillatory fluorescence signal detected. This 
will allow for the assessment of the accuracy and consistency of the sinusoidal concentrations 
produced. All pairs of pumps can be tested in this manner. Pumps can be adjusted based on the 
oscillatory fluorescence signal produced. Additionally, any resulting heterodyne peaks when 
tests are performed under conditions that exclude photo-bleaching can be concluded to be 
artifacts of the pumping or the fluorescence excitation. It is highly recommended that the 
pumps first be calibrated either with the method discussed in this work (the addition of two 
sinusoidal flows 180 degrees out of phase from each other add to a constant flow) or with the 
automated calibration methods currently under development within VIIBRE. 3) The next test 
that can be performed is similar to step 2, except fluorescein is in all reservoirs. This setup will 
result in a constant fluorescein concentration and constant fluorescence signal. Any remaining 
oscillations in the fluorescence signal will indicate issues with the pump calibration. 4) To test 
for the congruency of the pump phases and any discrepancies between pairs of pump, two pairs 
of pumps can be run with the same frequency and with fluorescein and water in the reservoirs. 
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In order to have the fluorescein concentration sum to a constant, as well as the resulting 
fluorescence signal, one pair of pumps should drive fluorescein with a zero degree phase offset, 
while the second pair of pumps should drive fluorescein with a 180 degree offset. Any 
noticeable oscillations in the resulting signal will indicate variations between the pairs of pumps 
or discrepancies in the phase offsets. After successful completion of this pump and detector 
calibration with fluorescein, quenching experiments can continue. 5) The Stern-Volmer 
relationship can be explored and calibrated on a spectrophotometer with a range of fluorescein 
and KI concentrations. While a high quencher concentration (known to be in the nonlinear range 
of the Stern-Volmer) has been used in the experiments discussed in this work, exploring the 
concentration space may result in a set of concentrations that will demonstrate the reaction 
nonlinearities to an even greater extent. 6) A similar concentration space exploration can also 
be performed with the RPPM-mixer-CFP setup so as to investigate the Stern-Volmer relationship 
on the instrumentation that will be utilized in future experiments. Through comparison of this 
data set to that gained in step 5, it may be possible to detect any instrumentation-specific issues 
that could cause experimental results to vary. 7) Next, fluorescein quenching experiments with 
pairs of pumps driven at the same frequency can be conducted over a range of frequencies. 8) 
Finally, fluorescein quenching experiments can be performed with pairs of pumps driven at 
different frequencies. Resulting heterodyne frequencies can be compared to those discovered in 
step 2 above in order to rule out heterodyne frequencies caused by the pumps or the excitation. 
Statistical assessment of the assignments of each heterodyne peak must also be performed. 
Remaining heterodyne frequencies that differ from the mathematical models can be more 
confidently contributed to the physical quenching phenomenon and modifications to the model 
can be made in order to mimic the experimental results.  
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CHAPTER IV 
 
4 SUMMARY, FUTURE WORK AND ETHICAL IMPACT 
 
The previous chapters have described work on the following projects: Real-time Cellular 
Exometabolome Analysis with a Microfluidic-Mass Spectrometry Platform and Heterodyne 
Framework for the Generation and Receiving of Oscillatory Chemical Signals in Nonlinear Light-
Producing Systems. At first read, these projects may appear disconnected; however, they are 
highly related and intertwined as each contributes to the movement towards a system for 
automated biology. With the success of the integrated microfluidic-ion mobility-mass 
spectrometry platform, rapid progress has been made towards the analysis of cell states under 
varying environmental conditions as evidenced by the differential cocaine metabolism of naïve 
and experienced cells demonstrated in Chapter II. Additionally, the development of the 
heterodyne framework, based on the radio frequency deconvolution methodology, has 
successfully generated sinusoidal concentration profiles, combined these together in a mixer, 
received the subsequent light-based signal and analyzed the resulting data in the Fourier 
domain to detect heterodyne (sum and difference) frequencies.  
While both the microfluidic-mass spectrometry platform and the heterodyne techniques 
are still in their infancy, they share a common characteristic of expansive potential for the 
advancement of biological studies. With the ability to detect distinct cellular phenotypes or 
states based on the exometabolomic profile of a given cell population, honing in on key features 
causing separation between various states, there is limitless potential for discovery in the realm 
of complex cellular, biochemical networks. For instance, through further investigation into the 
identity of the unknown features found in the naïve and experienced Jurkat T cell cocaine 
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exposure experiment, along with the pathways that may be affected by the challenge, new 
insight may be gleaned relating to the long-term effects of cocaine exposure on the immune 
system. As the heterodyne techniques develop and extend beyond chemical reaction test 
systems, the power of the two platforms can be combined with an upstream sinusoidal 
concentration profile generator feeding oscillator chemical signals into the bioreactor. As mass 
spectrometry technology advances along with desalting techniques for true real-time desalting, 
the detector of the mass spectrometer may have the potential to serve as the heterodyne 
receiver for numerous oscillatory chemical signals at once. Extreme caution is advised as species 
abundance as recorded by the detector is highly dependent on the ionization which can vary as 
the composition of complex sample changes. Targeted studies, utilizing a constant 
concentration standard addition to the media, possibly with stable isotope labeling, may provide 
an initial starting point for these heterodyne biology experiments incorporating the two 
platforms discussed in this work. Though a future goal of the combination of these two projects 
into a unified system is possible, each individual system has further refinements that should be 
undertaken before the merger is attempted. A thorough analysis of the two platforms along 
with suggestions for further enhancement is provided. 
 
4.1 MF-SPE-nESI-IM-MS 
 This online platform for analysis of the cellular exometabolome consists of a microfluidic 
bioreactor, a solid phase extraction desalter, and nanoelectrospray ionization-ion mobility-mass 
spectrometry. As described in Chapter II, the system has been successfully integrated and 
utilized for the analysis of naïve and cocaine-experienced T cells with a dynamic stimulus of 
cocaine. Though these results provide initial evidence of differential cocaine metabolism 
between these two cell populations, continued work is desirable on both the platform and this 
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particular biological investigation. Future users of this platform are directed to Appendix B for a 
complete use and troubleshooting guide. 
 
4.1.1 Microfluidic Device Design and Control 
The signal intensities achievable upon downstream detection are related to the size of 
the cell population on which experiments are conducted. Any desired increase in signal from 
lower concentration species would require a greater number of cells. Two options exist for 
increasing the size of the cell population: 1) multiple devices in parallel and 2) increasing the size 
of the device and number of traps. Using multiple MTNPs in parallel could be an option, though 
they require a greater number of syringes and expensive syringe pumps. The second option of 
increasing the size of the device is perhaps a better option as any new device design could be 
easily adapted from current designs and would not require any increase in the number of pumps 
and syringes, providing this new, larger device is designed appropriately to function with only 
three or four inlets.  
 
4.1.2 Online Desalting 
In the current arrangement, the solid phase extraction desalter produces small batches 
of desalted effluent. In the experiments reported, effluent filled a sample loop for 9 minutes 
(4.5µL at 500nL/min) and was then directed by the flow of aqueous solvent over the column at a 
rate of 0.9µL/min. This setup provides a 1.5µL aqueous column equilibration volume followed by 
the 4.5µL of sample effluent load and then an additional 2.1µL of aqueous salt removal. Further 
fine tuning of these flow rates, the size of the sample loop and its fill time, and the column 
length could result in higher efficiency desalting with a shorter time averaging tradeoff. The low 
sample flow rate negatively affects the ability to compare downstream and upstream salt 
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concentrations as necessary dilution to larger volumes, in addition to sample evaporation during 
its collection, skews the measurements. A strategy for quantifying salt removal in the current 
setup could be paramount in fine tuning the desalter.  
Additional strategies for desalting are currently underway. For instance, a microdialysis 
desalter is presently being refined and tested. While this method for salt removal will provide an 
actual real-time signal, it does so with several tradeoffs. The use of commercially manufactured 
dialysis membranes is limiting due to the few selections in pore size of molecular weight cut-off. 
A 13kDa cutoff is the lower bound of the currently available products, which clearly is 
significantly larger than the molecular weight of most salts and relies upon the higher diffusivity 
of salts in aqueous solutions in order to achieve sufficient salt removal without the loss of 
precious sample. The overall size of the membrane tube diameter (as this microdialysis setup 
uses countercurrent sheath flow around a cylindrical shell membrane with the sample flow 
inside the dialysis membrane and buffer flow external to the membrane) is likewise limited and 
is an order of magnitude larger than the typical tubing used to direct sample effluent from the 
bioreactors creating a nozzle effect that greatly increases the timing delay from bioreactor to 
detector. Preliminary tests for packing this inner dialysis tubing with beads were promising and 
should be considered for this microdialysis desalting strategy. 
An analytical column as part of the current desalter setup has already been considered, 
though it has not yet been incorporated. This additional column, along with a gradient elution, 
would provide increased chromatographic separation of species similar to LC. However, the 
system timing would have to be tightly controlled in order to allow for the use of retention time 
data to be included. Without tight control of the timing, the retention time for a given m/z 
would shift from data file to data file, preventing inclusion of this information in the data 
analysis scheme. 
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4.1.3 Data Analysis 
The integrated platform produces data at an insurmountable rate for a single individual 
to handle. For typical online cellular studies that last 4-8 hours in length, data correction and 
peak detection with Markerlynx can require nearly as long as the experiment took to perform. 
Providing one is satisfied with the method used and resulting detection of peaks, an infinite 
amount of time may then be spent performing careful interrogation of the data, particularly 
when attempting to identify unknown features. In the meantime, while attempting to analyze 
this single set of experimental data, each day that passes produces an additional data set in 
need of similar analysis (particularly since these experiments are run back to back over the 
course of several weeks). For instance, in the course of developing this platform, 16 biologically 
valuable data sets were collected and processed with Markerlynx, each with sufficient 
complexity that would require a researcher’s sole attention for a minimum of 3 months in order 
to confidently glean biologically relevant information. This data avalanche and overwhelming 
time requirement spurs the need, not only for ever increasing data storage space, but also for 
parallel researchers or a perhaps, the more highly desirable, data analysis automation. At a 
minimum, future endeavors should entail continued analysis of the remaining 15 data sets 
produced from the online platform (as only one, the naïve and experienced T cell cocaine 
exposure, was analyzed thoroughly for the purposes of an initial manuscript detailing the 
capabilities of the platform). Enough data exists for potentially six additional publications solely 
using data that has already been collected. It is suggested that incoming mass spectrometry 
graduate student researchers be given the opportunity to learn data analysis and feature 
identification methods with these data sets, followed by the production of a manuscript relaying 
the pertinent biological findings. This serves not only to allow students early in their careers to 
gain valuable skills in mass spectrometry data analysis, but also provides the opportunity to 
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acquire a first author publication without having to develop, troubleshoot, and perform 
additional experiments.  
 
4.1.4 MTNP-SPE-nESI-IM-MS 
Seven unique biological experiments were performed using the online cellular analysis 
platform, though only one of these experiments was utilized for the purposes of this 
dissertation. The additional experimental data, though it has been processed through 
Markerlynx and preliminary analysis shows distinctions between different exposure sample 
groups, was not included to prevent any undesirable effects upon the release of this document 
to the public prior to completion of the data analysis and publication of those experimental 
results.  
This system is poised for conducting endless possibilities of biological experiments. In its 
current state, particularly concerning the data analysis, biological studies with anticipated 
exometabolomic components lower the high threshold for feature identification as determining 
the presence of expected compounds is significantly less convoluted. 
As the cellular memory of cocaine exposure is a unique biological question with 
interesting initial results, continued investigation is critical. The experienced population was 
created with a short-term period of cocaine exposure immediately followed by online 
experimentation. Experimental variations of particular interest would be extending the 
exposure incubation time and also incorporating a period of incubation in regular media 
(without serum) prior to online analysis. The length of time between the initial cocaine exposure 
in culture and the online analysis of those experienced cells should be increased to determine 
the time course of cocaine exposure memory. These same experimental concepts should also be 
applied to primary white blood cell populations from rat models of addiction. While this was 
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attempted in collaboration with Dr. Schramm-Sapyta at Duke University, the initial methods 
determined for blood sample transfer resulted in too few cells per sample for loading into a 
microfluidic device. If work with her group continues, separation of white blood cells from 
whole blood should be requested prior to freezing and shipping samples in order to provide 
sufficient population sizes for analysis with the online platform. 
Overall, this system for real-time elucidation of cellular response stands to revolutionize 
cell-based research, clinical laboratory testing and drug discovery and development. While it is 
in its infancy, I believe it has a bright future ahead providing it receives the necessary attention 
from researchers and funding agencies. Without additional attention from graduate students, 
post-docs and PIs, this potentially powerful technology will end up in the basement of the 
Stevenson Center building 6.  
 
4.2 Heterodyne Framework 
 Successful creation, integration and validation of a sinusoidal concentration generator, a 
mixer for combining multiple oscillating signals, a receiver for collection of the resulting product 
of the mixing, and a data analysis technique utilizing the fast Fourier transform for detection of 
high accuracy heterodyne frequencies has been performed. Underlying frequency oscillations, 
aside from those of the oscillating input signals, are indicative of frequencies of production of 
reaction intermediates that cause modulation of product formation. While this technique has 
been proven for two higher order light-producing chemical reactions and will be of interest to 
the analytical chemistry community, an offshoot of the technique for applications relevant to 
biological systems should be explored. Improvements on the current framework, in addition to 
suggestions for optimizing it for biological application, will be included in this section. 
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4.2.1 Sinusoidal Concentration Generation 
 Rotary planar peristaltic micropumps have been adapted for generation of sinusoidal 
concentration profiles. While the RPPMs have many strengths for use in heterodyne chemistry 
experiments, issues exist with pulsatility of the flow, inter-pump variation, and intra-pump 
variation over time. Attempts at reducing the flow pulsatility for sinusoidal flow rates with a 
microfluidic flow depulsitizer, characterized by compliant area with a thin membrane, was futile 
as the desired oscillations were dampened, in addition to the undesirable pulses, due to the 
compliance of the depulsitizer. Further work into alternate schemes for reducing pulsatile flow 
is already underway and could stand to reduce the noise in the experimental light production 
data, and therefore, the noise in the frequency domain.  
 Inter-pump variation is addressable through rigorous calibration procedures, though 
from the findings in Chapter III, constant flow calibration was not applicable to sinusoidal flow 
schemes. A multipoint constant calibration procedure should be tested prior to abandoning this 
technique as an option. Calibration, while reducing inter-pump variability to a certain extent, 
requires a significant time commitment (at least 30 minutes per pump currently) in the short 
lifetime of the pump (one week on average). The calibration procedure can also contribute to a 
reduced lifetime of the pumps as the repeated stopping and starting is problematic. To achieve 
the longest possibly lifetime out of a pump, it is recommended to maintain continuous flow 
through the pumps with minimal stopping. This prevents evaporation of fluids through the thin 
membrane as well as clogging of the channels. Automated pump calibration efforts are in 
progress and may serve to rectify these concerns with the current calibration procedure. 
 While a pump may be driven at a constant flow, over lengthy periods of time (multiple 
hours to days), the actual flow rate may change due to bubble formation, changes in the PDMS 
membrane upon rigorous and continuous mechanical deformation, clogged channels, and slight 
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misalignments of the channels with the thrust bearing that potentiate over time. Reducing the 
formation of bubbles is challenging as the cause is yet to be confidently assigned. Possibilities 
include intake of air through the thin membrane resulting from incomplete channel closure in 
square profile channels, intake of air around the punch hole due to splits in the PDMS or lack of 
a tight seal between the PEEK tubing and the PDMS, or intake of air through dissolved gas in the 
reservoir fluids. The first can be rectified through construction of rounded channels as opposed 
to square, though initial testing with a rounded channel device produced undesirable results in 
terms of the amount of bubbles generated. The second can be overcome by creating inlet and 
outlet ports with sharper punches or sealing the tube to the PDMS. In many cases, using a drop 
of high viscosity oil can provide an adequate seal. This can break down in some circumstances, 
causing the oil to enter the channels which leads to pump failure. Glue or PDMS can also be 
used to seal the PEEK tubing into the inlet, but is permanent, requiring disposal of either the 
device or inlet tubing should one or the other fail. The third can be overcome, as discovered by 
VIIBRE researchers, by heating and degassing the solutions under vacuum, yet some solutions 
(i.e. peroxide) will degrade rapidly with heat. Bubble formation, however, is only one cause of 
pump variation over time. PDMS deformation is unavoidable in this setup and can only be 
altered through the membrane thickness and ratio of curing agent to base polymer. Clogged 
channels are inevitable, particularly when using oil as a sealant, but also when stopping and 
starting the flow repeatedly with minutes or hours of time in between the periods of use. 
Continuous running is suggested, which complies with repeated trial heterodyne experiments. In 
the case where the pumps must be stopped for a significant periods of time, ethanol should be 
used to purge and pumps should be stored with no compression of the channels to prevent the 
formation of permanent indentations. A final contributor to pump variation over time may be 
due to an initial misalignment or a shift in alignment over time. Rigorous initial alignment is 
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required to reduce alignment issues, however, even a slight shift of the thrust bearing due to 
uneven wear of the PDMS washer or PDMS device can lead to an alteration in the alignment. 
Regular replacement of the PDMS washers could aid in alleviating this issue temporarily, while 
fixing the location of the thrust bearing could provide a more robust, long-term solution. Though 
significant, these pump weaknesses can be overcome satisfactorily to use them for the 
generation of sinusoidal concentration profiles.  
 In order to generate a true sinusoidal concentration profile with a constant flow rate, a 
pair of pumps must be used to define the profile for each reactant. This quickly scales a three 
reactant experiment to six pumps, increasing the difficulty significantly as maintaining six 
working pump instead of three is more than twice the challenge. While the work in Chapter III 
resulted in reduced noise in data produced with true sinusoidal concentration profiles, variable 
flow data still contained rich heterodyne frequencies that were of similar accuracy to those 
produced under constant flow regimes. Future endeavors should repeat the Fluorescein 
quenching experiments with a constant flow setup for a truer comparison of variable and 
constant flow. 
 
4.2.2 Upstream Chemical Signal Mixing 
 A simple serpentine mixer with four inlets was utilized as the reaction chamber in the 
peroxyoxalate chemiluminescence reaction. As this reaction requires the “mixing” of aqueous 
with non-aqueous solutions, a 2% pluronic solution driven at a constant flow rate was 
incorporated to aid in the mixing and diminish the oil in water droplet formation that occurs in 
its absence. Refinement of the pluronic concentration, as well as the dimensions of the 
serpentine mixer may result in higher efficiency mixing. The cross section of the mixer was 100 
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µm W x 70 µm H, though a channel that is taller than it is wide will decrease the relative 
diffusional distance, promoting more thorough mixing.  
 The fluorescein quenching reaction was performed in a straight channel as both 
solutions were aqueous. Bubble formation in these experiments was significant and device 
designs have already been created to allow for bubbles to exit the device through a separate 
outlet by taking advantage of the vertical channel orientation (fluid moves toward the bottom of 
the channel, while bubbles stay at the top). These devices should be constructed and tested 
with the Fluorescein quenching setup. 
 
4.2.3 Downstream Chemical Signal Detection 
 Signal detection by the Continuous Flow Photometer produces consistent data whether 
in chemiluminescence or fluorescence mode. The background signal caused by the excitation 
laser drifts over time, but by less than 50mV, which causes little issue with the data. The light-
tightness of the enclosure box should be improved as a change in the ambient room light (lights 
on or off, opening of nearby refrigerator) can be detected, though are currently mitigated by 
leaving the lights on and blocking the side of the enclosure facing the refrigerator. Additional 
improvements could include a controllable internal light source for instrument calibration, 
particularly for application to low signal setups.  
 
4.2.4 Data Analysis Techniques 
 Matlab, with its built in Fast Fourier Transform, is utilized for the analysis of the raw 
data sets. It remains unclear exactly how this FFT, based on the Cooley-Tukey algorithm, is 
implemented for long data sets. Work is ongoing by members of VIIBRE to create a Fourier 
transform with known implementation scheme with which to process these data sets. Once 
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complete, the frequency domain data output from Matlab should be compared to that from this 
developed FFT technique.  
 
4.2.5 Modeling Heterodyne Chemistry 
 Models of the Fluorescein quenching and peroxyoxalate chemiluminescence with 
sinusoidal concentration profiles for each reactant were constructed in Matlab. These models, 
solely based upon the reaction kinetics, lack the diffusion and flow components of the physical 
experiment. Constant concentration models of both reaction systems, along with their particular 
reaction mixer, have been constructed in Comsol Multiphysics 4.2a and include laminar flow, 
transport of dilute species, and chemical reaction modules. This model, for the purpose of the 
manuscript, will be altered to sinusoidal concentration profiles. It was not completed for this 
dissertation as the completion of this model assigned to a student to provide them the 
opportunity to be included as an author.  
 
4.2.6 Probing Biochemical Reactions 
 Extension of this framework into biologically relevant areas should be a priority. While 
the current setup utilizes a detector for light produced by a reaction, the possibilities of using 
fluorescently labeled reactants could provide a biochemical application with the existing setup. 
Exploration of biochemical reactions, particularly those that follow Michaelis-Menten kinetics, 
should follow the completion of the Fluorescein quenching and peroxyoxalate 
chemiluminescence.  
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APPENDIX B 
 
B MTNP-SPED-NESI-IM-MS USE AND TROUBLESHOOTING GUIDE 
 
 This manual provides documentation of all aspects of the current microfluidic-mass 
spectrometry platform (Figure B.1) for real-time analysis of the cellular exometabolome as 
discussed in Chapter II. Please consult this guide for part numbers, instrumentation settings, and 
protocols. 
 
 
Figure B.1 MTNP-SPE-nESI-IM-MS platform with Harvard Apparatus syringe pumps, Nikon 
Eclipse Ti-e with stage incubator, solid phase extraction desalter with Eksigent and 
nanoAcquity pumps for solvent flow control, nanoelectrospray ionization source for 
continuous flow sample analysis in the Waters Synapt G2 ion mobility-mass spectrometer. 
Beyond the initial experimental setup, all components are fully automated and capable of 
running multi-hour experiments limited by the lifetime of cells in the MTNP. 
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B.1 Liquid Management 
B.1.1 Fittings and Connectors 
 Common thread types of fittings and connectors are shown in Figure B.2. 10-32 thread 
type will most often be encountered when using 1/16” PEEK tubing for high-volume/high-
flowrate applications. In order to use 10-32 1/16” PEEK connectors (as shown in top left), one 
must use IDEX Health and Science ‘Green sleeves’ (IDEX Health and Science F-242X). From IDEX: 
“Silica SealTight Sleeves are designed to connect 70 μm – 1mm OD capillary tubing to any 
standard 10-32 coned port normally intended for 1/16” OD tubing. The 1.6” long Silica SealTight 
sleeves withstand up to 50°C and can be finger tightened to hold up to 5,000 psi when using the 
NanoTight fittings”. Luer lock connections will most often be used to connect 360 μm OD tubing 
 
Figure B.2 Common fittings and part numbers used in this instrumentation setup. 
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to syringes for liquid perfusion. The use of 5/16-24 fittings involves a male part (e.g., IDEX PN: P-
888), which has threads on the outside, a female nut (IDEX PN: P-416), which has threads on the 
inside, and a ferrule piece (IDEX PN: F-152, for 360 μm OD tubing) which goes between those 
two parts. The ferrule receives force as the female nut is tightened and in doing so causes the 
ferrule to crimp the 360 μm OD PEEK or fused silica tubing. Fittings with 2-56 thread are 
common to VICI-Valco type fittings and will most commonly be used on VICI unions (VICI PN: 
C360UPK(G)4), and for valve fitting connectors(VICI PN: C360NFPKG, C360PPK, See Valves). 
Thread type 6-32 is found on coned nuts (e.g., IDEX PN: F-124S) and is similar to ferrules (F-152) 
in the sense that it crimps 360 μm tubing directly. CAUTION: When using connectors on tubing 
and using finger tightening it is generally not recommended to tighten very strongly when direct 
connector-to-tubing combinations are used. For example, when using an IDEX P-888 (5/16-24) 
union, where a PEEK ferrule directly crimps the 360 μm OD tubing, one should tighten just tight 
enough to not let the tubing pull out under moderate force. Tightening past this point leads to 
occlusion of the line (especially for PEEK tubing). When using fittings that require a 1/16” sleeve 
to connect to 360 μm OD tubing, more force can be used to tighten the fitting as the pressure 
applied must first penetrate the green sleeve before crimping the underlying 360 μm OD tubing.   
 
B.1.2 Syringe Pumps 
 Media perfusion of microfluidic devices was carried out using a Harvard Apparatus 
Model ‘11’ Plus Dual Syringe Pump with Serial Communication (MA1-70-2212). The syringe 
pumps drive the plunger of a syringe at a rate that is directly dependent on the user’s inputted 
syringe inside diameter. Common syringe diameters can be found in the manual. When 
operating the syringe pumps, the ‘pusher block brackets’ (small black bars that screw into place 
to hold the disc shaped end of the syringe plunger) are often removed to provide a more level 
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surface for the edge of the syringe plunger to rest against. Infusion can be performed manually 
using the pump’s interface and LED screen, or automatically using the RS-232 data connection 
cables and either the pump control buttons or a macro written in NIS Elements. When operating 
manually the choice between infusion and withdraw can be selected based on the direction of 
the “FLOW” button. If operated using software and then disconnected and used manually, 
occasionally the “FLOW” button can become reversed. When operating the syringe pump it 
may become customary to press on the pusher block to expedite flow, however, after pressing 
on the block, the pump driving mechanism will ‘kick’ back, causing cessation of flow 
immediately thereafter. Use of syringe retainer is recommended, however, use of the syringe 
block bracket is not necessary. It is important to be sure the “Infuse limit switch adjuster” is 
placed at the maximum position (as shown on page 6 of the instruction manual) and tightened 
often (as use of the pump seems to loosen this adjuster). The pump manual is included in this 
work. 
 
B.1.3 Syringes 
 Commonly, 250 μL (Hamilton 81120 250 µL, Model 1725 TLL) or 500 μL (Hamilton 81220 
500 µL, Model 1750 TLL) glass syringes are used to infuse media through microfluidic devices. 
Syringe-to-360 μm tubing connections are made using a PEEK female Luer adapter assembly 
(IDEX Health and Science, P-662, 5/16-24 thread port connection, 0.006 in thru hole). This 
results in less leaking than that experienced when using 10-32 PEEK female Luer lock adapter 
(IDEX Health and Science, P-659, 10-32 thread port connection, coned Female). 
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B.1.4 Tubing 
 Typically polyether ether ketone (PEEK) tubing is used wherever possible. An OD of 360 
μm with varying ID’s (IDEX Health and Science, 1574, 1570, 1573, 1571) will be used for most 
applications (with 1/16” tubing being required very infrequently). Polymer tubing cutters (IDEX 
Health and Science, A-327, Standard Polymer Tubing Cutter for 1/16” and 1/8” tubing) are used 
to cut PEEK tubing to best ensure the severed end is not occluded. A main drawback to PEEK is 
the fact that noticeably large amounts of sample and biomolecular material have potential to 
adhere (reversibly and irreversibly) to its surfaces. This has been seen to cause, at times, 
massive tailing and memory effects. For this reason fused silica is used on sections of long 
uninterrupted tubing due to the glass’s less adherent surface properties. Teflon tubing is 
available from IDEX as well (PNs: 1930, 1931, 1932, and 1933) in 360 μm OD and 50-150 μm IDs. 
Teflon is recommended as being compatible with all type of solvents, which could lead one to 
believe that chemical reactivity with this material is low relative to other types of tubing. 
 
B.2 Microfluidic Device 
 
B.2.1 Device Design 
 Microfluidic devices such as the MTNP in Figure B.3 are designed in 2D through the use 
of AutoCAD or similar computer-aided design software. Designs are compiled by VIIBRE staff 
engineer (David Schaffer) and sent to Advanced Reproductions for creation of a chrome mask. It 
can take anywhere from two weeks to several months for a mask to be sent out and to arrive 
depending on how full the mask design is when drawings are submitted.  
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B.2.2 Photolithography 
 A master can be created from the chrome mask through photolithography techniques. 
The protocol for a ~12 µm high T12 trap design such as those on Mask 38iii in the mask 
repository is as follows:  
1. silicon wafers are rinsed with acetone then isopropanol, dried under a stream of 
nitrogen, dehydration baked for 5 minutes at 180°C and allowed to cool to <60°C. 
2. SU-8 2010 is spun on clean wafers for 10 seconds at 500 rpm (acceleration of 2) 
followed by 35 seconds at 2500 rpm (acceleration of 5). 
3. The wafer with SU-8 is then covered, soft baked under a ramped temperature from 50 
to 95°C (2 min at 95°C), and allowed to cool to <60°C. 
 
Figure B.3 Design of the MTNP (i) with 18 µm x 12 µm cell traps (ii) capable of trapping 2-3 
cells each (iii) in a device with a 234 nL volume and 7056 cells traps. 
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4. The edge bead is then removed by spinning under a stream of edge bead remover. 
5. The mask is positioned overtop of the SU-8 coated master with uncovered portions 
covered by ruby tape and exposed for 20-45 seconds at a 45 J/cm2 dose. 
6. The master is then covered, post-exposure baked with a temperature ramp of 180°C/hr, 
baked for 5 minutes at 95°C, and allowed to cool to <60°C. 
7. The master is then developed on the spinner for 3 minutes or until rinsing with 
isopropanol is completely clear. 
 
 
Figure B.4. Sequence of steps in photolithography and replica molding. 
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8. The master is hard baked with a temperature ramp of 120°C/hr, baked for 30 minutes at 
180°C, and allowed to cool completely. 
 
B.2.3 Soft Lithography and Device Silanization 
 PDMS devices on glass coverslips are constructed through replica molding and silanized 
with a PEG-silane to prevent non-specific metabolite, peptide and protein adsorption. The 
protocol is as follows:  
1. The cooled master is placed in a round petri dish, poured with mixed 10:1 Sylgard 84 
elastomer: curing agent (until roughly 3-4mm deep), and degassed under vacuum until bubbles 
are gone. 
2. PDMS is allowed to cure for 4 hours at 60°C. 
3. Patterned areas are then cut with a scalpel and removed from the master. 
4. Inlet and outlet ports are created by inserting a sharpened biopsy punch through the cut 
PDMS, patterned side up, with a sacrificial PDMS layer underneath to protect the punch, NOTE: 
Cores should be removed after each punch and can be aided by keeping a piece of wire inserted 
into the shaft of the punch stopping a few millimeters before the tip. 
5. Both sides of the PDMS are cleaned with tape and coverslips are cleaned with acetone 
and IPA. 
6. The device is placed patterned side up along with one of the coverslips on a 2”x3” glass 
slide and placed in the chamber of the Harrick Plasma cleaner about 3 inches from the back of 
the chamber. 
7. Device and coverslip are then plasma activated under vacuum for 30-45 seconds, 
removed from the chamber and the device is placed patterned side down on the coverslip, 
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NOTE: Tweezers can be used to lightly press on the top of the PDMS to assist with bonding if 
needed. 
8. Immediately after bonding, the PEG-Silane solution (2% in 95% EtOH, 5% H2O, 10 mM 
acetic acid) is flowed through the device from the outlet until it just comes out the inlets. 
9. Devices are allowed to sit at room temperature for at least 10 minutes and are then 
rinsed with EtOH and H2O. 
10. Devices are then incubated at 110°C for 10 minutes and allowed to cool.  
 
 
Figure B.5. PDMS Silanization Procedure. 
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B.2.4 Priming 
 Prior to experiment, the microfluidic device is primed by first putting a drop of methanol 
on the outlet port, allowing it to move by capillary action through the device. If it does not easily 
move, gently flick one end of the cover slip against the bench top. Devices that do not easily 
allow ethanol to flow in this way should not be used. The outlet can then be intubated with 
PEEK tubing attached to a syringe containing the basic media for the experiment (i.e. RPMI or 
Running buffer) and the plunger can be depressed until beads of media form on the inlets. The 
outlet and inlets should be covered with a drop of the same media before removing the PEEK 
tubing from the outlet.  
 
B.3 Cells 
 
B.3.1 Culture 
 Cells should be cultured according to supplier’s instructions. Techniques will not be 
addressed herein as many cell culture resources exist. 
 
B.3.2 Loading 
 An aliquot of cells is obtained just prior to the experiment. For non-adherent cells, ~500 
µL of cell suspension is dispensed into a clear or light-colored microcentrifuge tube (dark colors 
are difficult to see through under the microscope). These cells can be used almost any day 
during the culturing procedure and volume dispensed adjusted to account for changing cell 
density. For adherent cells, subculturing procedures are followed to detach cells from surfaces 
of the culture flask. When cell suspensions are transferred to a centrifuge tube for trypsin 
removal, an aliquot is placed in an additional tube that is destined for the experiment. Cells are 
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centrifuged according to culture instructions (typically low speed, ~100xg, is best). 
Media/trypsin is removed from the cell pellet and the aliquot for the experiment is resuspended 
in the desired media at the desired cell density (recommended at full density of split flask or 
greater).The cell suspension is transferred to a clear or light-colored microcentrifuge tube. For 
either adherent or non- adherent cell suspensions, aliquots are centrifuged at 1200 rpm for 2 
minutes in the McLean lab centrifuge (Eppendorf Minispin Plus) just prior to cell loading. 
 The tube of pelleted cells is placed in the orange foam tube holder and onto the stage 
insert, fitting over the four pegs on the insert. The microscope and software are both ready for 
use (see below for instructions) and all syringes have been prepared and set to run forward on 
syringe pumps. The DIC optical configuration in NIS Elements is selected and the Ti-pad is 
checked for the halogen shutter to be open with the lamp in the on position and at 3V. The light 
will be physically visible if the settings are correct. The stage is then positioned with the light 
immediately overtop of the open tube containing cells. Looking into the eye piece, the focus is 
adjusted to bring some portion of cells into focus. This can be tricky at first, but with experience 
 
Figure B.6 Cell Loading Diagram 
(i)
(ii)
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it becomes easy to quickly bring cells into focus. The light path can be switched from the eye 
piece to the camera and play button hit to view the cells on the monitor. The end of the PEEK 
tubing into which the cells are to be loaded is then placed in the microcentrifuge tube (fluid 
should always be exiting the tubing when inserting into the cells to avoid any air bubbles) and 
pushed down towards the bottom to contact the cell pellet. It is useful to put a small kink in the 
tubing about 1.5 inches from the end, but keep the bend <90 degrees. The plunger of the 
syringe attached to this tubing can be clamped to the pusher and the pump flow direction can 
then be reversed to withdraw cells into the PEEK tubing. There is a delay when the flow is 
revered before suction occurs. For a flow rate of 500 nL/min, it is around 1.5 minutes. The PEEK 
tubing should be constantly held in order to manipulate the location of the end relative to the 
cells. It is helpful during the loading process to adjust the exposure as needed and to move in 
and out of focus of the tubing end in order to view moving cells. Once cell movement into the 
tube is visually confirmed, loading continues for 3 minutes at 500 nL/min with a 2 ft PEEK tubing 
length with an inner diameter of 50 µm. If the tubing length, ID or the flow rate is altered, the 
amount of time for loading should be recalculated. Once the desired loading time has been 
achieved, the pump is reversed and plunger unclamped from the pusher. Again, there will be a 
delay before the flow is in the forward direction. During this time, the device should be 
intubated with tubing from the remaining forward flowing syringes. If the cells need to avoid the 
contents of the syringe, the pump can be stopped right before the tubing is intubated, but a 
drop of liquid should be on the end while inserting the tubing to prevent air bubbles. The tubing 
containing the cells can then be intubated as well to begin the loading. The outlet tubing is also 
connected at this time. Note that if a given pump is stopped while cells are loaded into the 
device, some back flow of cells into those lines may occur. One way to prevent this is by putting 
crimped plugs of PEEK tubing into the remainder of the inlet ports during loading, then 
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intubating with syringe tubing post-cell loading. Cells are allowed to load the device completely 
while the device is carefully moved into the stage incubator. Outlet tubing should not be 
connected until the rate of cells exiting the device has slowed significantly. 
 
B.4 Microscopy 
 
B.4.1 Nikon Eclipse Ti-e 
 The startup procedure must be followed or connection to the microscope/camera will 
not work correctly. Startup procedure is as follows: 
1. If the computer has been shut down or logged off, it is started, logged into and allowed 
to load completely. 
2. Power to all microscope components (except for the mercury arc lamp and the camera) 
is achieved by turning on the power strip on the back right of the cart.  
3. If fluorescence images are to be taken, the mercury arc lamp power must be turned on 
separately from its power switch.  
4. Once the initialization procedure has completed, the camera can be turned on from its 
power switch.  
5. NIS Elements is then started.  
 
A common issue results from the software not loading the camera driver. In the event of this 
error message, close the software, wait and try to reopen again. This problem is just as likely a 
result of a faulty shut down procedure as it is from the startup procedure. Shut down procedure 
is as follows: 
1. All desired image files are saved. 
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2. NIS Elements is closed.  
3. The camera power is turned off from its specific power switch. 
4. If the mercury arc lamp is on, its power switch can be set to off. 
5. The power strip is then turned off.  
B.4.2 NIS Elements 
 For detailed instructions on the use and capabilities of NIS Elements, consult the user 
guide located in the NIS Elements folder.  
 
B.4.3 Stage Incubator 
 Temperature, gas and humidity control can be achieved using the stage incubator. Its 
control box will turn on and off with the power strip on the back right of the cart. The gas line 
with Luer lock fitting is attached to the incubator for CO2 control, the tank turned on and the 
stop valve and needle valve on the back of the cart are adjusted appropriately. (The end of the 
tubing can be placed in a beaker filled with water to check the gas flow rate.) Once the device 
has been intubated and loading has begun, the device is carefully moved onto the stage 
incubator. It is important to have the stage incubator pressed into place on the stage before 
transferring the device. The clips are screwed into place to hold the cover slip, the side channels 
are filled with water to maintain humidity, and the lid of the incubator is placed carefully on top, 
allowing inlet and outlet tubing to rest between the top and bottom pieces. The incubator 
channel is then set to 37°C. Once the experiment is completed, the channel is set to off and the 
gas turned off. The control box power is turned off with the microscope power strip. 
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B.5 Desalter Apparatus 
 
B.5.1 Inline Filters 
 Inline filters have been used to prevent cellular debris escaping from the microfluidic 
device from entering the valves and column setup, where clogging is much more likely and 
problematic. Two types of inline filters are primarily used: black 0.5 μm PEEK frit inline filters 
(IDEX PN: M-120X) and natural colored 1 μm SST filter screen (IDEX PN: M-130X). Typically, 
these filters were replaced every experiment because it can be difficult to assess their level of 
occlusion. 
 
B.5.2 Eksigent/Desalting Pumps 
 An Eksigent Nanoflow Metering System is used to supply the organic-based elution 
solvent. The Eksigent system is capable of flowing from 10-500 nL/minute from each of four 
independent channels, all of which are gas driven by 100psi of either air or nitrogen. Typically 
the organic solvent is perfused through the desalting apparatus at 500 nL/min. This flowrate was 
chosen to match the flow of the microfluidic bioreactors but also due to typical pressure 
constraints with regards to downstream columns and frits. To track this pressure, one must 
create a “Run Manager” flow profile. While this is running the pressure information is 
automatically collected and displayed on the chart on the main window of the Eksigent 
software. Maintenance and calibration must be performed routinely to ensure the pumps work 
efficiently and without the complications of air bubbles. 
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B.5.3 Waters NanoAcquity UPLC Pump 
The NanoAcquity pump is used to perfuse the desalting apparatus with aqueous solvent for the 
purpose of rinsing the columns of salt contaminants. The NanoAcquity pump is controlled 
through the Binary Solvent Manager portion of the MassLynx program and set to a flow rate of 
0.9µL/min in arrangement 2.  
 
B.5.4 Valves 
 Three 10-port Nanovolume UPLC Valves with 360 μm fittings, C72MH-4690ED (VICI 
Valco Instruments Co. Inc., Houston, TX), were arranged as seen in Figures B.8 and B.10 These 
valves connect to the computer through a RS-232 daisy chain cable to the “2-position actuator 
control module”. The “manual controller”, the valve itself and the power supply cable also all 
connect to this control module (see Figure B.7). It is important to note that there are different 
models of controller modules and using the incorrect part will cause valves to malfunction. 
 
B.5.5 Columns 
 Columns and comprised of three components: the fused silica tubing, the chemically 
interactive silica packing phase, and the frit, which prevents the phase from escaping with the 
solvent flow. Columns are made from 360 μm OD fused silica tubing. The ID of the tubing is 
chosen based on the size of the packing phase particles that are going to be used to pack the 
column. The packing phase used in these exometabolomic experiments was 3 μm C18 silica 
phase (Jupiter 3 μm C18 300 Å bulk packing phase, PN: 04A-4263, 404951-1, Phenomenex) and 
typically fused silica with 100 μm ID and 360 μm OD. 
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Column frits are made by using the following protocol: 
1. Mix 170 μL of KASIL (PQ ®KASIL® 1 Potassium Silicate Solution) and 30 μL of formamide 
(F9037 SIGMA) in an eppendorf tube. Vortex mixture. 
2. Spin mixture down for <2min at a moderate RPM in a benchtop centrifuge. Yields a 
semi-solid lower layer of unusable polymerized material, and an upper layer of mixed 
unpolymerized material. 
 
 
Figure B.7 Wiring and connection diagram for VICI/Valco/Cheminert actuated valves. 
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3. Dip pre-cut fused silica tubing into liquid upper layer for ~5-10 seconds. Liquid will rise 
into tubing due to capillary action. 
4. Remove tubing from liquid and, keeping as still as possible, bake the fritted ends under a 
heating block for >3 hours/overnight at 100°C (Setting of 4.5 (high) on the VWR analog 
heatblock). 
5. Cut frit to a few millimeters or shorter (depending on back pressure desired). Typical 
length for these experiments was a 2mm frit 
 
 Columns are bomb loaded using a New Objective Nanobomb apparatus (New Objective 
PIP-500 Pressure Injection System). The Nanobomb accepts in incoming air/nitrogen pressure of 
1000 psi to generate the necessary pressure to drive the beads into the tubing. It not necessary 
to use ultra-pure nitrogen as the gas is only used as a pressure source. Follow standard protocol 
for the Nanobomb and always wear eye protection. 
 
B.5.6 Sample Loop 
 The sample loops in this experiment were made from fused silica tubing with the 
dimensions: 360 μm OD and 250 μm ID. This large ID allowed the sample loops to be much 
shorter. 
 
B.5.7 Desalter Arrangements 
 There are two primary valve arrangements that have been used to desalt a continuous 
bioreactor sample stream. The first arrangement is a six-step arrangement, as depicted in Figure 
B.8, which was used for multiple years and was used for collecting most the preliminary data for 
the system. This cycle provides a constant loading condition, ensuring that all analyte material in 
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the online sample effluent is collected. In addition, contaminants were rinsed from the SPE 
columns during a purge step which is directed to waste. Valve cycle steps can be scaled in time 
uniformly to yield a cycle which is better for detecting high frequency oscillations (short step 
durations) or one which is better for detecting very low abundance analytes (long step 
durations). Figure B.9 outlines the valve switching scheme for online sample preparation. In step 
1, the valve orientation was as pictured in Figure B.9, such that SPE column A was loaded with 
online sample effluent and SPE column B was desalting a sample plug and sending salts to 
waste. Valve 3 was switched such that SPE column A was receiving sample effluent and SPE 
 
Figure B.8. Valve arrangement 1. This arrangement incorporated a 6-step valve cycle to 
achieve online SPE desalting. This arrangement was entirely capable of performing online 
desalting of a continuous sample stream, but suffered from back pressure problems when 
used for online desalting of PDMS bioreactor effluent. 
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column B was eluted and directed towards the MS for ion detection. Because this is the first 
time through the cycle, column B has not actually been loaded with any analytical material at 
this time and so this elution is blank. After this, valve 3 was switched so that SPE column B was 
 
Figure B.9. Stepwise depiction of the 6-step desalting method using valve arrangement 1. 
The top portion shows the valve positions during each step. The chart in the bottom portion 
shows a graphical representation of these valve position during each step, where the number 
in the circle between each step (at the top of the chart) is indicative of which valve is 
switching to achieve the next step. 
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equilibrated with aqueous solvent in preparation for its subsequent loading step. SPE column A 
continued to load sample throughout the equilibration of SPE column B. Next, valve 1 was 
switched such that the online sample effluent was directed to the newly equilibrated SPE 
column B. SPE column A was purged with water at this step allowing for desalination of the 
sample collected on the column. Valve 2 switched and SPE column A was eluted with organic 
solvent, while SPE column B was left in the loading position. Lastly, valve 2 was switched to 
equilibrate SPE column A and the SPE apparatus started the entire cycle again. 
 This arrangement suffered from constant problems associated with back pressure. As 
aqueous solvent was perfused over the columns, when using the first arrangement, a high back 
pressure, usually on the order of 2000-3000 psi, was generated immediately preceding the 
columns. Because there was a direct “line of sight” between the SPE columns and the 
microfluidics, when the valves switched back to load from the microfluidics, this enormous back 
pressure plug would travel backwards and cause the PDMS device to delaminate from the glass 
cover slip. 
 The second arrangement was designed in response to the frequent problems 
experienced with back pressure when using the first arrangement. This second arrangement was 
designed to ensure that the microfluidics never had a direct “line of sight” with the SPE columns. 
In Figure B.10, it can be seen that the arrangement is almost identical to the previous design 
except for the incorporation of sample loops. This addition simplified the valve switching 
scheme required by shortening it to only two steps. To explain the arrangement: sample loops, 
which were made of 360 μm OD/250 μm ID tubing, were 12.2cm long, providing a sample loop 
volume of 6 μL. The continuous sample stream was diverted into each sample loop for exactly 9 
min at 500 nL/min, thus filling the sample loop 75% of the way. Because water was always 
flowing through these sample loops immediately prior to sample flow, a plug of 1.5 μL of water 
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preceded each sample effluent plug. This plug served to quickly and roughly equilibrate the 
column with an aqueous solvent. Once the loop was filled to 75% with online sample effluent, 
the small water plug and sample effluent were passed over the column, using the aqueous 
solvent line to generate the necessary backpressure. Once the effluent had cleared the sample 
loop and had been entirely passed over the column, an additional 2.3 min or 2.1 uL of aqueous 
solvent (H2O with 0.1% formic acid) was run over the column to serve as the rinsing/purging 
step to remove residual salts. Following the salt purge, the column was eluted with organic 
solvent (90% Methanol, 10% H2O, 0.1% formic acid). Whenever effluent was filling through a 
 
Figure B.10. Valve arrangement 2. This valve arrangement was a simplification of valve 
arrangement 1 and negated the effects of back pressure on the microfluidics by providing a 
waste port to vent excessive pressure. This arrangement incorporated a 2-step valve 
switching cycle to achieve online SPE desalting. 
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sample loop, the other end of the sample loop was open to a waste port. This allowed any 
residual back pressure that may have been generated by the pumping of water over the 
 
 
Figure B.11. Stepwise depiction of the 2-step desalting method using valve arrangement 2. 
The top portion shows the valve positions during each step. The chart in the bottom portion 
shows a graphical representation of these valve position during each step, where the number 
in the circle between each step (at the top of the chart) is indicative of which valve is 
switching to achieve the next step. 
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columns to be alleviated out of the waste port instead of traveling upstream and delaminating 
the PDMS device. 
 
B.6 Mass Spectrometry Data Acquisition 
 
B.6.1 nESI Source 
 The nano-electrospray ionization (nESI) source is a probe “door” for the Waters Synapt 
G2. The nESI source can produce a sufficient spray so long as the incoming flow is in the range of 
200nL/min to 2 μL/min. The output line of the online SPE desalter is connected directly to the 
nESI source. The incoming tube is connected with a PEEK fitting to a stainless steel union. The 
nanospray capillary connects to the other end of the union. This union and also the nanospray 
 
Figure B.12 The nESI source as it appears during normal operating conditions. 
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capillary are very susceptible to clogging when analyzing complex sample matrices such as 
bioreactor effluent. 
 
B.6.2 Sample List 
 Continuous collection of discrete “samples” of data for processing in MarkerLynx is 
accomplished by creating a sample list within MassLynx, analogous to UPLC type sample 
collection. Each sample is a set length of continuously running analytes eluted off of the 
columns. For the medium length sample loops (12.2 cm), an 8.8 minute data file is collected, 
allowing for delay time between each sample. Analogous data file length for the long sample 
loops (24.5 cm) is 17.8 minutes. Samples are named chronologically to prevent confusion. Once 
samples are ready to be acquired, the sample list can be saved and started. 
 
B.6.3 Method File/Data Dependent Analysis 
 When performing online, real-time analyses, data collection can be quite onerous. In 
traditional discreet sample analysis, such as might be performed with LC or just by direct 
infusion, it may be customary to acquire a preliminary data file and search through this file to 
find the pertinent feature/peaks and then during a second acquisition, set up the instrument to 
fragment or better accentuate these features/peaks. When performing online, real-time 
analyses, it can be difficult to setup the instrument to collect the information most pertinent to 
your study because there is no indication of when this material will show up and it may only 
show up once and perhaps only for a very short period of time. For this reason it was quickly 
decided to acquire data using Data Dependent Analysis (DDA). MassLynx provides the option for 
this type of experiment in the MS method portion of the software. Within the DDA profile there 
are many options that can be used to tailor this type of acquisition to the experiment being 
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performed. The following DDA profile settings were used for most online cellular effluent 
acquisitions: 
 
 
2012_03_06_ENDERS_880_ONLINE_MS_DDA_LOCK_FILE_trapCE_50.EXP 
[ACQUISITION] [COLLISION ENERGY] 
Survey Start Time    0.00 
Survey End Time    8.80 
Using MS Auto Trap Collision Energy (eV)                    
4.000000 
Using MS Auto Transfer Collision Energy (eV)
 0.000000 
[MS SURVEY] [CONE VOLTAGE] 
 Survey Start Mass    50.0000 
Survey End Mass   
 2000.0000 
Discard uninteresting scans   NO 
Switch to MS/MS when   Intensity 
rising  
                                                                                                   above  
                                                                                                   threshold 
Intensity Threshold    15.0 
Survey Scan Time    1.000 
Survey Interscan Time   0.024 
Survey Data Format   
 Continuum 
ADC Sample Frequency (GHz)   3.0 
Survey Use Tune Page CV   YES 
MSMS CV Ramp Start Voltage   0.0 
MSMS CV Ramp End Voltage   80.0 
[INCLUDE] 
Precursor Selection    Included 
Masses Take Priority 
Use Include Masses List   YES 
Include Mass Range    600-
1200 
Use Include File Masses   NO 
Include Window +/- (mDa)   100.0 
Include Retention Time Window                     10.0 
[MS/MS] [EXCLUDE] 
MSMS Start Mass    50.0 
MSMS End Mass    2000.0 
Number of components   1 
Switchback threshold (intensity / second)                    10.0 
Use MSMS to MS Switch After Time  NO 
Use MSMS to MS Switch After 1 Scan  NO 
Use MSMS to MS Switch After N Scans  YES 
MSMS Switch After Scans   1.0 
MSMS Scan Time (sec)   1.000 
MSMS Interscan Time (sec)   0.024 
MSMS Data Format   
 Continuum 
Use MS/MS ipr File    NO 
Detected Precursor Inclusion   Using 
Real Time Exclusion 
Detected Precursor Inclusion   Include 
After Time 
Include After Time (s)    120.0 
Use Exclude Masses List   NO 
Use Exclude File Masses   NO 
Exclude Window +/- (mDa)   100.0 
FragmentationMode    CID 
[MOBILITY] 
Use Precursor Drift Times   NO 
Maintain Mobility Separation   YES 
Calibration    Dynamic 
1 
[PEAK DETECTION] 
Use Intensity based Peak Detection  YES 
Peak Detection Window   3.0 
Deisotope Peak Selection   YES 
Charge State Tolerance Window   3.0 
Charge State Extraction Window                     2.0 
Deisotope Tolerance Window   3.0 
Deisotope Extraction Window   2.0 
 
B.7 Mass Spectrometry Data Analysis 
 Once data files are collected, they can be transferred to a data analysis computer, 
aligned through MassLynx and processed with MarkerLynx and GEDI, if desired. 
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B.7.1 MassLynx Data Alignment 
 Data collected in the method described above does not correct, on-the-fly, or collect 
data to allow for a lock spray collection. To align the data, a peak of reasonable intensity and 
presence in all samples is chosen, commonly HEPES + Na+ (m/z = 261.0888 Da). Data is aligned 
by first opening any file in the data set in Chromatogram to set the file path, then in the 
MassLynx window selecting ‘Tools’, ‘Automated Mass Measure’. In the AFAMM box, files 
desired to be aligned are double-clicked to change the red ‘ ’ to a green ‘ ’. ‘Automatic Peak 
Detection’ parameters are set such that the lockspray mass is 261.0888, if aligning to HEPES, 
mass window is +/-0.150 and background subtraction is not selected. Samples are then 
processed. Once complete an additional, centroided data file is created with the name as set in 
the ‘Automatic Peak Detection’ parameters. The sample list is then altered to include these new 
file names along with any standards that may be ideal to incorporate into the data processing. A 
method file for processing must be created within MassLynx by selecting ‘Tools’, ‘Edit Method’. 
For this type of non-chromatographic data, ‘Combined Scan Range’ is selected, with a threshold 
of 1000 and mass tolerance of 0.05. Deisotoping of the data is not possible in the ‘Combined 
Scan Range’ feature. The method file is then saved. 
 
B.7.2 MarkerLynx 
 Once data is aligned and centroided, it can be processed with MarkerLynx for detection 
of peaks across the samples within the sample list. Data is processed by selecting ‘MarkerLynx’ 
from within the MassLynx window. In the box that appears, the appropriate project file which 
contains the data set to be processed, the altered sample list, and the method file are selected. 
The output file is named, all boxes checked, and data processed (a time-consuming process). 
Once the MarkerLynx file is created, samples are labeled both in terms of the experimental 
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condition(s) and order of experiment for a “walking Principal Component Analysis (PCA)”. For 
statistical analysis of the data, the ‘XS’ button is selected. This creates an Extended Statistics 
report (if not already produced during the data processing). Within Extended Statistics, the 
template is changed to PCA with pareto scaling and applied. Any plot can be double-clicked to 
enter the plots and something window. Data labels are changed to reflect given labels and 
desired plots and data lists are saved for further analysis. Groups are selected to produce OPLS-
DA plots if needed for the particular data set.  
 
B.7.3 Metabolite Expression Dynamics Identification (MEDI) 
 If desired, data sets can be exported from Extended Statistics and processed with MEDI 
for the production of heat map style plots for enhanced data visualization. MEDI, along with 
documentation and instructions, is free for download. For large data sets (>16,000 columns), 
data cannot be copied or opened within Excel prior to transposition. To transpose data, it is first 
saved in Extended Statistics as a .dif file, and then opened as a new project. Within this new 
project area, the data can be transposed, selected, copied and then pasted in Excel. Once in 
Excel, the header is adjusted to comply with MEDI input format and the file is saved as a tab 
delimited text file. If standards are to be subtracted, the data must be run as ‘Static’ even 
though it is dynamic data. From with MEDI, this file can be selected, and settings altered to 
those desired, typically 50 x 51 tiles, Random Selection, Pearson Correlation, and 10 Seed 
something. MEDI is then set to analyze. Once finished, averages of standards are calculated and 
subtracted from samples. Heat maps are then incorporated into figures as desired.   
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APPENDIX C 
 
C MEDI HEAT MAPS 
MEDI heat maps showing the differences (right) in metabolite profile between cocaine 
experienced (left) and naïve (middle) cells.  
 
198 
 
 
199 
 
 
200 
APPENDIX D 
 
D CHEMICAL REACTION MODELS 
 
D.1 Fluorescein Quenching 
fquenching.m 
% Reaction of fluoro 
% Efluoro===> Fluoro + E, kf(light emission)=0.24e-9; 
% Efluoro===> Fluoro + heat, knr(non-radiative decay)=3.8e-11; 
% Efluoro + KI ==> Fluoro+EKI, kq(quenching)=1.8e-9; 
%dEf/dt=-(kf+knr)*Ef-kq*KI*Ef; 
%dKI/dt=-kq*KI*Ef; 
%dE/dt=kf*Ef; 
%dH/dt=knr*Ef; 
%dEKI=kq*KI*Ef; 
  
function dy=fquenching(t,y) 
  
kf=0.24e-9; 
knr=3.8e-11; 
kq=1.8e-9; 
  
  
y1=y(1); 
y2=y(2); 
y3=y(3); 
  
r1 = kf*y1; 
r2 = knr*y1; 
r3 = kq*y1*y2; 
  
dy=zeros(3,1); 
dy1=-r1-r2-r3;    %-(kf+knr)*y(1)-kq*y(1)*y(2);% Ef 
dy2=-r3;% KI 
dy3=r1;% E 
dy = [dy1 dy2 dy3]'; 
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fquenchingfaster_2.m 
% Simulation for Heterodyne Chemistry for Fluorescent Quenching 
  
f1=1/223; % KI input 
f2=1/269; % FL input 
  
Ef0=0.00001; 
KI0=1; 
ic=zeros(3,1); 
ic(1)=Ef0; 
ic(2)=KI0; 
ic(3)=0; 
  
T=100;%223*269*307; 
%data=zeros(1,T); 
counter = 0; 
parfor t= [0:0.5:T]; 
    counter = (i*10)+1; 
%     t=i; 
   flow1=30*(1+sin(2*pi*f1*t)); 
    flow2=30*(1+sin(2*pi*f2*t)); 
    flowtotal=flow1+flow2; 
    CF0 =0.00001*flow1; %0.00001 mol/liter Fluorescein 
    CI0 = 1*flow2;%1 mol/liter KI 
  
C0 = [CF0 CI0 0 ]/flowtotal; 
  
t0 = 0; % initial volume for solving  
tf = 3600; % .003 microliter -- final volume, volume of reactor  
  
trange = [t0 tf]; % range of simulation variable  
  
% Apply Matlab ODE solver to equations, initial condition  
%     ode113 returns two vectors  
%     v = vector of volume steps  
%     f = matrix of flows, one row per v step.  
  
options = odeset('RelTol',1e-8,'AbsTol',1e-9); 
[T,Y] = ode15s(@fquenching,trange,C0,options); %[T,Y] = ode15s(@fquenching,[0 3600],ic,options); 
%[time,f] = ode113(@TCPO,trange,C0);  
  
QY = .88; 
data(counter)=Y(end,1).*(0.24e-9)*QY; %Compensation for Scale rEMIT 
end 
 
 
fquenching_constant.m 
% Simulation for Heterodyne Chemistry for Fluorescein Quenching - constant flow 
  
f1=1/223; % KI input 
f2=1/269; % FL input 
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Ef0=0.0001; 
KI0=1; 
ic=zeros(3,1); 
ic(1)=Ef0; 
ic(2)=KI0; 
ic(3)=0; 
  
T=28800;%223*269*307;28800 
datac=zeros(1,T); 
counter = 0; 
for i=(0:0.1:T); 
    counter = counter + 1; 
    t=i; 
%     flow1(counter)=30*(1+sin(2*pi*f1*t)); 
%     flow2(counter)=30*(1+sin(2*pi*f2*t)); 
%     flow3(counter)=30*(1-1*sin(2*pi*f1*t)); 
%     flow4(counter)=30*(1-1*sin(2*pi*f2*t)); 
%     flowtotal(counter)=flow1(counter)+flow2(counter)+flow3(counter)+flow4(counter); 
% CF0(counter) =0.00001*flow1(counter)./(flowtotal(counter)); %0.00001 mol/liter Fluorescein 
% CI0(counter) = 1*flow2(counter)./(flowtotal(counter));%1 mol/liter KI 
CF0 = 0.00001*(sin(2*pi*f1*t)+1);%.8 ; % micromol/microliter H2O2 
CI0 =1*(sin(2*pi*f2*t)+1);% 
  
C0 = [CF0 CI0 0 ]; 
  
t0 = 0; % initial volume for solving  
tf = 3600; % .003 microliter -- final volume, volume of reactor  
  
trange = [t0 tf]; % range of simulation variable  
  
% Apply Matlab ODE solver to equations, initial condition  
%     ode113 returns two vectors  
%     v = vector of volume steps  
%     f = matrix of flows, one row per v step.  
  
options = odeset('RelTol',1e-8,'AbsTol',1e-9); 
[T,y] = ode15s(@fquenching,trange,C0,options); %[T,Y] = ode15s(@fquenching,[0 3600],ic,options); 
%[time,f] = ode113(@TCPO,trange,C0);  
  
QY = .88; 
datac(counter)=y(end,1).*(0.24e-9)*QY; %Compensation for Scale rEMIT 
end 
% T=32768; 
% d=fft(data(1:32768),T); 
% Pd=d.*conj(d)/T; 
% Y=1/T*(1:(T+1)/2); 
% plot(Y(:),Pd(2:(T+3)/2)); 
% title('light Emmison'); 
% axis([0 0.025 -0.001 2]); 
% xlabel('Frequency'); 
% ylabel('FFT magnitude'); 
% [X,Y]=find(Pd>0.1); 
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% Y=Y/T; 
% plot(Y); 
  
%plot(datac);figure(gcf); 
 
D.2 Peroxyoxalate Chemiluminescence 
TCPO.m 
function y = TCPO(v,f)  
  
k1 = 1.485; % (dm^3/mol)/s  
k2 = 0.1485; % 1/s 
k3 = 0.00891; % (dm^3/mol)/s  
k5 = 0.00111; % 1/s  
  
fa = f(1);  
fb = f(2);  
fc = f(3);  
fd = f(4);  
fe = f(5);  
ff = f(6); 
fh = f(7); 
fk = f(8); 
  
% rates of formation  
r1 = k1*fa*fb;  
r2 = k2*fd;  
r3 = k3*fe*ff;  
r5 = k5*fk;  
  
ya = -(r1);  
yb = -(r1);  
yc = (r1+r2);  
yd = (r1 - r2); 
ye = (r2 - r3);  
yf = (r5 - r3); 
yh = (2*r3); 
yk = (r3 - r5); 
  
% Return vector of derivatives  
y = [ya yb yc yd ye yf yh yk]';  
 
 
run_TCPO_constant.m 
w1=2*pi/223;% fluorophore 
w2=2*pi/269;% TCPO 
w3=2*pi/307;% H2O2 
T=28800 
data2=zeros(1,T); 
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counter = 0; 
for i=1:0.1:T; 
    counter = counter + 1; 
    t=i; 
CF0 =0.00056*(sin(w1*t)+1); %micromol/microliter Fluorophore 
CA0 = 0.98*(sin(w3*t)+1);%.8 ; % micromol/microliter H2O2 
CB0 =0.01*(sin(w2*t)+1);% .7 ; % micromol/microliter TCPO 
  
C0 = [CA0 CB0 0 0 0 CF0 0 0]; 
   
t0 = 0; % initial volume for solving  
tf = 60; % .003 microliter -- final volume, volume of reactor  
  
trange = [t0 tf]; % range of simulation variable  
  
% Apply Matlab ODE solver to equations, initial condition  
%   ode113 returns two vectors  
%     v = vector of volume steps  
%     f = matrix of flows, one row per v step.  
  
[time,f] = ode113(@TCPO,trange,C0);  
QY = 12964; 
data2(counter)=f(end,5).*f(end,6).*(.00891)*QY; %Compensation for Scale rEMIT 
end 
 
D.3 Additional Simulations 
 
Simulation Summary       
Figure Table [Rub] [TCPO] [H2O2] k1 k2 k3 k4 
  (mM) (mM) (M) (L/mole)/s) (1/s) (L/mole)/s) (1/s) 
3.5 3.3 0.56 10 0.98 1.485 0.1485 0.00891 0.00111 
D.1 D.1 560 10 0.98 1.485 0.1485 0.00891 0.00111 
D.2 D.2 0.56 10000 0.98 1.485 0.1485 0.00891 0.00111 
D.3 D.3 0.56 10 9.8 1.485 0.1485 0.00891 0.00111 
D.4 D.4 0.56 10 0.98 14.85 0.1485 0.00891 0.00111 
D.5 D.5 0.56 10 0.98 1.485 1.485 0.00891 0.00111 
D.6 D.6 0.56 10 0.98 1.485 0.1485 0.0891 0.00111 
D.7 D.7 0.56 10 0.98 1.485 0.1485 0.00891 0.0111 
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Figure D.1 Peroxyoxalate Chemiluminescence Model. A) Input sinusoidal concentration 
profiles for Rubrene, TCPO, and H2O2 oscillating at periods of 223, 269, and 307 seconds. 
Rubrene concentration is 1000x original (0.56 mM). B) The simulated raw 
chemiluminescence data is shown with the fluorescence signal scale inverted to adhere to 
the experimental data convention of increase in signal intensity in the downward direction. 
Exploring the frequency domain returns many heterodyne frequencies as listed in Table D.1. 
The amplitude of the drive frequency of H2O2 is much lower than expected. 
* * 
* 
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Table D.1 Peroxyoxalate chemiluminescence drive and heterodyne frequencies 
corresponding to the data shown in Figure D.1. 
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Figure D.2 Peroxyoxalate Chemiluminescence Model. A) Input sinusoidal concentration 
profiles for Rubrene, TCPO, and H2O2 oscillating at periods of 223, 269, and 307 seconds. 
TCPO concentration is 1000x original (10 mM). B) The simulated raw chemiluminescence 
data is shown with the fluorescence signal scale inverted to adhere to the experimental data 
convention of increase in signal intensity in the downward direction. Exploring the frequency 
domain returns many heterodyne frequencies as listed in Table D.2.  
* 
* 
* 
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Table D.2 Peroxyoxalate chemiluminescence drive and heterodyne frequencies 
corresponding to the data shown in Figure D.2. 
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Figure D.3 Peroxyoxalate Chemiluminescence Model. A) Input sinusoidal concentration 
profiles for Rubrene, TCPO, and H2O2 oscillating at periods of 223, 269, and 307 seconds. 
H2O2 concentration is 10x original (0.98 M). B) The simulated raw chemiluminescence data is 
shown with the fluorescence signal scale inverted to adhere to the experimental data 
convention of increase in signal intensity in the downward direction. Exploring the frequency 
domain returns many heterodyne frequencies as listed in Table D.3.  
* * 
* 
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Table D.3 Peroxyoxalate chemiluminescence drive and heterodyne frequencies 
corresponding to the data shown in Figure D.3. 
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Figure D.4 Peroxyoxalate Chemiluminescence Model. A) Input sinusoidal concentration 
profiles for Rubrene, TCPO, and H2O2 oscillating at periods of 223, 269, and 307 seconds. The 
value of k1 was increased by 10. B) The simulated raw chemiluminescence data is shown with 
the fluorescence signal scale inverted to adhere to the experimental data convention of 
increase in signal intensity in the downward direction. Exploring the frequency domain 
returns many heterodyne frequencies as listed in Table D.4.  
* * 
* 
212 
 
Table D.4 Peroxyoxalate chemiluminescence drive and heterodyne frequencies 
corresponding to the data shown in Figure D.4. 
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Figure D.5 Peroxyoxalate Chemiluminescence Model. A) Input sinusoidal concentration 
profiles for Rubrene, TCPO, and H2O2 oscillating at periods of 223, 269, and 307 seconds. The 
value of k2 was increased by 10. B) The simulated raw chemiluminescence data is shown with 
the fluorescence signal scale inverted to adhere to the experimental data convention of 
increase in signal intensity in the downward direction. Exploring the frequency domain 
returns many heterodyne frequencies as listed in Table D.5.  
* * 
* 
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Table D.5 Peroxyoxalate chemiluminescence drive and heterodyne frequencies 
corresponding to the data shown in Figure D.5. 
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Figure D.6 Peroxyoxalate Chemiluminescence Model. A) Input sinusoidal concentration 
profiles for Rubrene, TCPO, and H2O2 oscillating at periods of 223, 269, and 307 seconds. The 
value of k3 was increased by 10. B) The simulated raw chemiluminescence data is shown with 
the fluorescence signal scale inverted to adhere to the experimental data convention of 
increase in signal intensity in the downward direction. Exploring the frequency domain 
returns many heterodyne frequencies as listed in Table D.6.  
* * 
* 
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Table D.6 Peroxyoxalate chemiluminescence drive and heterodyne frequencies 
corresponding to the data shown in Figure D.6. 
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Figure D.7 Peroxyoxalate Chemiluminescence Model. A) Input sinusoidal concentration 
profiles for Rubrene, TCPO, and H2O2 oscillating at periods of 223, 269, and 307 seconds. The 
value of k4 was increased by 10. B) The simulated raw chemiluminescence data is shown with 
the fluorescence signal scale inverted to adhere to the experimental data convention of 
increase in signal intensity in the downward direction. Exploring the frequency domain 
returns many heterodyne frequencies as listed in Table D.7.  
* * 
* 
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Table D.7 Peroxyoxalate chemiluminescence drive and heterodyne frequencies 
corresponding to the data shown in Figure D.7. 
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APPENDIX E 
 
E RPPM CODE 
 
/* 
Author: Loi Hoang 
Date: 03/20/2012 
Edited by FBlock 12 june 2012 
Edited again by E Werner 28 June 2012 
 
Arduino code for running up to 4 stepper motors at constant or sinusoidal speeds. 
 
Syntax: 
 
  Setting parameters: 
 
    set (motor number) (mode, 1 for sin, 0 for constant) (dir, 0 or 1) (rpm) (duration in minutes) 
        (yOffset) (phaseOffset) (period) 
         
    * space bar can be used as delimiter 
    * Duration can be left out for continuous running time. yOffset, phaseOffset, and period 
    can be left out if running in constant mode. 
    * Typical values for RPM are on the order of 60 (30 for sin wave) 
    * Duration has not worked reliably 
    * yOffset should be > RPM (i.e. RPM=30, yOffset>33 to prevent long runtimes when speeds are slow 
and move distance is great) 
    * phaseOffset of sine wave in degrees 
    * period of sine wave (i.e. number of periods of sine wave between 0 and 180 degrees) 
    
  To Run: 
     
    go (integer) 
     
    Integer is a four digit number consisting of 1 or 0. 1 represent that the respective  
    motor is to be run. Ex: "go 1000" to start the first motor, or "go 0001" to start the fourth motor 
*/ 
///////////////////<Definitions>/////////////////////////////////// 
#include <AccelStepper.h> // Needed for access to the AccelStepper library, an "improved" library of 
functions for stepper motor control. 
#define int MAX_RPM = 150, STEP_PER_REV = 200; //Defines a max speed and steps per revolution of the 
stepper. Initialized in all motors. 
float CONVERSION_RPM_TO_STEP_SEC = STEP_PER_REV/60.0; // float conversion of RPMs to revolutions 
int DIR[5], STEP[5], MS1[5], MS2[5], SLEEP[5]; //Create arrays to store output pins for direction, step, 
microstep, and sleep for each motor. 
#define double pi = 3.1415926535897932; 
     
///////////////////</Definitions>////////////////////////////////// 
///////////////////<Constructor>/////////////////////////////////// 
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AccelStepper stepper[] = { //Constructor five stepper objects. Note pin assignments are for easy driver, 
not arduino board. i.e. 4 is step pin, 5 is drive pin*/ 
  AccelStepper(1,99,99),AccelStepper(1,4,5), //stepper 0 is an extra to make the array indices easier for 
the feeble-minded 
  AccelStepper(1,6,7),AccelStepper(1,8,9), 
  AccelStepper(1,10,11)};  
//the syntax for AccellStepper(1,X,Y) is 1 means a stepper driver with step and direction pins, X is step pin, 
and Y is direction pin 
char input_str[255]; //declares an array of input strings 
char *token; //declares token as a pointer to char and points it at a string literal which is non-modifiable. 
int offset = 0; 
int motorParam[5][7] = {0}; // 0 = sin or const, 1 = dir, 2 = rpm, 3 = duration(0 = inf), 4 = y offset, 5 = phase 
offset, 6 = period 
///////////////////</Constructor>///////////////////////////////////// 
void setup()  
{ 
  Serial.begin(9600);   // open the serial connection, BAUD rate set at 9600bps 
  Serial.flush();      //flushes serial buffer. In arduino 1.0+, this function has changed to flush the serial 
output buffer, so it is no longer useful in this application. 
  delay(100); 
   
  //setting PINS for stepper[1] (the first stepper motor) 
  DIR[1] = 5; 
  STEP[1] = 4;         
  SLEEP[1] = 12;        
  MS1[1] = 3;         
  MS2[1] = 2; 
  //By default these pins are output. This double checks./////////////////////////////////////////////// 
  pinMode(DIR[1], OUTPUT);  //output on pin 5///////////////////////   MS1 MS2 Resolution           /// 
  pinMode(STEP[1], OUTPUT);  //output on pin 4///////////////////////   L   L   Full step (2 phase)  // 
  pinMode(SLEEP[1], OUTPUT); //output on pin 12 /////////////////////   H   L   Half step            //  
  pinMode(MS1[1], OUTPUT); //output on pin 3/////////////////////////   L   H   Quarter step         //  
  pinMode(MS2[1], OUTPUT); //output on pin 2//////////////////////////  H   H   Eighth step          // 
  ///////////////////////////////////////////////////////////////////////////////////////////////////// 
  //executes to begin with motor off (i.e. sleep function is turned on for one motor) 
  digitalWrite(SLEEP[1], HIGH); //turn motor off 
  
  
 ////Now repeat the procss to setup the other three steppers 
  DIR[2] = 7;        
  STEP[2] = 6;        
 // SLEEP[2] = 9;        
// MS1[2] = 10;        // PIN 12 = MS1 
//  MS2[2] = 11;        // PIN 13 = MS2 
  pinMode(DIR[2], OUTPUT);   // set pin 4 to output 
  pinMode(STEP[2], OUTPUT);  // set pin 5 to output 
 // pinMode(SLEEP[2], OUTPUT); // set pin 9 to output 
 // pinMode(MS1[2], OUTPUT);   // set pin 12 to output 
 // pinMode(MS2[2], OUTPUT);   // set pin 13 to output 
 // digitalWrite(SLEEP[2], LOW);  // saves power 
 
  DIR[3] = 9;        
  STEP[3] = 8;      
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  //SLEEP[3] = 12;       
  pinMode(DIR[3], OUTPUT);   
  pinMode(STEP[3], OUTPUT);   
//  pinMode(SLEEP[3], OUTPUT); 
// digitalWrite(SLEEP[3], LOW); 
 
  DIR[4] = 11;       
  STEP[4] = 10;      
 // SLEEP[4] = 13;      
  pinMode(DIR[4], OUTPUT);    
  pinMode(STEP[4], OUTPUT);  
 // pinMode(SLEEP[4], OUTPUT);  
 // digitalWrite(SLEEP[4], LOW);  
 
//set max speeds converted properly for accellstepper format 
  stepper[1].setMaxSpeed(MAX_RPM*CONVERSION_RPM_TO_STEP_SEC);  
  stepper[2].setMaxSpeed(MAX_RPM*CONVERSION_RPM_TO_STEP_SEC); 
  stepper[3].setMaxSpeed(MAX_RPM*CONVERSION_RPM_TO_STEP_SEC); 
  stepper[4].setMaxSpeed(MAX_RPM*CONVERSION_RPM_TO_STEP_SEC); 
 
} 
//////////////END OF SETUP 
 
void loop() 
{ 
  while (Serial.available() > 0) //checks for bytes in the buffer. Serial.available() returns the number of 
bytes waiting. 
  {  
 
    char c = Serial.read(); //read a byte from the serial line 
    Serial.print(c);  // Echo each character, print out what is received 
    if ((c == '\n') || (c == '\r') || (c == 'X')) //if character entered is new line, return, or "X" then parse the 
string 
    { 
      Serial.println(); 
 
      input_str[offset] = 0;          // Terminate string with a 0 
 
      parse_str();           // Parse input through our own parse_str() function 
      memset(input_str,0,sizeof(input_str));  // Reset input char array 
      offset=0;  // Reset offset 
      return; 
    } 
    if (offset < 255) 
      input_str[offset++] = c; 
 
  } 
} 
///////////////END OF MAIN LOOP////////////////// 
 
void parse_str() 
{ 
  char* token; 
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  if (!strncmp(input_str,"set",3)) //if the user inputs set as this funciton 
  { 
    //Parse the input string and convert characters to integers for accelstepper (atoi = alphanumeric to 
integer) 
    token = strtok(input_str,"() ,.-");   
    set( atoi(strtok(NULL,"() ,.-")),atoi(strtok(NULL,"() ,.-")),//this is a giant call to the SET function with the 
parsed string 
    atoi(strtok(NULL,"() ,.-")),atoi(strtok(NULL,"() ,.-")), 
    atoi(strtok(NULL,"() ,.-")),atoi(strtok(NULL,"() ,.-")), 
    atoi(strtok(NULL,"() ,.-")),atoi(strtok(NULL,"() ,.-")));  
  } 
  else if (!strncmp(input_str,"go",2)) 
  { 
    //this handeles the go function 
    token = strtok(input_str,"() ,.-");   
    go(atoi(strtok(NULL,"() ,.-"))); 
  } 
} 
//END OF OUR FUNCTION PARSE STRING for interpreting keyboard input to drive the motors 
 
 
 
void set( int motor, int mode, int dir, int rpm, int duration, int yOffset, int phaseOffset, int period) 
{ 
  //each motor has its own array of motor paramaters, we are setting the attributes of each motor below 
  motorParam[motor][0] = mode; // 1 for sin, 0 for constant 
 //we are omitting direction, that is handeled below  
  motorParam[motor][2] = rpm; 
  motorParam[motor][3] = duration; //duration is in minutes!! 
  motorParam[motor][4] = yOffset; 
  motorParam[motor][5] = phaseOffset; 
  motorParam[motor][6] = period; 
  if(dir == 0) //direction cannot be set to either 0 or 1, we set the correct syntax for accellstepper below 
  { 
    motorParam[motor][1] = -1; 
  } 
  else 
  { 
    motorParam[motor][1] = 1; 
  } 
} 
//END OF OUR SET FUNCTION 
 
 
void go(int motor) //starts the inputed motor number 
{ 
  bool flag1 = false, flag2 = false, flag3 = false, flag4 = false, //initializes all run and constant/sin booleans as 
"false" 
  constInf1 = false, constInf2 = false, constInf3 = false, constInf4 = false; 
  int ii = 0,jj = 0, kk = 0, ll = 0; ////prepare variables for an array which is used in our sine functions. 180 
sample iterations  
 
  if( motor >= 1000) ////////////////////starting the first motor; input from keyboard is "go 1000" 
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  { 
    stepper[1].setCurrentPosition(0); ///initializes the first stepper motor at position 0 
    flag1 = true; ///////////////////////sets flag1 true, we are using this motor 
    if(motorParam[1][0] == 0) ///////////checking to see if constant or sine mode operating 
    { 
      stepper[1].setSpeed(CONVERSION_RPM_TO_STEP_SEC*motorParam[1][1]*motorParam[1][2]);//sets 
speed to the direction * rpm converted properly 
      if(motorParam[1][3] == 0) //if duration = 0 then run forever 
      { 
        constInf1 = true; //run forever 
      } 
      else 
      { 
        //sets number of revolutions to make if not running forever 
        
stepper[1].move(CONVERSION_RPM_TO_STEP_SEC*motorParam[1][1]*motorParam[1][2]*motorParam[
1][3]); //if not set to run forever, move the motor the direction * rpm * duration 
      } 
    } 
  } 
  if( motor % 1000 >= 100) //this is for the second motor, all comments same as above 
  { 
    stepper[2].setCurrentPosition(0); //initiliaze second motor 
    flag2 = true; //sets flag2 to true, we are using this motor as well 
    if(motorParam[2][0] == 0) 
    { 
      stepper[2].setSpeed(CONVERSION_RPM_TO_STEP_SEC*motorParam[2][1]*motorParam[2][2]);  
      if( motorParam[2][3] == 0) 
      { 
        constInf2 = true; 
      } 
      else 
      { 
        
stepper[2].move(CONVERSION_RPM_TO_STEP_SEC*motorParam[2][1]*motorParam[2][2]*motorParam[
2][3]); 
      } 
    } 
  } 
   
  if( motor % 100 >= 10) //this is for the 3rd motor 
  { 
    stepper[3].setCurrentPosition(0); 
    flag3 = true; 
    if(motorParam[3][0] == 0) 
    { 
      stepper[3].setSpeed(CONVERSION_RPM_TO_STEP_SEC*motorParam[3][1]*motorParam[3][2]);  
      if( motorParam[3][3] == 0) 
      { 
        constInf3 = true; 
      } 
      else 
      { 
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stepper[3].move(CONVERSION_RPM_TO_STEP_SEC*motorParam[3][1]*motorParam[3][2]*motorParam[
3][3]); 
      } 
    } 
  } 
   
   
  if( motor % 10 >= 1) //this is for the 4th motor 
  { 
    stepper[4].setCurrentPosition(0); 
    flag4 = true; 
    if(motorParam[4][0] == 0) 
    { 
      stepper[4].setSpeed(CONVERSION_RPM_TO_STEP_SEC*motorParam[4][1]*motorParam[4][2]);  
      if( motorParam[4][3] == 0) 
      { 
        constInf4 = true; 
      } 
      else 
      { 
        
stepper[4].move(CONVERSION_RPM_TO_STEP_SEC*motorParam[4][1]*motorParam[4][2]*motorParam[
4][3]); 
      } 
    } 
  } 
     //END OF IF BLOCK to setup motors 
   
  //run the motors as long as one flag is set to true 
  while(flag1 || flag2 || flag3 || flag4) 
  { 
    if (flag1 && stepper[1].distanceToGo() == 0 && !constInf1) //as long as we are not finished running 
    { 
      if (motorParam[1][0] == 1) //if sin mode THIS IS THE SINE MODE CODE!!! set to define first motor here 
      { 
         
        //here we are setting the speed of our motor, speed is variable depeding on our sine curve  
        
stepper[1].setSpeed(CONVERSION_RPM_TO_STEP_SEC*(motorParam[1][4]+(motorParam[1][1]*motorPa
ram[1][2]*sin(((ii*2*motorParam[1][6])+motorParam[1][5])*pi/180)))); 
        //ALITERED from origional version to  
        //=  yOffest + (direction)* RPM * [sin((ii*2*period + phaseOffset * (pi/180)))]   
        //this includes our conversion factor; ii is set to 0 initially 
 
        //here we are instructing our motor to move, variable with respect to our sine curve 
        
stepper[1].move(CONVERSION_RPM_TO_STEP_SEC*(motorParam[1][4]+(motorParam[1][1]*motorParam
[1][2]* 
                        sin(((ii*2*motorParam[1][6])+motorParam[1][5])*pi/180)))*(1.0/180.0));  
        //this is set to =  yOffest + (direction)* RPM * [sin((ii*2*period + phaseOffset * (pi/180)))] * (1/180)  
        //including our conversion factor   
                         
225 
        ii++; //incrimenting ii 
         
        if( motorParam[1][3] != 0 && ii >= 180.0*motorParam[1][3]/motorParam[1][6]) //if motor is not set 
to run indefinatly and 180 * duration / period is less than ii 
        { 
          flag1 = false; //disable motor 1 
        }                   
      } 
      else 
      { 
        flag1 = false;  //end running the motor if no sine function 
      } 
    } 
    //this is the if block for the second motor 
    if (flag2 && stepper[2].distanceToGo() == 0 && !constInf2) 
    { 
      if (motorParam[2][0] == 1) //if sin mode 
      { 
        
stepper[2].setSpeed(CONVERSION_RPM_TO_STEP_SEC*(motorParam[2][4]+(motorParam[2][1]*motorPa
ram[2][2]*sin(((jj*2*motorParam[2][6])+motorParam[2][5])*pi/180))));  
        
stepper[2].move(CONVERSION_RPM_TO_STEP_SEC*(motorParam[2][4]+(motorParam[2][1]*motorParam
[2][2]* 
                        sin(((jj*2*motorParam[2][6])+motorParam[2][5])*pi/180)))*(1.0/180.0)); 
        jj++; 
        if( motorParam[2][3] != 0 && jj >= 180.0*motorParam[2][3]/motorParam[2][6]) 
        { 
          flag2 = false; 
        }                   
      } 
      else 
      { 
        flag2 = false;   
      } 
    } 
    //if block for 3rd motor 
    if (flag3 && stepper[3].distanceToGo() == 0 && !constInf3) 
    { 
      if (motorParam[3][0] == 1) //if sin mode 
      { 
        
stepper[3].setSpeed(CONVERSION_RPM_TO_STEP_SEC*(motorParam[3][4]+(motorParam[3][1]*motorPa
ram[3][2]*sin(((kk*2*motorParam[3][6])+motorParam[3][5])*pi/180))));  
        
stepper[3].move(CONVERSION_RPM_TO_STEP_SEC*(motorParam[3][4]+(motorParam[3][1]*motorParam
[3][2]* 
                        sin(((kk*2*motorParam[3][6])+motorParam[3][5])*pi/180)))*(1.0/180.0)); 
        kk++; 
        if( motorParam[3][3] != 0 && kk >= 180.0*motorParam[3][3]/motorParam[3][6]) 
        { 
          flag3 = false; 
        }                   
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      } 
      else 
      { 
        flag3 = false;   
      } 
    } 
    //if block for 4th motor 
    if (flag4 && stepper[4].distanceToGo() == 0 && !constInf4) 
    { 
      if (motorParam[4][0] == 1) //if sin mode 
      { 
        
stepper[4].setSpeed(CONVERSION_RPM_TO_STEP_SEC*(motorParam[4][4]+(motorParam[4][1]*motorPa
ram[4][2]*sin(((ll*2*motorParam[4][6])+motorParam[4][5])*pi/180)))); 
        
stepper[4].move(CONVERSION_RPM_TO_STEP_SEC*(motorParam[4][4]+(motorParam[4][1]*motorParam
[4][2]* 
                        sin(((ll*2*motorParam[4][6])+motorParam[4][5])*pi/180)))*(1.0/180.0));  
        ll++; 
        if( motorParam[4][3] != 0 && ll >= 180.0*motorParam[4][3]/motorParam[4][6]) 
        { 
          flag4 = false;  
        }                   
      } 
      else 
      { 
        flag4 = false;   
      } 
    } 
    ///////////////////////////////////Calls the run function of accel stepper. Run should be called as often 
as possible/////////// 
    if(flag1) stepper[1].runSpeed(); 
    if(flag2) stepper[2].runSpeed();  
    if(flag3) stepper[3].runSpeed();  
    if(flag4) stepper[4].runSpeed();                             
 
  }    
  Serial.println("Finished Running."); 
  Serial.println("Ready for new command."); //end of running motors 
} 
//END OF OUR "GO" FUNCTION  
 
 
//END OF PROGRAM. 
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APPENDIX F 
 
F HETERODYNE DATA ANALYSIS 
Readfile.m 
 
clc; 
%% environment variables (first three need to be set for each PC) 
NI_TDM_DLL_Path = 'C:\Users\Seniors\Desktop\RV TDMS read\dev\bin\32-bit\nilibddc.dll' 
NI_TDM_H_Path   = 'C:\Users\Seniors\Desktop\RV TDMS read\dev\include\32-bit\nilibddc_m.h' 
  
% NI_TDM_DLL_Path = strcat([pwd '\nilibddc.dll']) 
% NI_TDM_H_Path   = strcat([pwd '\nilibddc_m.h']) 
libname = 'nilibddc' 
  
%Recreate needed property constants defined in nilibddc_m.h 
DDC_FILE_NAME                   =   'name'; 
DDC_FILE_DESCRIPTION            =   'description'; 
DDC_FILE_TITLE                  =   'title'; 
DDC_FILE_AUTHOR                 =   'author'; 
DDC_FILE_DATETIME               =   'datetime'; 
DDC_CHANNELGROUP_NAME           =   'name'; 
DDC_CHANNELGROUP_DESCRIPTION    =   'description'; 
DDC_CHANNEL_NAME                =   'name'; 
  
%% Check if the paths to 'nilibddc.dll' and 'nilibddc_m.h' have been 
%selected. If not, prompt the user to browse to each of the files. 
if exist('NI_TDM_DLL_Path','var')==0 
    [dllfile,dllfolder]=uigetfile('*dll','Select nilibddc.dll'); 
    libname=strtok(dllfile,'.'); 
    NI_TDM_DLL_Path=fullfile(dllfolder,dllfile); 
end 
if exist('NI_TDM_H_Path','var')==0 
    [hfile,hfolder]=uigetfile('*h','Select nilibddc_m.h'); 
    NI_TDM_H_Path=fullfile(hfolder,hfile); 
end 
  
%% Prompt the user to browse to the path of the TDM or TDMS file to read 
[filepath,filefolder]=uigetfile({'*.tdms';'*.tdm'},'Select a TDM or TDMS file'); 
Data_Path=fullfile(filefolder,filepath); 
  
%Load nilibddc.dll (Always call 'unloadlibrary(libname)' after finished using the library) 
loadlibrary(NI_TDM_DLL_Path,NI_TDM_H_Path); 
  
%Open the file (Always call 'DDC_CloseFile' when you are finished using a file) 
fileIn = 0; 
[err,dummyVar,dummyVar,file]=calllib(libname,'DDC_OpenFileEx',Data_Path,'',1,fileIn);  
  
%Read and display file name property 
filenamelenIn = 0; 
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%Get the length of the 'DDC_FILE_NAME' string property 
[err,dummyVar,filenamelen]=calllib(libname,'DDC_GetFileStringPropertyLength',file,DDC_FILE_NAME,file
namelenIn); 
if err==0 %Only proceed if the property is found 
    %Initialize a string to the length of the property value 
    pfilename=libpointer('stringPtr',blanks(filenamelen)); 
    
[err,dummyVar,filename]=calllib(libname,'DDC_GetFileProperty',file,DDC_FILE_NAME,pfilename,filename
len+1); 
    setdatatype(filename,'int8Ptr',1,filenamelen); 
    disp(['File Name: ' char(filename.Value)]); 
end 
  
%Read and display file description property 
filedesclenIn = 0; 
%Get the length of the 'DDC_FILE_DESCRIPTION' string property 
[err,dummyVar,filedesclen]=calllib(libname,'DDC_GetFileStringPropertyLength',file,DDC_FILE_DESCRIPTIO
N,filedesclenIn); 
if err==0 %Only proceed if the property is found 
    %Initialize a string to the length of the property value 
    pfiledesc=libpointer('stringPtr',blanks(filedesclen)); 
    
[err,dummyVar,filedesc]=calllib(libname,'DDC_GetFileProperty',file,DDC_FILE_DESCRIPTION,pfiledesc,file
desclen+1); 
    setdatatype(filedesc,'int8Ptr',1,filedesclen); 
%     disp(['File Description: ' char(filedesc.Value)]); 
end 
  
%Read and display file title property 
filetitlelenIn = 0; 
%Get the length of the 'DDC_FILE_TITLE' string property 
[err,dummyVar,filetitlelen]=calllib(libname,'DDC_GetFileStringPropertyLength',file,DDC_FILE_TITLE,filetitl
elenIn); 
if err==0 %Only proceed if the property is found 
    %Initialize a string to the length of the property value 
    pfiletitle=libpointer('stringPtr',blanks(filetitlelen)); 
    
[err,dummyVar,filetitle]=calllib(libname,'DDC_GetFileProperty',file,DDC_FILE_TITLE,pfiletitle,filetitlelen+1)
; 
    setdatatype(filetitle,'int8Ptr',1,filetitlelen); 
    disp(['File Title: ' char(filetitle.Value)]); 
end 
  
%Read and display file author property 
fileauthlenIn = 0; 
%Get the length of the 'DDC_FILE_AUTHOR' string property 
[err,dummyVar,fileauthlen]=calllib(libname,'DDC_GetFileStringPropertyLength',file,DDC_FILE_AUTHOR,fil
eauthlenIn); 
if err==0 %Only proceed if the property is found 
    %Initialize a string to the length of the property value 
    pfileauth=libpointer('stringPtr',blanks(fileauthlen)); 
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[err,dummyVar,fileauth]=calllib(libname,'DDC_GetFileProperty',file,DDC_FILE_AUTHOR,pfileauth,fileauthl
en+1); 
    setdatatype(fileauth,'int8Ptr',1,fileauthlen); 
    disp(['File Author: ' char(fileauth.Value)]); 
end 
  
%Read and display file timestamp property 
yearIn = 0; 
monthIn = 0; 
dayIn = 0; 
hourIn = 0; 
minuteIn = 0; 
secondIn = 0; 
msecondIn = 0; 
wkdayIn = 0; 
[err,dummyVar,year,month,day,hour,minute,second,msecond,wkday]=calllib(libname,'DDC_GetFilePrope
rtyTimestampComponents',file,DDC_FILE_DATETIME,yearIn,monthIn,dayIn,hourIn,minuteIn,secondIn,ms
econdIn,wkdayIn); 
if err==0 %Only proceed if the property is found 
    disp(['File Timestamp: ' num2str(month) '/' num2str(day) '/' num2str(year) ', ' num2str(hour) ':' 
num2str(minute) ':' num2str(second) ':' num2str(msecond)]); 
end 
%% process 
%Get channel groups 
%Get the number of channel groups 
numgrpsIn = 0; 
[err,numgrps]=calllib(libname,'DDC_GetNumChannelGroups',file,numgrpsIn); 
%Get channel groups only if the number of channel groups is greater than zero 
if numgrps>0 
    %Initialize an array to hold the desired number of groups 
    pgrps=libpointer('int32Ptr',zeros(1,numgrps)); 
    [err,grps]=calllib(libname,'DDC_GetChannelGroups',file,pgrps,numgrps); 
end     
% for i=1:numgrps %For each channel group 
for i=1:1 %reads 2 while there is but one dataset? 
    %Get channel group name property 
    grpnamelenIn = 0; 
    
[err,dummyVar,grpnamelen]=calllib(libname,'DDC_GetChannelGroupStringPropertyLength',grps(i),DDC_C
HANNELGROUP_NAME,grpnamelenIn); 
    if err==0 %Only proceed if the property is found 
        %Initialize a string to the length of the property value 
        pgrpname=libpointer('stringPtr',blanks(grpnamelen)); 
        
[err,dummyVar,grpname]=calllib(libname,'DDC_GetChannelGroupProperty',grps(i),DDC_CHANNELGROUP
_NAME,pgrpname,grpnamelen+1); 
        setdatatype(grpname,'int8Ptr',1,grpnamelen); 
    else 
        grpname=libpointer('stringPtr','');  
    end 
         
    %Get channel group description property 
230 
    grpdesclenIn = 0; 
    
[err,dummyVar,grpdesclen]=calllib(libname,'DDC_GetChannelGroupStringPropertyLength',grps(i),DDC_CH
ANNELGROUP_DESCRIPTION,grpdesclenIn); 
    if err==0 %Only proceed if the property is found 
        %Initialize a string to the length of the property value 
        pgrpdesc=libpointer('stringPtr',blanks(grpdesclen)); 
        
[err,dummyVar,grpdesc]=calllib(libname,'DDC_GetChannelGroupProperty',grps(i),DDC_CHANNELGROUP_
DESCRIPTION,pgrpdesc,grpdesclen+1); 
    end 
         
%     figure('Name',char(grpname.Value)); 
%     hold on; 
     
    %Get channels 
    numchansIn = 0; 
    %Get the number of channels in this channel group 
    [err,numchans]=calllib(libname,'DDC_GetNumChannels',grps(i),numchansIn); 
    %Get channels only if the number of channels is greater than zero 
    if numchans>0 
        %Initialize an array to hold the desired number of channels 
        pchans=libpointer('int32Ptr',zeros(1,numchans)); 
        [err,chans]=calllib(libname,'DDC_GetChannels',grps(i),pchans,numchans); 
    end 
     
    channames=cell(1,numchans); 
     
    for j=1:numchans %For each channel in the channel group 
        %Get channel name property 
        channamelenIn = 0; 
        
[err,dummyVar,channamelen]=calllib(libname,'DDC_GetChannelStringPropertyLength',chans(j),DDC_CHA
NNEL_NAME,channamelenIn); 
        if err==0 %Only proceed if the property is found 
            %Initialize a string to the length of the property value 
            pchanname=libpointer('stringPtr',blanks(channamelen)); 
            
[err,dummyVar,channame]=calllib(libname,'DDC_GetChannelProperty',chans(j),DDC_CHANNEL_NAME,pc
hanname,channamelen+1); 
            setdatatype(channame,'int8Ptr',1,channamelen); 
            channames{j}=char(channame.Value); 
        else 
            channames{j}=''; 
        end 
         
        %Get channel data type 
        typeIn = 0; 
        [err,type]=calllib(libname,'DDC_GetDataType',chans(j),typeIn); 
         
        %Get channel values if data type of channel is double (DDC_Double = 10) 
        if strcmp(type,'DDC_Double') 
            numvalsIn = 0; 
231 
            [err,numvals]=calllib(libname,'DDC_GetNumDataValues',chans(j),numvalsIn); 
            %Initialize an array to hold the desired number of values 
            pvals=libpointer('doublePtr',zeros(1,numvals)); 
            [err,vals]=calllib(libname,'DDC_GetDataValues',chans(j),0,numvals,pvals); 
            setdatatype(vals,'doublePtr',1,numvals); 
             
            %Add channel values to a matrix. The comment, #ok<AGROW>, at 
            %the end of the line prevents warnings about the matrix needing  
            %to allocate more memory for the added values. 
              chanvals(:,j)=(vals.Value); %#ok<AGROW> 
%              chanvals(:,j)=single((vals.Value)); %#ok<AGROW> 
        end 
             
    end 
    %next line added to halve memory usage - RV 
    chanvals = single(chanvals); 
%%    %Plot Data from channels in this group 
    %test if length is doable - RV 
    if(length(chanvals)>1000000) 
        xIDX = 1:1000:length(chanvals); 
        figure 
        plot(xIDX, chanvals(xIDX)); 
    else 
        figure 
        plot(chanvals); 
    end 
%     clear chanvals; 
%     legend(channames); 
end 
  
%Close file 
err = calllib(libname,'DDC_CloseFile',file); 
  
%Unload nilibddc.dll 
unloadlibrary(libname); 
 
hd_zpf.m 
 
function [f,amp]=hd_zpf(datai,Fsi,B) 
%This function takes an original data signal ('data') and will zero-pad the 
%data times B and decimate it by B to keep the same number of points. 
%Consequently, the sampling rate (Fs) will go down by a factor of B.  
global amp 
global f 
%Calculate the length of the data and pad the end of the original data  
%signal by a factor of B and then decimate to keep the number of data  
%points the same. 
data=datai; 
L=length(data); 
data=[data zeros(1,L*(B-1))]; 
data=decimate(data,B);    
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%Filter the data using fftfilt. P is the filter at 48th order 
%p=fir1(48,.000005,'low'); 
%data=fftfilt(p,data); 
  
%Detrend the data (get rid of DC-offset) 
data=detrend(data, 0); 
  
% Next power of 2 from length of y and calculate the fft 
NFFT = 2^nextpow2(L);  
Y = fft(data,NFFT)/L; 
Fs=Fsi/B; 
f = Fs/2*linspace(0,1,NFFT/2+1); 
amp=2*abs(Y(1:NFFT/2+1)); 
  
% Plot the orginal signal, filtered signal, and the single-sided  
%amplitude spectrum. 
%ORIGINAL SIGNAL% 
figure(1); 
subplot(2,1,1); plot(1:length(datai),datai) 
title('Time Domain of y(t) [Original]','FontWeight','bold') 
xlabel('Time') 
ylabel('V') 
                    %Filtered SIGNAL% 
                    %subplot(2,2,2); plot(1:(L/B),data(1:(L/B))) 
                    %title('Time Domain of y(t) [Filtered]','FontWeight','bold') 
                    %xlabel('Time') 
                    %ylabel('V') 
%FFT SIGNAL% 
subplot(2,1,2);plot(f,amp) 
%xlim(subplot(2,1,2),[0 0.02]); 
title('Single-Sided Amplitude Spectrum of y(t)','FontWeight','bold') 
xlabel('Frequency (Hz)') 
ylabel('|Y(f)|') 
  
end 
hd_zpfcorr.m 
 
function [f,amp]=hd_zpfcorr(datai,Fsi,B, P1, P2) 
%This function takes an original data signal ('data') and will zero-pad the 
%data times B and decimate it by B to keep the same number of points. 
%Consequently, the sampling rate (Fs) will go down by a factor of B.  
global amp 
global f 
%Calculate the length of the data and pad the end of the original data  
%signal by a factor of B and then decimate to keep the number of data  
%points the same. 
data=datai; 
t=1:1:length(datai); 
%data=zeros(1,length(datai)); 
  
% v=zeros(1,length(datai)); 
for ii=1:1:length(datai) 
v(ii)=(2+sin(2*pi*(t(ii)/Fsi)*(1/P1))+sin(2*pi*(t(ii)/Fsi)*(1/P2)))/40; %/40; 
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end 
% length v 
% datai=datai'; 
% data=datai.*v; 
%  
L=length(data); 
% data=[data zeros(1,L*(B-1))]; 
% data=decimate(data,B); 
for jj=1:length(datai) 
    data(jj)=datai(jj)*v(jj); 
end 
  
  
%Filter the data using fftfilt. P is the filter at 48th order 
%p=fir1(48,.000005,'low'); 
%data=fftfilt(p,data); 
  
%Detrend the data (get rid of DC-offset) 
data=detrend(data, 0); 
  
% Next power of 2 from length of y and calculate the fft 
NFFT = 2^nextpow2(L);  
Y = fft(data,NFFT)/L; 
Fs=Fsi/B; 
f = Fs/2*linspace(0,1,NFFT/2+1); 
amp=2*abs(Y(1:NFFT/2+1)); 
  
% Plot the orginal signal, filtered signal, and the single-sided  
%amplitude spectrum. 
%ORIGINAL SIGNAL% 
figure(1); 
subplot(3,1,1);  
plot(1:length(datai),datai, 'Color','b') 
title('Time Domain of y(t) [Original]','FontWeight','bold') 
xlabel('Time') 
ylabel('V') 
                    %Filtered SIGNAL% 
                    %subplot(2,2,2); plot(1:(L/B),data(1:(L/B))) 
                    %title('Time Domain of y(t) [Filtered]','FontWeight','bold') 
                    %xlabel('Time') 
                    %ylabel('V') 
subplot(3,1,2);  
plot(1:length(data),data, 'Color','m') 
title('Time Domain of y(t) [Original]','FontWeight','bold') 
xlabel('Time') 
ylabel('V') 
                     
                     
                    %FFT SIGNAL% 
  
subplot(3,1,3); 
plot(f,amp) 
%xlim(subplot(2,1,2),[0 0.02]); 
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title('Single-Sided Amplitude Spectrum of y(t)','FontWeight','bold') 
xlabel('Frequency (Hz)') 
ylabel('|Y(f)|') 
  
end 
 
 
hd_zpfcorr3.m 
 
function [f,amp]=hd_zpfcorr(datai,Fsi,B,P1,P2,P3) 
%This function takes an original data signal ('data') and will zero-pad the 
%data times B and decimate it by B to keep the same number of points. 
%Consequently, the sampling rate (Fs) will go down by a factor of B.  
global amp 
global f 
%Calculate the length of the data and pad the end of the original data  
%signal by a factor of B and then decimate to keep the number of data  
%points the same. 
data=datai; 
t=1:1:length(datai); 
%data=zeros(1,length(datai)); 
  
% v=zeros(1,length(datai)); 
for ii=1:1:length(datai) 
v(ii)=(3+sin(2*pi*(t(ii)/Fsi)*(1/P1))+sin(2*pi*(t(ii)/Fsi)*(1/P2))+sin(2*pi*(t(ii)/Fsi)*(1/P3)))/60; 
end 
% length v 
% datai=datai'; 
% data=datai.*v; 
%  
L=length(data); 
% data=[data zeros(1,L*(B-1))]; 
% data=decimate(data,B); 
for jj=1:length(datai) 
    data(jj)=datai(jj)*v(jj); 
end 
  
  
%Filter the data using fftfilt. P is the filter at 48th order 
%p=fir1(48,.000005,'low'); 
%data=fftfilt(p,data); 
  
%Detrend the data (get rid of DC-offset) 
data=detrend(data, 0); 
  
% Next power of 2 from length of y and calculate the fft 
NFFT = 2^nextpow2(L);  
Y = fft(data,NFFT)/L; 
Fs=Fsi/B; 
f = Fs/2*linspace(0,1,NFFT/2+1); 
amp=2*abs(Y(1:NFFT/2+1)); 
  
% Plot the orginal signal, filtered signal, and the single-sided  
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%amplitude spectrum. 
%ORIGINAL SIGNAL% 
figure(1); 
subplot(3,1,1);  
plot(1:length(datai),datai, 'Color','b') 
title('Time Domain of y(t) [Original]','FontWeight','bold') 
xlabel('Time') 
ylabel('V') 
                    %Filtered SIGNAL% 
                    %subplot(2,2,2); plot(1:(L/B),data(1:(L/B))) 
                    %title('Time Domain of y(t) [Filtered]','FontWeight','bold') 
                    %xlabel('Time') 
                    %ylabel('V') 
subplot(3,1,2);  
plot(1:length(data),data, 'Color','m') 
title('Time Domain of y(t) [Original]','FontWeight','bold') 
xlabel('Time') 
ylabel('V') 
                     
                     
                    %FFT SIGNAL% 
  
subplot(3,1,3); 
plot(f,amp) 
%xlim(subplot(2,1,2),[0 0.02]); 
title('Single-Sided Amplitude Spectrum of y(t)','FontWeight','bold') 
xlabel('Frequency (Hz)') 
ylabel('|Y(f)|') 
  
end 
 
 
fft_corrector_og.m 
 
function [amp,f]=FFT_corrector_og(datai,Fsi,B,w1,w2) 
%This function takes an original data signal ('data') and will zero-pad the 
%data times B and decimate it by B to keep the same number of points. 
%Consequently, the sampling rate (Fs) will go down by a factor of B.  
global amp 
global f 
%Calculate the length of the data and pad the end of the original data  
%signal by a factor of B and then decimate to keep the number of data  
%points the same 
  
data=(datai); 
t=1:1:length(data); 
for ii=1:length(datai) 
data(ii)=datai(ii)*(2+sin(2*pi*w1*t(ii)/Fsi)+sin(2*pi*w2*t(ii)/Fsi))/40;  
end 
L=length(data); 
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%Filter the data using fftfilt. P is the filter at 48th order 
%p=fir1(48,.000005,'low'); 
%data=fftfilt(p,data); 
  
%Detrend the data (get rid of DC-offset) 
%data=detrend(data, 0); 
  
% Next power of 2 from length of y and calculate the fft 
NFFT = 2^nextpow2(L);  
Y = fft(data,NFFT)/L; 
Fs=Fsi/B; 
f = Fs/2*linspace(0,1,NFFT/2+1); 
amp=2*abs(Y(1:NFFT/2+1)); 
  
% Plot the orginal signal, filtered signal, and the single-sided  
%amplitude spectrum. 
%ORIGINAL SIGNAL% 
figure(1); 
subplot(3,1,1);  
plot(1:length(datai),datai, 'Color','b') 
title('Time Domain of y(t) [Original]','FontWeight','bold') 
xlabel('Time') 
ylabel('V') 
                    %Filtered SIGNAL% 
                    %subplot(2,2,2); plot(1:(L/B),data(1:(L/B))) 
                    %title('Time Domain of y(t) [Filtered]','FontWeight','bold') 
                    %xlabel('Time') 
                    %ylabel('V') 
subplot(3,1,2);  
plot(1:length(data),data, 'Color','m') 
title('Time Domain of y(t) [Original]','FontWeight','bold') 
xlabel('Time') 
ylabel('V') 
                     
                     
                    %FFT SIGNAL% 
  
subplot(3,1,3); 
plot(f,amp) 
%xlim(subplot(2,1,2),[0 0.02]); 
title('Single-Sided Amplitude Spectrum of y(t)','FontWeight','bold') 
xlabel('Frequency (Hz)') 
ylabel('|Y(f)|') 
  
end 
 
 
FFT_correcctor_new.m 
 
function [amp,f]=FFT_correcctor_new(datai,Fsi,B,w1,w2) 
%This function takes an original data signal ('data') and will zero-pad the 
%data times B and decimate it by B to keep the same number of points. 
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%Consequently, the sampling rate (Fs) will go down by a factor of B.  
global amp 
global f 
%Calculate the length of the data and pad the end of the original data  
%signal by a factor of B and then decimate to keep the number of data  
%points the same 
 
data=(datai); 
t=1:1:length(data); 
for ii=1:length(datai) 
v(ii)=(2+sin(2*pi*w1*t(ii)/Fsi)+sin(2*pi*w2*t(ii)/Fsi))/40; 
end 
L=length(data); 
 
for jj=1:length(datai) 
data(jj)=datai(jj)/v(jj); 
end 
 
 
% Next power of 2 from length of y and calculate the fft 
NFFT = 2^nextpow2(L);  
Y = fft(data,NFFT)/L; 
Fs=Fsi/B; 
f = Fs/2*linspace(0,1,NFFT/2+1); 
amp=2*abs(Y(1:NFFT/2+1)); 
 
 
figure(1); 
subplot(3,1,1); 
plot(1:length(datai),datai,'Color','b') 
title('Time Domain of y(t)','FontWeight','bold') 
xlabel('Time') 
ylabel('V') 
                    %Filtered SIGNAL% 
                    %subplot(2,2,2); plot(1:(L/B),data(1:(L/B))) 
                    %title('Time Domain of y(t) [Filtered]','FontWeight','bold') 
                    %xlabel('Time') 
                    %ylabel('V') 
%FFT SIGNAL% 
subplot(3,1,2); 
plot(1:length(data),data,'Color','m') 
xlabel('Time') 
ylabel('V 
 
subplot(3,1,3); 
plot(f,amp) 
%xlim(subplot(2,1,2),[0 0.02]); 
title('Single-Sided Amplitude Spectrum of y(t)','FontWeight','bold') 
xlabel('Frequency (Hz)') 
ylabel('|Y(f)|') 
 
%xlim(subplot(2,1,2),[0 0.02]); 
end  
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APPENDIX G 
 
G PUMP CALIBRATION ANOVA 
 
G.1 Raw Data Table  
Q2b (uL/min) Q2a (uL/min) Q4b (uL/min) Q4a (uL/min) Q1 (uL/min) Q3b (uL/min) Q3a (uL/min) 
Pump 2b Pump 2a Pump 4b Pump 4a Pump 1 Pump 3b Pump 3a 
2.8184 2.4566 2.3476 2.5064 2.2621 2.1767 2.7635 
2.7482 2.607 2.6136 2.7536 2.3611 2.4784 2.7822 
2.3179 2.7936 1.6395 2.1137 1.8809 1.562 2.1831 
2.6041 2.4735 2.4387 3.1846 2.5238 2.2723 3.0625 
2.8517 2.655 2.67 2.6605 2.0218 2.3777 2.7085 
2.0152 2.7215 1.9499 2.3018 2.0099 1.3597 2.2359 
2.7716 2.4476 2.4969 3.0116 2.3665 2.303 2.9464 
2.7934 2.6915 2.5114 2.4273 1.8325 2.3673 2.4115 
2.3198 2.5429 1.9704 2.5198 2.3682 1.4521 2.3051 
2.8016 2.4523 2.5948 2.6083 2.0775 2.3482 2.9365 
2.6291 2.6393 2.4678 2.4959 1.8076 2.3631 2.2816 
2.2301 2.414 1.9898 2.7232 2.4816 1.7185 2.6274 
2.8624 2.4912 2.6588 2.3808 2.0019 2.4364 2.8019 
2.534 2.5849 2.3748 2.5959 2.2669 2.4529 2.4391 
2.2983 2.2898 2.0555 2.645 2.0522 1.813 2.3383 
2.9737 2.5229 2.7275 2.2156 2.145 2.518 2.6958 
2.5001 2.5675 2.2929 2.6667 2.3273 2.1587 2.1815 
2.3575 2.196 2.1062 2.5579 1.8135 1.9184 2.6213 
2.9142 2.5263 2.7493 2.3371 2.5881 2.5329 2.5287 
2.4397 2.3523 2.1908 2.8156 2.0088 2.0752 0.6635 
2.4127 2.1998 2.1915 2.3148 2.0663 2.0389 2.606 
2.8551 2.6415 2.7791 2.5642 2.3227 2.5088 2.4203 
2.4006 2.4111 2.0838 2.8314 1.8487 2.0252 2.3482 
2.5219 2.1486 2.2462 2.184 2.3671 2.1604 2.7305 
2.7804 2.636 2.7496 2.8651 1.9223 2.4902 2.2962 
2.3883 2.3379 2.015 2.7341 2.058 1.9776 2.4059 
2.5811 2.1368 2.316 2.1258 2.3223 2.262 2.7529 
2.665 2.669 2.7035 3.1227 1.7942 2.4512 2.2674 
2.4022 2.2578 1.9488 2.5528 2.3667 1.9445 2.4136 
2.6663 2.2342 2.4056 2.2174 2.0461 2.4467 2.6009 
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2.5456 2.7056 2.6732 3.2434 2.1164 2.3941 2.2658 
2.4541 2.177 1.8921 2.3325 2.3981 1.9974 2.5919 
2.7245 2.3074 2.4684 2.47 1.8963 2.479 2.5759 
2.4036 2.7053 2.588 3.2319 2.4516 2.327 2.2952 
2.5262 2.138 1.8746 2.1478 2.0822 1.9746 2.7035 
2.7953 2.3531 2.5848 2.8192 2.0787 2.5578 2.5585 
2.3911 2.6768 2.5294 3.0702 2.309 2.2387 2.3425 
2.6497 2.0588 1.8989 2.0491 2.0482 1.9787 2.6973 
2.7892 2.438 2.6795 2.9988 2.5215 2.5868 2.3238 
2.3135 2.6434 2.4522 2.725 2.0334 2.1369 2.4296 
2.7429 2.0499 1.9097 2.0118 2.274 2.0098 2.7397 
2.7867 2.5232 2.747 3.0576 2.4851 2.591 2.24 
2.3019 2.5675 2.3754 2.4423 1.817 2.0656 2.575 
2.8718 2.0462 1.9391 2.1009 2.5104 2.0544 2.7265 
2.7215 2.5956 2.7939 2.934 2.0627 2.572 2.14 
2.3177 2.5114 2.2578 2.2646 1.93 1.9902 2.6691 
2.9747 1.9989 1.9777 2.3741 2.4643 2.1141 2.6189 
2.6259 2.6627 2.825 2.694 1.9325 2.5413 2.089 
2.3079 2.4465 2.1502 2.2922 3.4722 1.9222 2.8461 
2.9911 2.0871 2.0132 2.47 4.4082 2.1744 2.8967 
2.4972 2.7036 2.8349 2.4379 2.1545 2.4934 2.1319 
2.3719 2.3525 2.0535 2.402 2.4176 1.8757 2.9802 
3.1089 2.14 2.0687 2.4957 2.0621 2.2192 2.5087 
2.7179 2.6753 2.8258 2.2464 2.329 2.4008 2.2262 
2.4574 2.2571 1.9931 2.6099 2.0074 1.817 3.0282 
3.1308 2.2266 2.1319 2.3221 2.3436 2.2609 2.3436 
2.3038 2.6297 2.7865 2.2473 2.3367 2.3218 2.2532 
2.5433 2.1717 1.9305 2.8913 1.8543 1.7935 3.0019 
3.1454 2.3197 2.22 2.0722 2.6215 2.3244 2.2183 
2.2321 2.6197 2.7395 2.7858 1.8434 2.2316 2.3944 
2.6575 2.1418 1.8864 2.9013 2.0287 1.7955 2.9546 
3.112 2.3816 2.3038 1.7725 2.3415 2.3666 2.1047 
2.189 2.6075 2.6712 2.5996 1.8286 2.1491 2.5336 
2.785 2.0421 1.8685 2.9652 2.3106 1.8086 2.862 
3.0421 2.5571 2.3989 1.6858 1.9561 2.4188 2.8993 
2.2001 2.4743 2.5917 2.878 2.0028 2.0649 2.5272 
2.9095 2.0461 1.856 2.735 2.3152 1.8146 2.6392 
3.5236 2.6136 2.4812 1.8233 1.8255 2.4165 2.1568 
2.0061 2.3764 2.4846 3.0685 2.316 1.9762 2.8109 
2.9745 2.0534 1.8802 2.551 2.0292 1.832 2.5558 
2.8243 2.6634 2.5669 2.0781 2.1019 1.9258 2.1527 
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2.3162 2.3161 2.3806 3.1356 2.4569 2.2674 2.8205 
3.0912 2.0882 1.912 2.2824 1.8603 1.8936 2.4234 
2.7187 2.6818 2.6415 2.4649 2.4373 2.4022 2.2571 
2.4073 2.2452 2.2793 2.9374 2.1173 1.888 2.8173 
3.121 2.1275 1.9489 2.1233 2.2395 1.9453 2.3139 
2.5546 2.6808 2.6632 2.8752 2.4228 2.3659 2.3765 
2.524 2.1902 2.1492 2.7706 1.9751 1.8493 2.7833 
3.1203 2.2038 2.0015 2.2088 2.6652 1.9917 2.275 
2.4937 2.6525 2.7093 3.1026 2.0592 2.3678 2.4682 
2.6815 2.1385 2.0528 2.5314 2.2246 1.8505 2.5843 
3.0861 2.2562 2.0735 2.3557 2.5701 2.1225 2.2312 
2.3478 2.5621 2.7273 3.1449 1.7676 2.2003 2.5613 
2.7497 2.0857 1.9828 2.3499 2.4868 1.9646 2.597 
3.0271 2.3092 2.1364 2.5837 2.1256 2.282 2.3156 
2.2907 2.4775 2.7022 2.8823 1.8476 2.2057 2.6923 
2.9448 2.0728 1.9238 2.2666 2.3395 2.6879 2.4958 
2.9563 2.3856 2.2319 2.8341 1.8444 0.5896 2.3602 
2.2687 2.4031 2.679 2.5501 2.1341 2.1053 2.7029 
3.0471 2.0655 1.8742 2.3207 1.9956 1.9697 2.4187 
2.847 2.4384 2.3086 2.9056 2.0002 2.3172 2.4896 
 
G.2 ANOVA Results 
Anova: Single Factor 
      
       
SUMMARY 
      
Groups Count Sum Average Variance 
  
Pump 2b 91 241.0157 2.648524 0.089395 
  
Pump 2a 91 218.2247 2.398074 0.048721 
  
Pump 4b 91 210.8672 2.317222 0.103415 
  
Pump 4a 91 232.9577 2.559975 0.123016 
  
Pump 1 91 200.1993 2.199992 0.128581 
  
Pump 3b 91 195.2694 2.145818 0.101499 
  
Pump 3a 91 227.9487 2.504931 0.100034 
  
       
ANOVA 
      
Source of Variation SS df MS F P-value F crit 
Between Groups 19.08649 6 3.181082 32.05536 9.98E-34 2.112954 
Within Groups 62.5194 630 0.099237 
   
       
Total 81.60589 636         
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